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ABSTRACT
Morphogenesis is the process which will define the final form of an organism 
by a series of complex cellular events such as cell division, shape changes and 
migration, events that require the coordinated modification of the cytoskeleton. The 
cytoskeleton is mainly regulated by the Rho family of small GTPases. The Guanine 
Nucleotide Exchange Factor, DRhoGEF2, is an activator of Rho 1 and it is essential for 
morphogenetic cell shape changes.
Signalling through DRhoGEF2 seems to be restricted to a specific area in the 
cell. One major question in the field is the mechanism by which the activity of 
RhoGEFs is spatially and temporally limited. The multidomain nature of DRhoGEF2 
provides the framework for a tight regulation and the participation in a protein network.
The activity of the distinct structural elements of DRhoGEF2 has not been 
completely elucidated. This thesis investigates the role of the PDZ domain for the 
function of DRhoGEF2. Preliminary results indicate that the PDZ domain acts as a 
positive regulator. In addition, an interaction has recently been discovered between the 
DRhoGEF2 PDZ domain and the novel protein DMec2. This thesis explores the 
functional significance of DMec2 and in particular its putative contribution to 
morphogenesis through its interaction with DRhoGEF2. Overexpression and 
elimination of DMec2 does not alter the actin nor microtubule cytoskeleton and ectopic 
expression does not produce any obvious phenotypes therefore its role remains obscure. 
Furthermore, DMec2 binds to the PDZ domain however there is no indication of a 
functional relevance of this interaction. This work suggests further study to explore the 
integration of signals by the PDZ domain of DRhoGEF2.
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Chapter 1: Introduction
Chapter 1: INTRODUCTION
1. MORPHOGENESIS
Morphogenesis is the process by which the mature forms of a cell, tissue, organ, 
or organism develop. In the beginning the embryo consists of a large number of cells 
with the same genetic content. The development starts by the establishment of anterior- 
posterior and dorsal-ventral axes more or less perpendicular to each other (Leptin, 
2005). The axis patterning determines regions within the embryo allowing specific 
transcription factors to differentiate the various cell groups and give rise to the germ 
layers (Leptin, 1995). During development the cells go through morphogenetic 
movements requiring a precise coordination of the cells’ cytoskeletal and adhesive 
properties in order to change their shape, intercalate and migrate to give rise to the final 
form of an organism.
In order to function as a coordinated tissue, cells must have the right shape and 
structure to pack all together. Furthermore, differentiated cells have morphological 
features that reflect their specialised functions in the organs they are part of. Having 
various surface architectures the cells can carry out different specialised functions. 
Therefore, as cell shape is intrinsically related to cell function, it is necessary to 
understand the mechanism by which components of the cytoskeleton get reorganised 
during morphological modification.
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1.1 Gastr illation
One process during which conspicuous cell shape changes occur is gastrulation. 
Gastrulation is a developmental process in embryos of multicellular organisms by 
which the presumptive mesoderm and endoderm move inside the ectoderm to form a 
three-layered embryo consisting of the ectoderm on the outside, the endoderm on the 
inside, and the mesoderm in between the ectoderm and endoderm. The mesoderm will 
form the future middle layer of the adult body plan, the endoderm will form the future 
lining of the gut, and the ectoderm will form the adult integument and nervous system.
A hallmark event during Drosophila gastrulation is invagination of the 
mesodermal precursor cells initiated by the formation of a ventral furrow (Fig. 1.1). 
Ventral furrow formation in Drosophila embryos occurs in a stripe about 10 cells wide 
along the ventral midline (Leptin, 1995). First the cell apices flatten, then the apical 
plasma membrane slowly constricts, followed by a random faster constriction resulting 
in formation of a shallow groove and compressing the cells’ contents to the basal side. 
The cells assume a wedge shape as the apical side remains constricted, and the basal 
side extends. The cells then shorten along the apical-basal axis causing further basal 
extension and deepening of the furrow (Fig. 1.1). At the end as the furrow closes, the 
invaginated mesodermal cells undergo an epithelial-to-mesenchymal transition (Leptin, 
1995). One protein that is required for gastrulation is DRhoGEF2. The intriguing 
feature of the ventral furrow formation is that this constriction happens in a very limited 
number of cells while DRhoGEF2 is ubiquitously expressed. One possibility for the 
localised cell shape changes is that DRhoGEF2 is shuttled apically and therefore 
activates Rhol only locally.
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Figure 1.1: Schematic representation of the cell 
shape changes as they occur in Drosophila 
gastrulation. (Picture taken from Leptin, 1999)
However, it is not known how DRhoGEF2 might be localised apically. One hypothesis 
is that it is recruited by pH- spectrin, whose apical localisation becomes particularly 
strong during ventral furrow formation (Thomas and Kiehart, 1994). Another 
possibility is, being a multidomain protein, one of its domains, for instance the PDZ 
(Postsynaptic density protein/Discs Large/ Zonula occludens), PH (Pleckstrin 
Homology) or Cl domain (phorbol ester/diacylglycerol (DAG)-binding), could be 
targeting it to specific locations in the plasma membrane. Understanding how 
DRhoGEF2 gets localised is very important because this specific localisation could be 
important for restricting the activation of Rho GTPase to membrane subdomains, 
thereby eliciting specific cell shape changes to a limited area.
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Figure 1.2: The Rhol-mediated pathway for cell shape changes during Drosophila 
gastrulation.
(Picture taken from Schmidt and Hall, 2002)
1.2 The actin cytoskeleton
The actin network provides the basis for the cellular architecture and a scaffold 
for the recruitment of regulatory factors all of which generate and maintain the cell 
form. The major component of the cytoskeleton is actin, an ATP-binding protein that 
exists as a globular monomer called G-actin and as a filamentous polymer called F- 
actin. Actin polymerisation starts with the nucleation of a few free actin monomers 
aided by the Arp2/3 complex and continues by the addition of more monomers in one 
direction so that the newly created filaments are bestowed with a polarity by virtue of 
the two ends with distinct biochemical properties (Welch and Mullins, 2002). Then the 
actin filaments are organized into bundles and networks. The Arp2/3 complex promotes
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also the formation of branched actin filament networks (Welch and Mullins, 2002). The 
Rho family of small GTPases has a well established role in regulating the actin 
cytoskeleton. Rac and Cdc42 both initiate peripheral actin polymerisation (i.e. branched 
filament network) through the Arp2/3 complex via WAVE (a WASP family protein) 
and WASP respectively but leading to morphologically distinct protrusions at the 
plasma membrane (Jaffe and Hall, 2005). When microinjected into fibroblasts Rac 
induces membrane ruffling (lamellipodia formation) (Ridley et al., 1992). In contrast, 
Cdc42 promotes the formation of filopodia (Nobes and Hall, 1995). Rho activates 
formins to promote linear elongation or filaments at barbed ends (plus end of the actin 
filament where monomers of actin can be added) (Jaffe and Hall, 2005). When 
microinjected into fibroblasts activated Rho stimulates the formation of actin stress 
fibres and focal adhesions (Ridley and Hall, 1992).
Cell shape changes refer to the modification in one or two dimensions within an 
epithelial sheet and actin polymerisation is the driving force for these changes of the 
cellular form. In addition, actin polymerisation generates contractile structures at the 
cell cortex whereby bipolar assemblies of non muscle myosin II molecules can slide 
actin filaments over each other; this differential actomyosin contractility is supported 
by the spectrin network that recruits the regulators to the apical or basolateral domain 
(Schock and Perrimon, 2002).
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1.3 Microtubule-actin interactions in morphogenesis
Actin and microtubule filament systems coordinate dynamic processes such as 
cell shape changes and shape maintenance. These polarized cytoskeletal polymers 
assemble and disassemble rapidly, and interact with binding proteins and molecular 
motors.
The Rho family of small GTPases regulates both microtubules and actin 
(Whittman and Waterman-Storer, 2001). For example PAK activated by Cdc42/Rac 
can inactivate by phosphorylation members of the Opl8/stathmin family which 
promote catastrophic disassembly and polymerisation of microtubules (Daub et al., 
2001). Microtubules through interactions of their plus ends with proteins at the cell 
cortex such as CLIP-170 and EB-1 whose activity is indirectly regulated by Cdc42 can 
play a major role in defining cell shape and polarity (Jaffe and Hall, 2005).
Rhol mediates formation of contractile actin structures, such as stress fibres 
(Etienne-Manneville and Hall, 2002), and at the same time promotes stabilisation of a 
sub-population of microtubules (Cook et al., 1998). Two key factors are known to 
function downstream of Rhol: Rho kinase, which promotes contractility by increasing 
phosphorylation of the regulatory light chain of myosin-II, and Diaphanous (mDia), 
which regulates actin polymerisation into bundles and also mediates microtubule 
stabilisation (Jaffe and Hall, 2005). In turn, the activity of Rho proteins is regulated 
directly or indirectly by microtubules and actin (Whittman and Waterman-Storer,
2001). For instance, microtubule disassembly activates Rhol by a release .of the 
microtubule-bound Rho guanine nucleotide-exchange factor (GEF) GEF-H1 (Krendel 
et al., 2002).
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2. MECHANICS AND BIOLOGICAL PROCESSES
Gastrulation is considered a biomechanical process in the sense that the cell 
reshaping is intricately dependent on the physical constrains imposed by the 
environment. During its course there are massive tissue rearrangements that could exert 
a force on the surrounding tissues or, conversely, the surrounding tissues or 
extracellular matrix (ECM) components could restrict the cell shape changes feeding 
back to the actin cytoskeleton.
How mechanical forces influence cell shape and consequently cellular processes 
has been gaining a lot of attention. Mechanotransduction is the process by which a 
mechanical stimulus exerted on a cell or tissue elicits a biochemical response (Shyy and 
Chien, 1997; Chicurel, et al., 1998). This happens through a coordination of 
biochemical signalling pathways with permutations of the cytoskeletal organisation. 
The change of the so called “tensegrity” architecture (Ingber, 2003) occurs when a 
mechanical force transduced directly to the underlying cytoskeleton via integrins, alters 
the force balance that exists between the cytoskeleton elements resulting in a change in 
their assembly and organisation (Alenghat and Ingber, 2002). Examples of processes 
influenced by forces that alter the cytoskeletal equilibrium are osteoblast differentiation 
(McBeath et al., 2004), remodelling of vascular endothelial cells due to shear stress 
caused by blood flow (Malek and Izumo, 1996; Nelson et al., 2003), modulation of 
fibroblast morphology during collagen matrix remodelling (Tamariz and Grinnell,
2002), and mechanical stress sensed by cardiac myocytes (Aikawa et al., 1999). In 
another model, mechanosensitive ion channels play a central role in influencing 
biochemical signalling pathways as a consequence of a change in the ion flux after
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being stimulated by perturbed components of the extracellular matrix that deflect the 
plasma membrane (Gillespie and Walker, 2001). Processes such as hearing, touch, 
nociception and proprioception follow this model (Garcia-Anoveros and Corey, 1997; 
Emstrom and Chalfie, 2002).
Different kinds of force elicit different kinds of responses depending on the cell 
type. Mechanical signals can influence for example gene expression. One system where 
mechanical tension influences transcription is the migrating border cells that delaminate 
from the Drosophila follicular epithelium (Somogyi and Rorth, 2004). When the border 
cells are stretched MAL-D, a transcriptional cofactor for serum response factor (SRF), 
translocates from the cytoplasm to the nucleus. However, when these cells could not be 
stretched as happens in mutants of slbo, a gene required for migration and elongation, 
the nuclear translocation was blocked. The nuclear translocation and transcriptional 
activity of the mammalian homologue of MAL-D is also regulated by actin 
polymerisation (Miralles et al., 2003).
Another example showing that a force balance can direct transcriptional events 
in cells comes again from experiments in flies. In a study by Farge (2003) it was firstly 
shown that an artificial external mechanical compression of Drosophila embryos 
caused P-catenin/armadillo to move from the cell membrane, where it associates with 
cadherin, to the nucleus where it can activate expression of twist, which is required for 
the invagination and development of stomodeum. When P-catenin/armadillo was 
inhibited, this stress-induced expression of twist was suppressed. Secondly, the same 
process was studied under normal conditions during embryogenesis. In wild type 
embryos stomodeal cells express twist when the anterior-pole cells feel a compression
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caused by the germ band extension. It was shown that if this compression was 
abolished by photo ablation of the dorsal epithelium so that the pushing of the 
extending germ band was not felt by the anterior-most cells then the stomodeal cells 
failed to switch on twist and no longer invaginated. Failure to invaginate also happens 
with bicoid, nanos, torso-Xiks mutants that do not undergo germ band extension.
Rho GTPases can respond to mechanical forces and induce cell shape changes 
(Aoki et al., 1998; Aikawa et al., 1999; Numaguchi et al., 1999; Katsumi et al., 2002; 
Kole et al., 2004; Kaunas et al., 2005). For example, cell differentiation can be 
determined by the cell shape regulated by modulating endogenous Rhol activity: in an 
activated Rhol-ROCK signalling pathway that generated an actin-myosin tension 
human mesenchymal stem cells (hMSCs) able to adhere and spread, underwent 
osteogenesis, while hMSCs expressing a dominant-negative Rhol, remained round and 
became adipocytes (McBeath et al., 2004). Endothelial cells experience shear stress due 
to the blood flow and this type of force has been shown to activate Rho GTPases (Li et 
al., 1999; Tzima, et al., 2001; 2002; 2003; Wojciak-Stothard and Ridley, 2003). 
Microtubules are also a potential cytoskeletal target influenced by mechanical forces. 
For instance, it was shown that in cultured smooth muscle cells external mechanical 
strain controls microtubule assembly which regulates membrane targeting of Rho 
GTPases (Putnam et al., 2003).
From the above presented evidence it is seen that in mammalian cells Rho 
GTPases have an established role in regulating the actin cytoskeleton due to a 
biochemical signal but also due to a physical force. In Drosophila there is an indication 
that the Rhol activator, DRhoGEF2 interacts with a protein called DMec2 (K. Barrett,
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unpublished data). The fact that Mec2 in C. elegans interacts with a mechanosensitive 
ion channel to relay a mechanical stimulus suggests the possibility that the interaction 
between DRhoGEF2 and DMec2 could provide a link between mechanical cues and 
actin regulation in Drosophila.
3. THE Rho FAMILY OF SMALL GTPases
3.1 Rho GTPases as Signalling Molecules
The Rho GTPases belong to the Ras superfamily of small GTPases that have 
been shown to regulate a variety of cellular processes. The primary structure of these 
proteins has been highly conserved throughout evolution, from yeast to humans 
showing a 50-55% homology to each other (Table 1.1), (Van Aelst and D’ Souza- 
Schorey, 1997). Seven Drosophila Rho GTPases have been identified so far (Table 
1.1). These include Rhol, Racl, Rac2, Cdc42, RhoL, RhoBTB, and Mtl which are 70- 
90% identical in amino acid sequences to their mammalian orthologues (Lu, and 
Settleman, 1999). These GTPases are expressed throughout embryogenesis, and some 
are widely expressed in many tissues (such as Rhol) while others are restricted in the 
mesoderm, gut, and nervous system later in development (such as Racl and Cdc42) 
(Settleman, 2001).
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Table 1.1
Mammals S. cerevisiae S. pombe Drosophila Dictyostilium C. elegans
Rho Rho (A,B,C) Rhol Rhol Rhol RhoA
Rac Rac (1,2,3) Rac (1,2) Rac Rac (1,2)
(1A,1B,B)
Cdc42 Cdc42, Cdc42 Cdc42 Cdc42
G25K
Wrch-1
Others RhoD Rho2 Rho2 RhoL RacA mig2
RhoE/Rndl Rho3 Rho BTB RacC
Rnd2 Rho4 Mtl
Rnd3
RhoG RacD
TC10 RacE
TTF
.15E:1______
Table 1.1: Rho GTPases. Members of the Rho family are listed for mammals and for 
selected model organisms where their function has been analysed in most detail. Some 
of these are grouped into subfamilies based on their homology to mammalian Rho, Rac, 
Cdc42. Other members (Others) are not organised into subfamilies as homologues of 
the mammalian proteins have so far not been identified in other species. Rho2 in S. 
cerevisiae and S. pombe are homologues, however. [.Modified table and legend from  
Ridley, A.J, page 90, GTPases ed. Hall, 2000].
Like all members of the Ras superfamily, the Rho GTPases function as 
molecular switches, cycling between an inactive GDP-bound state and an active GTP- 
bound state (Etienne-Manneville and Hall, 2002). The nucleotide state of Rho family 
proteins is regulated by three classes of regulatory proteins: guanine nucleotide 
exchange factors (GEFs), GTPase activating proteins (GAPs), and guanine nucleotide 
dissociation inhibitors (GDIs) (Etienne-Manneville and Hall, 2002). GEFs catalyse the 
exchange of GDP for GTP by facilitating the release of GDP and transient stabilisation 
of the nucleotide-free protein. GAPs stimulate the relatively weak intrinsic GTP 
hydrolysing capacity of the Rho proteins, thereby enhancing their conversion to the 
GDP-bound form. GDIs preferentially bind to GDP-bound GTPases and prevent 
spontaneous and GEF-catalysed release of the nucleotide, thereby maintaining the
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GTPases in the inactive state. Rho GDI appears to be a molecule capable of blocking 
the GTP binding/GTPase cycle at two points: at the GDP/GTP exchange step and at the 
GTP hydrolytic step (Van Alest and D ’ Souza-Schorey, 1997).
3.2 Activation of Rho GTPases
The upstream signalling pathways that lead to activation of the Rho GTPases 
are under intense investigation. Various receptors such as the seven transmembrane- 
domain family of receptors linked to heterotrimeric G protein (e.g. LPA, bradykinin, 
and bombesin), cytokine and adhesion receptors or growth factor receptors (e.g. PDGF, 
and insulin) may be required for activating Rho GTPases (Van Aelst and Souza- 
Schorey, 1997) to elicit a variety of cellular responses (Fig. 1.3). Other examples of 
receptors and ligands that lead to activation of Rho include the Plexin receptors and 
their ligands the Semaphorins which can activate Rho to induce neuronal specific 
outcomes (Hu, et al., 2001; Liu and Strittmatter, 2001; Swiercz et al., 2002). The T-cell 
receptor (TCR) can activate the Rho signalling pathway required for maturation from 
early to late pre-T-cell (Cantrell, 1994; Cleverley et al., 1999).
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Figure 1.3: Upstream activation, 
regulation and downstream targets of 
the Rho signaling pathway. Various 
extracellular stimuli via different 
kind of receptors trigger the 
activation Rho GTPases and elicit 
specific responses. Rho cycles 
between an active and an inactive 
state which is regulated by GEFs, 
GAPs, and GDIs, (figure taken from 
Zheng, 2001).
Upon activation, Rho GTPases change their conformation thereby allowing the 
binding of different partner proteins. GEFs stimulate the dissociation of the tightly 
bound GDP nucleotide from the small GTP-binding protein in response to upstream 
signals. This reaction involves several stages (Fig. 1.4). First, the GEF forms a low 
affinity, docking complex with the GDP-bound small GTP-binding protein. Upon 
dissociation of GDP from this initial complex, a high affinity complex is formed 
consisting of GEF-small-GTP-binding-protein. This intermediate does not accumulate 
in the cell because it is rapidly dissociated by GTP (Cherfils and Chardin, 1999; Snyder 
et al., 2002). Thus GEFs can destabilise the strong interaction with GDP and stabilise 
the nucleotide-free small GTP-binding protein.
A B C D  E
G-GDP G -G DP-G EF «—► G-GEF <«—► G -G TP-G EF «— ► G-GTP
Figure 1.4: The guanine-nucleotide-excahange reaction. Small GTP-binding proteins 
and GEFs. The small GTP-binding proteins adopt different conformations in the 
complexes A, C, and E and possibly also at stages B and D.
(Figure and modified legendfrom Cherfils and Chardin, 1999).
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An exception to this circular mode of activation of Rho GTPases is Wrch-1 
which shares sequence and functional similarity with the Cdc42 small GTPase (Shutes 
et al., 2004). Wrch-1 is upregulated by Wntl signalling and it is able to promote 
formation of filopodia and activate the PAK serine/threonine kinase (Tao et al., 2001). 
Wrch-1, unlike Cdc42, possesses a high intrinsic guanine nucleotide exchange rate and 
its N- terminus acts as a negative regulator for its activity (Shutes et al., 2004); it is the 
interaction with the adaptor protein Grb2 that relieves this inhibition to promote Wrch- 
1 effector activation (Shutes et al., 2004).
3.3 Targeting of Rho proteins to their effectors.
The current theory is that Rho GTPases are primarily cytosolic and that they 
shuttle from the cytosol, where they are probably inactive, to specific membrane sites 
where they activate their effectors (Fukata & Kaibuchi, 2001). The Rho GDIs seem to 
have a crucial role in the translocation of the Rho GTPases between membranes and the 
cytoplasm. In resting cells, GDIs maintain Rho GTPases as soluble cytosolic proteins 
by masking their geranyl-geranyl membrane-targeting moiety present at the C-terminus 
(DerMardirossian and Bokoch, 2005). On activation the Rho GTPases are released 
from the GDI and targeted to the membrane microdomains through isoprenylated C- 
terminus by specific geranyl-geranyl transferases (GGTases) or famesyl-transferases 
(FTases) (DerMardirossian and Bokoch, 2005). These membrane sites can be adherens 
junctions, cell-matrix adhesion sites, or intracellular membranes involved in vesicle 
targeting.
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How do GTPases get to these specific intracellular sites and how are they 
retained there? GEFs could be recruiting GTPases to specific places of the plasma 
membrane through interaction with other proteins which are localised to the plasma 
membrane. For instance, PDZ-GEF1, a RhoGEF for the Rapl GTPase (de Rooj et al.,
1999), binds to p catenin and colocalises with P catenin at adherens junctions in MDCK 
epithelial cells (Kawajiri et al., 2000). GEFs contain domains that are involved in 
localisation of proteins to the plasma membrane such as PDZ domains (Jelen et al., 
2003) and PH domains. Tiaml, a GEF specific for Rac, contains both a PDZ and 
Pleckstrin homology (PH) domain and is localised to adherens juctions by virtue of its 
PH domain (Hordijk et al., 1997). Moreover, Tiam 1 localises to adherens junctions in 
epithelial MDCK cells but in migrating cells is found in lamellipodia (Sander et al., 
1998). This provides evidence that the GTPases can be recruited to different subcellular 
locations depending on the conditions. RhoGEFs being multidomain proteins could be 
creating a compact signal transduction centre by recruiting to specific places both the 
GTPases and their downstream effectors.
Upon recruitment to the right place in the plasma membrane and activation to 
the GTP-bound form, GTPases undergo a conformational change that enables the 
interaction with so-called downstream effector targets, which contribute to the cellular 
response to GTPase activation. Many of the putative GTPase effector targets are protein 
kinases. For example, the Rho GTPase associates specifically with several identified 
protein kinases, including the PKC-related PKN (Watanabe et al., 1996; Amano et al.,
1996) and PRK2 kinases (Quilliam et al., 1996), the ROK (Rho kinase) family of 
serine/threonine kinases (Vincent and Settleman, 1997), and the kinase called Citron
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(Zhao and Manser, 2005) (Fig. 1.5). The closely related Rac and Cdc42 GTPases 
associate with a distinct family of kinases referred to as PAK (p21-activated) kinases 
among other kinases, summarised in Fig. 1.6.
Rho
PIP5
Kinase
Rhotekin Rhophilin PKN 
PRK2
citron ROK MBS p140mDia
i
actin reorganisation
actin reorganisation stress fiber formation 
focal adhesion formation
Figure 1.5: Mammalian targets of RhoA. The kinases PKN and PRK2, and the non­
kinases Rhotekin and Rhophilin contain a homolgous Rho-binding motif, whereas ROK 
(Rho Kinase/ROKa and p 160ROCK/ROKp/ROCK II) and citron share a distict Rho- 
binding motif. MBS (myosin-binding subunit of myosin light chain phosphatase). The 
PIP5 kinase interaction may not be direct. (Modifiedpicture and legend from Van Aelst 
and D ’ Souza-Schorey, 1997).
Different targets of Rho bind to different parts of the protein, which can be 
divided in three regions: the amino terminal part, aminoacids 23-40, called switch I, is 
the binding region for a class of effectors that include the kinase citron (Fujisawa et al., 
1998). The second region spanning from amino acids 75-92, called switch II, is the 
binding region for yet another class of molecules, such as the non-kinase molecule, 
rhophilin (Fujisawa et al., 1998). A third region between amino acids 92-119 together 
with switch I and II, are required for a third type of target, which is the different 
isoforms of the kinase ROK (Fujisawa et al., 1998). It is possible that when one target
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Figure 1.6: Mammalian targets of Rac and Cdc42. Rac and Cdc42 interact with a 
variety of common targets. The serine/threonine kinases belonging to the PAK family, 
MLK3, MEKK4, MSE55, and WASP share a common Rac/Cdc42 binding motifs; 
(PORI) partner of Rac; (IQGAP) GAP-containing Ile-Gln motifs. ‘PRK2, ‘citron, and 
‘ROK also interact with Rho. (Modified picture and legend from Van Aelst and D ’ 
Souza-Schorey, 1997).
is bound to Rho, it can mask the binding site of other targets, as in the case of PKN 
which when bound to Rho probably blocks the site involved in the binding with 
Diaphanous (Flynn et al., 1998; Maesaki et al., 1999). Many of these proteins exhibit 
specific interactions with a particular Rho GTPase, although a few of them appear to be 
shared among different Rho proteins. Thus it has been difficult to establish the 
mechanisms by which signalling specificity is achieved in vivo.
3.4 Biological Functions mediated by Rho GTPases
Rho proteins regulate many cellular processes such as differentiation (Takano et 
al., 1998), cell morphology (Moorman et al., 1999), cell motility and adhesion 
(Kaibuchi et al., 1999), phagocytosis (Chimini et al., 2000), cytokinesis (Prokopenko et
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al., 2000), and smooth muscle contraction (Somlyo et al., 2000). Studies have shown 
not only how individual Rho family GTPases mediate multiple temporally and spatially 
distinct developmental processes but also how the coordinated action of multiple Rho 
GTPases can sometimes be used to accomplish a single morphogenetic process.
3.4.1 Rho and the early Drosophila embryo
The Drosophila embryo initially consists of a syncytial of individual nuclei that 
subsequently are going to be enveloped by plasma membrane recruited from the 
cytoplasm (Lecuit and Wieschaus, 2000). For cellularisation, a process that involves 
reorganisation of the actomyosin cytoskeleton Rho GTPases are required (Crawford et 
al., 1998).
After cellularisation is completed, a series of post blastoderm mitoses follow 
throughout embryogenesis that also require Rho GTPases probably because these 
regulate the function of cytoskeletal components such as actomyosin and microtubules 
which are necessary for the contractile ring of the mitotic furrow. It has been shown 
that Rho localises to the cleavage furrow and plays a crucial role in contractile ring 
function by activating at least three known effectors, ROK, Citron kinase, and mDia 
(Glotzer, 2001). Loss of Pebble, a Rho-specific GEF, results in failed cytokinesis 
events in the post blastoderm embryo leading to an accumulation of multinucleated 
cells (Prokopenko et al., 1999). Regulated Rho activity is required for cytokinesis as 
GAPs are also responsible for a well defined process (Lee et al., 2004).
35
Chapter 1: Introduction
3.4.2 Rho and development of the Drosophila embryo
Rho GTPases are involved in many developmental processes such as oogenesis, 
gastrulation, dorsal closure, muscle development, neural development, eye 
development and tissue polarity (Lu and Settleman, 1999). During embryogenesis, at 
the last stages of gastrulation, the dorsal surface of the embryo is covered by a thin 
layer of cells, referred to as the amnioserosa. During dorsal closure the amnioserosa is 
sealed by epidermal cells that stretch along the dorsal-ventral axis to meet the dorsal 
midline and undergo a zippering-like process. This does not involve either cell division 
or migration but is solely dependent on cell shape changes by some of the embryonic 
cells. Three distinct family GTPases are implicated in the cytoskeletal-mediated shape 
changes during this process (Harden et al., 1995; Jacinto et al., 2002). More precisely 
evidence points to a requirement for these GTPases in leading edge cell stretching 
(Woolner et al., 2005) through activation of distinct signalling pathways.
Rho GTPases have a role in various aspects of neural development (Luo, 2000; 
Govek et al., 2005). Significantly, the growth cone (tip of neurite) is an actin-rich 
dynamic structure that exhibits morphological and cytoskeletal features resembling 
filopodia, lamellipodia, and stress fibres of fibroblasts known to be regulated by the 
various Rho GTPases. In Drosophila Rhol is involved in the cytokinesis of neuroblasts 
and in dendritic morphogenesis (Lee et al., 2000). In another study, expression of 
mutationally activated and inhibitory forms of Rac and Cdc42 in the developing fly 
nervous system revealed roles for these GTPases in establishing neuronal polarity, and 
in the outgrowth of neurites (Luo et al., 1994). Specifically, Rac has a precise role in
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the initiation of axon outgrowth and axon elongation. In the same study, activated 
Cdc42 inhibited both axon and dendrite outgrowth.
In mature neurons Rho GTPases continue to play a role in the development of a 
fully functional nervous system. For example Racl is implicated in motor axon 
guidance (Kaufman et al., 1998), synaptogenesis (Allen et al., 2000), and in 
photoreceptor morphogenesis (Chang and Ready, 2000).
Following the completion of Drosophila embryogenesis, larval development 
begins during which epithelial polarization plays a particularly important role. Aside 
from the apical-basal polarity, epithelial cells organise themselves within tissues in 
such a way as to establish a so-called planar cell polarity (PCP) relative to the body axis 
and perpendicular to the anterior-posterior (A-P) axis. Examples of this are the 
appearance of distally pointing hairs in the wing blades of the fly as well as the hairs 
and bristles on the thorax and abdomen, and the chirality of regularly arrayed 
ommatidia. Rho GTPases play an essential role in the establishment of PCP in flies. 
Expression of mutationally activated and inhibitory forms of Racl in imaginal discs 
revealed Racl is essential for the proper assembly of cell adherens junctions as well as 
for the establishment of PCP, while Cdc42 was found to be required for epithelial cell 
shape changes but it is not required for actin assembly at adherens junctions (Eaton et 
al., 1995). Mutant tissue clones containing hypomorphic Rhol alleles exhibit abnormal 
wing hair polarity, and in somatic eye clones harbouring such alleles, ommatidia are 
incorrectly oriented, while the position of photoreceptors is unaffected (Strutt et al.,
1997). Genetic interaction studies established that Rhol functions downstream of 
frizzled, encoding a G protein coupled receptor, and dishevelled, encoding for a
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cytoplasmic signalling molecule, to mediate tissue polarity (Lu and Settleman, 1999). 
The roles of RhoGTPases in different developmental processes are summarised in
Table 1.2. 
Table 1.2
Developmental Genes/Pathways
Processes involved
Oogenesis: border cell
Migration Racl
Oogenesis: transfer of
nurse cells contents to
oocytes Racl, Cdc42, RhoL
Gastrulation Rhol
Dorsal closure Rhol, Racl, Cdc42
Muscle development Racl
Neural development Racl, Cdc42
Eye development Rhol, Racl, Rac2, Cdc42
Tissue polarity: wing
development Racl, Cdc42, Rhol
Tissue polarity: eye
development Rhol
Table 1.2: Summary of Rho GTPase signalling components involved in various
Drosophila developmental processes, (updated and modified version from Lu and 
Settleman, 1999).
3.5 Summary
To summarise so far, the Rho GTPase protein family influences diverse cellular 
and developmental events most commonly by regulating the actin cytoskeleton. The 
change in the architecture of a cell is a sequence of events: first a cue has to trigger the 
signaling pathway, this will cause the translocation, activation and retention of the Rho 
GTPase to the right place where it can interact with its effectors to cause morphological
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permutations that reflect the function of the cell. Each of these steps is to a certain 
degree a regulatory step that dictates the outcome of the Rho protein activation. All 
evidence points to GEFs being the critical mediators of Rho GTPases activation. The 
following text considers GEFs and their role.
4. GUANINE NUCLEOTIDE EXCHANGE FACTORS FOR Rho GTPases
Guanine nucleotide exchange factors (GEFs) activate directly the Rho GTPases 
in response to extracellular signals in a specific spatio-temporal frame. Therefore, their 
timing (presence at the right place and activity) is crucial for many cellular processes. 
They activate Rho GTPases by exchanging GDP for GTP. GEFs that contain the DH 
(Dbl Homology) domain in tandem with the PH domain (Pleckstrin Homology) form 
the Dbl family. The DH domain is responsible for catalysing the exchange of GDP for 
GTP. Other than the DH/PH domain, they also contain a variety of other domains. The 
Dbl family of GEFs is composed of a large number of members, structurally very 
different from each other, with particular mechanisms of regulation participating in 
different signalling pathways.
There are also Rho GEFs called Dock without the DH/PH domain. These have 
two regions called DHR1 and DHR2 (Dock-Homology Region-1 and -2). It is probably 
the DHR2 domain which is sufficient for promoting guanine nucleotide exchange 
activity for this family of GEFs (Rossman et al., 2005). Certain members of this family 
also have additional domains such as PH, SH3, C2 or coiled coil regions (Rossman et 
al., 2005).
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4.1 Structural features of GEFs
Rho GEFs are large proteins consisting of domains, 200-300 amino acid long, 
with catalytic activity; they also contain various other domains involved in 
oligomerisation, protein-protein interactions or membrane targeting as well as of 
regions whose functions remain unknown (Fig. 1.7). Dbl-family GEFs have a DH 
domain, which is necessary for GEF activity. DH domains have three conserved 
regions: CR1, CR2, and CR3, each 10-30 aminoacids long but for the rest they do not 
show homology between them. Although GEFs can activate the same GTPase they 
have very small (<20%) sequence identity (Schmidt and Hall, 2002).
Adjacent and C-terminal to the DH domain there is a Pleckstrin homology (PH) 
domain which binds to phosphorylated phosphoinositides. PH domains could affect the 
catalytic activity of the DH domain in GTPase binding (Rossman et al., 2002). In 
addition, they could be involved in recruiting GEFs to the appropriate intracellular 
location (Rossman et al., 2002). Aside the DH-PH module that is always present in the 
Dbl family members, GEFs contain additional functional domains that include SH2, 
SH3, Ser/Thr or Tyr kinase, Rho-GAP, Ca2+-dependent lipid binding, coiled coil, 
cysteine-rich zinc butterfly motif, GpY, RGS, PDZ or additional PH domains (Fig. 1.7). 
These domains are involved in coupling GEFs to upstream receptors and signalling 
molecules, and in localising them to subcellular structures; moreover they could confer 
additional functions associated with GEFs.
A sub-family of RhoGEFs has been identified by virtue of the presence of a 
regulator of G protein signalling (RGS) domain (Fukuhara et al., 2001) that directly 
binds activated heterotrimeric G protein a  subunits of the G 12 family.
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Figure 1.7: Schematic structures of representative mammalian Dbl family members. 
Note that the only Dbl family members that have PDZ domain are Tiaml, GTRAP 
(mouse homogue of the PDZ-RhoGEF not shown here) and LARG (not shown here). 
(Picture taken from Zheng, 2001)
In humans, three RGS domain-containing RhoGEFs have been described, namely 
pi 15-RhoGEF, PDZ-RhoGEF, and LARG. All three can be activated by a \2 or a n  and 
are specific for RhoA but not the other Rho family GTPases Racl and Cdc42 (Hart et 
al., 1996; Rumenapp et al., 1999). DRhoGEF2 also belongs to the RGS subfamily of 
GEFs.
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4.2 Regulation of GEFs
GEFs are themselves tightly regulated and each member of the family has a 
different mechanism of activation. One way of controlling their activity is through 
relief of an intramolecular inhibitory sequence. This regulatory domain can be the N- or 
C- terminus blocking access of the DH domain to the substrate (Fig. 1.8). The 
autoinhibition can be relieved either by phosphorylation of aminoacids in this region as 
is the case of Vav (Aghazadeh et al., 2000), or by interacting with another protein as in 
the case of Asef. Asef binds to the tumor suppressor gene product APC through its SH3 
domain and this interaction is sufficient to stimulate GEF activity towards Rac in vitro 
(Kawasaki et al., 2000). Similarly, in the case of p i 15RhoGEF and Lbc, removal of C- 
terminal sequences activates the protein (Wells et al., 2001).
Similarly, the PH domain has been reported to regulate the catalytic activity of 
Vav, Dbl, Sosl, and P-Rexl (Das et al., 2000; Russo et al., 2001; Welch et al., 2002) by 
binding to the lipid PI-4,5 -P2 (Fig. 1.8). When bound, the PH domain strongly interacts 
with the DH domain and masks the binding site for Rac binding (Das et al., 2000). The 
autoinhibitory constraint imposed by the PH domain is relieved in response to 
activation by PI 3-kinase. PI-4,5 -P2 is converted to PI-3,4,5-P3 the DH/PH interaction is 
weakened leaving DH domain free for binding to Rac. The Rho/Rac GEFs appear to be 
regulated by a variety of factors, including, lipid interactions and membrane 
localisation, indicating that diverse regulatory inputs may be utilised to promote their 
ability to activate Rho family GTPases (Van Aelst and Souza-Schorey, 1997).
Several GEFs are stimulated by phosphorylation (Crespo et al., 1997) or 
protein-protein interactions (Fig. 1.8). For example, in the case of pll5RhoGEF,
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stimulation of cells by LPA or thrombin induces release of the a i3 subunit from the 
heterotrimeric G protein G13, which subsequently binds to an RGS-like domain of 
pll5RhoGEF. Upon binding a n  enhances the GEF activity of pll5RhoGEF both in 
vivo and in vitro (Hart et al., 1998; Kozasa et al., 1998). The RGS domain is not always 
involved in the GEF regulation: interestingly, a n  interacts with and stimulates the GEF 
activity of Dbl in vivo, although it does not contain an RGS domain (Jin and Exton,
2000).
Another way of regulation is through GEF oligomerisation (Fig. 1.8). 
Oligomerisation is mediated through the DH domain and requires the conserved region 
CR2. The current view is that oligomerisation is perhaps important for generating larger 
signalling complexes that augment GTPase activation. The fact that mutants that can no 
longer oligomerise still possess GEF activity in vitro but are less potent at activating 
Cdc42 and Rho in vivo (Zhu et al., 2001) are consistent with this view. It has thus been 
suggested that oligomers of Dbl can recruit multiple Rho GTPases into a large 
complex, raising the possibility that this serves to activate co-ordinately several 
pathways (Zhu et al., 2001). Oligomerisation has been reported for RasGRFl and 
RasGRF2 (Anborgh et al., 1999).
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Figure 1.8: Schematic representation 
of GEF activation through (i) relief of 
intramolecular inhibitory sequences 
and (ii) through protein-protein 
interactions or oligomerization. 
(Picture taken from Schmidt and Hall,
2002)
Very little is known about how GEFs are turned off. One possibility is simple 
reversal of the activation mechanism through dephosphorylation, or disruption of 
protein-protein or protein-lipid interactions. However many proteins have been 
identified as GEF inhibitors such as Cbl-b or hSiah2 that suppress Vav (Bustelo et al., 
1997; Germani et al., 1999). Tiaml is inhibited by binding to nm23Hl (Otsuki et al., 
2001); whereas pll5RhoGEF is turned off by association with the HIV-1 gp41 protein 
(Zhang et al., 1999). The mechanism of the inhibition is not known.
4.3 Rho GEFs can act as signalling landmarks for the direction of the pathway
Rho GTPases regulate a grand variety of cellular functions raising the question 
how specificity is achieved. Rho GEFs being the direct activators could be one factor
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responsible for conferring this specificity. One highly favoured hypothesis regarding 
how Rho GEFs activate Rho GTPases in a precise spatio-temporal manner is their 
subcellular localisation. Indeed GEF activation seems to be intimately linked with 
relocalisation (Schmidt and Hall, 2002). However it is not clear how GEFs find their 
way in the cell. The PH domain because it binds to phospholipids could be mediating 
the recruitment of GEFs to the plasma membrane. Mutants of Dbs, Dbl, Lsc, Lfc, and 
Lbc lacking the PH domain do not show transforming activity (Whitehead et al., 1995a, 
b; Zheng et al., 1996; Olson et al., 1997). However when Lfc and Dbs can be localised 
to the plasma membrane via a CAAX motif they re-acquire the in vivo activity 
(Whitehead et al., 1995b; 1999).
There are opposing views regarding the role of the PH domain as a membrane 
anchor as it has also been shown that the PH domain has a low binding affinity and 
little specificity for phospholipids indicating that these interactions are insufficient for 
membrane localisation (Snyder et al., 2001). In other cases such as that of Sosl, 
recruitment to tyrosine kinase receptors is mediated through adaptor proteins like Grb2 
and She and not through its PH domain (Buday and Downward 1993; Gale et al., 1993; 
Skolnik et al., 1993).
The Tiam-1 and Ras-GRF are recruited to the plasma membrane in response to 
cellular activation by serum and calcium, respectively through a N-terminally located 
second PH domain (Buchsbaum et a l l 996; Michiels et al., 1997). In other cases GEFs 
can be localised to the plasma membrane upon activation of receptors. For example, 
Vav is recruited to activated B- and T-cell receptors via its SH2/SH3 domains (Bustelo,
2000). Another GEF called Ephexin interacts with the receptor Ephrin A via its DH/PH
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module (Shamah et al., 2001) and pll5RhoGEF activated by binding to Gai3 linked to 
an activated heptahelical receptor is redistributed from the cytoplasm to the plasma 
membrane (Bhattacharyya and Wedegaertner, 2000).
In other cases Rho GEFs could interact with other proteins that can localise 
Rho: pi 15RhoGEF can bind to the heterotrimeric G protein after activation of the LPA 
heptahelical receptor and recruit Rho to the membrane (Seashotlz et al., 1999; Zheng, 
2001). The localisation of PDZRhoGEF either to the cytoplasm or the tip of neurites 
determines the Rho response to LPA stimulation, which is either stress fibre formation 
or neurite retraction respectively (Togashi et al., 2000), demonstrating that the 
subcellular localization of the GEF and the activated GTPase can select the cellular 
response. If Racl/Tiam 1 is localised at the E-cadherin adhesion sites and the cells 
attached to fibronectin, then cell-cell contacts are promoted. On the other hand if 
Racl/Tiaml is localised in the migratory edge and the cells are attached to collagen 
then cell migration is promoted (Price and Collard, 2001). In this case both the 
subcellular localisation of the Rho protein together with the exchange factor and the 
nature of the environmental conditions are crucial in balancing cell to cell adhesion and 
cell migration.
A distinct mechanism of regulation by localisation has been identified by 
Ect2/Pebble, and Netl which contain nuclear localisation signals within the N-terminus 
and through import into the nucleus they are sequestered away from their substrate 
(Prokopenko et al., 1999; Tatsumoto et al., 1999; Schmidt and Hall, 2002). Table 1.3 
summarizes some reported examples of interactions involved in GEF regulation.
46
Chapter 1: Introduction
Table 1.3
GEF
Interacting
molecule
Interacting/phosphory- 
iated domain Effect on GEF function
Vav syc/src kinases phosphorylation of N 
terminus
relief of autoinhibition, 
activation
PI-3,4,5P,* PH domain relief of autoinhibltion, 
activation
adaptors and 
receptors
SH2/SH3, other domains membrane recruitment
SOCSi N terminus ubiquitination
Cbl-b C terminus inhibition
hSiah2 C terminus inhibition
DM Ackl phosphorylation activation
FI-4,SPj, 
PI-3,4,5Pa
PH domain inhibition
Gaia NJD. activation
Gpy N terminus activation ?
Dbl DH domain 
[oligomerization)
potentiation of GEF activity
N.D. PH domain recruitment to stress fibers
Sosi PI-3,4,5Pa PH domain relief of autoinhibltion, 
activation
E3bl, Eps8 C terminus activation
N.D, PH domain membrane recruitment
P-REXI H-3,4,5,P* PH domain activation
g n N.D. activation
Asef APC N terminus activation, relief of 
autoinhibition ?
pllSRhoGEF G«ia RGS-like domain activation and membrane 
recruitment
H1V*1 gp4l C terminus inhibition
LARG G«U/|3 RGS-like domain N.D.
IGF-1 receptor FDZ domain membrane recruitment, 
activation ?
Lbc NX>. PH domain recruitment to stress fibers
RasGRF RasGRF DH domain 
[oligomerization!
activation, potentiation I
Dbs N.D, PH domain membrane recruitment
Lfc N.D. PH domain membrane recruitment
tubulin PH domain recruitment to microtubules
pl90RhoGEF tubulin C terminus recruitment to mkrotubules
Tiaml N.D. N terminal PH domain +- 
adjacent sequences
membrane recruitment
PKC, CamKU phosphorylation • activation
P!-3,4Pi, 
PI-3,4,5P,
N terminal PH domain activation
nm23HI N terminus inhibition
CD44 N-termina! PH domain ♦ 
adjacent sequences
membrane recruitment, 
activation
ankyrin N-terminal PH domain + 
adjacent sequences
membrane recruitment, 
activation
Ephcxin EphA4, other 
EphAs
DH-PH module membrane recruitment, 
activation
Pix Cat/Git/PKL C terminus recruitment to endosomal 
membranes ?
Ect2 Cdc2 * phosphorylation activation ?
Trio LAR recruitment ? activation ?
filamin PH domain recruitment to actin I
Table 1.3: Interactions involved in GEF regulation 
{Table taken from Schmidt and Hall, 2002).
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An interesting case demonstrating that protein platforms are necessary for 
channelling a signal towards a specific downstream target of Rho is the scaffold protein 
CNK1 which interacts with two Rho-specific GEFs, Netl and pll5RhoGEF linking 
them to components of the Rho-dependent JNK MAP kinase cascade (Jaffe et al., 
2005). This could indicate that in the cell an uneven distribution of protein complexes 
could compartmentalise a subset of outputs of the Rho signalling pathway.
4.4 Various biological functions of GEFs
RhoGEFs acting as signal integrators to activate Rho GTPases participate in 
many cellular functions. Rho GTPases play a major role in regulating cytoskeletal 
changes during neuronal morphogenesis (Luo, 2000; Dickson, 2001). Several GEFs 
have been involved in the regulation of various neuronal processes by the localised 
activation of their counterpart GTPases. Tiaml, a Rac-specific GEF, is involved in 
neuronal polarization, and is implicated in the axon formation process (Kunda et al.,
2001). The Drosophila homolog of Tiaml, Still life, is involved in synaptic 
development (Sone et al., 1997). Still life (Rac/Rho GEF) is also involved in proper 
synaptic function (Sone et al., 1997) and Trio and Ephexin have been shown to play 
essential roles in activating Rho GTPases during growth cone guidance (Steven et al., 
1998; Awasaki et al., 2000; Bateman et al., 2000; Liebl et al., 2000; Newsome et al., 
2000; Wahl et al., 2000; Shamh et al., 2001). Trio (Rac-specific GEF) is also required 
for normal axonal pathfmding in the central and peripheral nervous systems of 
developing embryos, as well as in the photoreceptors of the adult eye (Luo, 2000). One
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candidate GEF that might be controlling the formation of dendritic spines is Kalirin 
specific for Rac (Luo et al., 1996; Nakayama et al., 2000; Penzes et al., 2001). Studies 
in mouse embryos implicated Trio and Obscurin in the control of skeletal muscle 
development (O’Brien et al., 2000).
Mammalian GEFs play a role in immune responses. For example Vav 
downstream of T-cell receptors is required to stimulate Rac-mediated actin 
reorganization, which contributes to activation of the transcription factor NF-AT to 
produce the cytokine interleukin-2 (Holsinger et al., 1998; Bustello, 2000). In 
neutrophils, a different GEF, P-Rex-1, has been shown to control Rac-mediated 
NADPH oxidase activation (Welch et al., 2002).
4.5 RhoGEFs control the cell morphology
RhoGEFs relay a signal from various receptors to Rho GTPases thereby 
inducing cell shape changes. Controlled activity of RhoGEFs is required for correct 
regulation of the actin cytoskeleton by the Rho GTPases.
There are several studies that demonstrate the important role RhoGEFs have in 
the regulation of morphology of various cell types. For example RhoGEF Pebble is 
transducing a signal from the Heartless receptor to induce cell shape changes during 
migration of mesodermal cells of the Drosophila gastrula (Schumacher et al., 2004). 
The neuronal RhoGEF Kalirin-7 has been shown to regulate dendritic morphogenesis in 
response to NMDA receptor through activation of Racl (Penzes et al., 2001). Further 
studies on the functional role of RhoGEFs have shown that the mammalian LARG and 
PDZ-RhoGEF by controlling the cell shape of neurons can affect axon guidance and
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cell migration and growth cone collapse in response to semaphoring-plexin interaction 
(Perrot et al., 2002; Swiercz et al., 2002). Finally, a recent study showed that the Rho- 
specific GEF Lfc interacts with neurabin/spinophilin in response to activation of 
NMDA receptors and by virtue of this interaction can regulate dendritic spine 
morphology (Ryan et al., 2005).
4.6 The Rho-speciftc exchange factor DRhoGEF2
A genetic screen in Drosophila was conducted in order to identify important 
regulators of the Rho signalling pathway. The overexpression of two copies of Rho in 
the fly eye using the GMR promoter causes a rough eye phenotype (Hariharan et al., 
1995). This rough eye phenotype was used as a basis to screen for suppressors and 
enhancers of the Rho-induced effect. Flies were fed with a chemical mutagen (EMS) 
and crossed with GMR-Rho^Rho3 (Hariharan et al., 1995). Several lines of suppressors 
and enhancers were identified. One of the suppressors was found to be a Rho specific 
exchange factor named DRhoGEF2 (Barrett et al., 1997). DRhoGEF2 belongs to the 
Dbl family of nucleotide exchange factors, thus it has the DH and PH domains required 
for Rho activation. In addition it has a PDZ domain near its amino terminus whose 
function is not known. DRhoGEF2 has also two more domains, the G-protein 
Regulation Subunit (RGS) and a Cl domain. There are three mammalian orthologues to 
DRhoGEF2: pll5RhoGEF that has also an RGS domain but not a PDZ domain, 
PDZRhoGEF (also known as KIAA0382 or ArhGEF12) and LARG (Fig. 1.9). Both 
PDZ-RhoGEF and LARG have a PDZ domain and an RGS domain but not a Cl
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domain (Fukuhara et al., 2000; Wells et al., 2001; Schmidt and Hall 2002). DRhoGEF2 
is a specific exchange factor for Rho, since it modifies only GMR-Rho and not GMR- 
Racl, GMR-Rac2, GMR-Cdc42.
DRhoGEF2
5aa PDZ RGS C l DH PH
LARG
1544aa PDZ DH PH
FDZ-RhoGEF
1522aa PDZ RGS DH PH
o l l5  RhoGEF
913aa
RGS DH PH
Figure 1.9: Schematic representation of DRhoGEF2 protein with the putative domains 
and its mammalian orthologues.
In situ hybridisation of DRhoGEF2 mRNA in embryos and Northern blots showed that 
the mRNA is maternally loaded and expressed ubiquitously and at low levels (Barrett et 
al., 1997). The maternal product of DRhoGEF2 is required during gastrulation. 
Embryos derived from germ line clones of cells in which DRhoGEF2 had been mutated 
do not form a ventral furrow and the anterior and posterior midgut primordial tissues do 
not invaginate. As a result the embryos become wrinkled due to a failure in germ band 
extension and die. Transverse sections of DRhoGEF2 embryos demonstrate that the cell 
shape changes required for gastrulation do not occur (Fig. 1.10). Only a small number of
51
Chapter 1: Introduction
cells are able to constrict their apical side and a few nuclei migrate to the basal side but 
the overall constrictions and cell shape changes fail (Barrett et al., 1997; Hacker and 
Perrimon, 1998). The interesting thing about this process is how DRhoGEF2 being 
ubiquitously expressed directs these shape changes to only a subset of cells. One 
possibility is that it is recruited to the apical membrane at a specific moment to restrict 
the effects of Rhol. This could occur via its PDZ domain which has been shown to be 
important for the localisation of many proteins involved in epithelial polarisation 
(Bilder, 2001).
Figure 1.10: Transverse sections of 50% egg length of wild type (left column) and 
DRhoGEF24 1 embryos (right column) stained with anti-Twist to mark the nuclei of 
presumptive mesodermal cells. In wild type embryos there is a well choreographed 
movement of the nuclei and the formation of the ventral furrow. In the mutant embryos 
nuclear migration is not coordinated and not followed by ventral furrow formation. 
(Picture taken from Barrett et al., 1997)
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5. GTPase-ACTIVATING PROTEINS: not just inactivators of Rho GTPases
Another class of enzymes that regulates Rho protein activity is the one 
composed of the GTPase-activating proteins (GAPs) which catalyze GTP hydrolysis 
bringing Rho to its GDP-bound inactive state. The domain that confers the GAP 
activity consists of approximately 200-300 amino acids (Scheffzek et al., 1996; 
Rittinger et al., 1997) but sequences outside the GAP domain influence also the 
function of the catalytic domain (Molnar et al., 2001). This is consistent with the fact 
that individual RhoGAPs exhibit different kinetic properties in the interaction with 
Rhol GTPase suggesting a unique mechanism for each particular interaction as a result 
of distinct structural requirements (Zhang and Zheng, 1998). RhoGAPs conceal the 
effector-binding region of the GTPase by making contact with switch I and II region of 
the substrate and stabilize the transition state of GTP-hydrolysis reaction by providing 
an essential arginine residue into the GTPase active site (Rittinger et al., 1997) thereby 
terminating Rho protein activity. Probably the interaction of RhoGAPs with the Rho 
GTPases happens at the plasma membrane as membrane-associated GAPs increase the 
intrinsic rate of hydrolysis only on prenylated and thus membrane localized Racl and 
Rhol (Molnar et al., 2001).
The Drosophila genome has 64 genes encoding GAPs for Ras superfamily 
members of which 21 genes are for the Rho subfamily of small GTPases (Bernards, 
2003). Other than the GAP domain the RhoGAP proteins have also other domains that 
include C l, C2, SH2, SH3, PH, PDZ, and PTB domains which might be involved in the 
regulation of these proteins by various mechanisms such as protein or lipid interactions,
53
Chapter 1: Introduction
phosphorylation/dephosphorylation, subcellular localization and proteolytic 
degradation (Bernards and Settleman, 2004).
Since there is a functional interplay between the various Rho GTPases their 
activity has to be modulated. Certain GAPs act as effectors of Rho GTPases for 
example RhoE/Rnd activate pl90 RhoGAP which inactivates Rhol (Wennerberg et al., 
2003). p i90 RhoGAP can also be stimulated by Src family phosphorylation induced by 
cadherin engagement (Noren et al., 2003). In addition to cadherins, integrin activation 
(Arthur et al., 2000) and growth factor can promote phosphorylation of p i 90 RhoGAP 
by Src family kinases (Ellis et al., 1990). In the nervous system a class of GAPs 
responds to Slit-Robo signaling having an effect on neuronal migration (Wong et al.,
2001).
In conclusion, RhoGAPs by inhibiting Rhol participate in various cellular 
processes such as migration (Arthur and Burridge, 2001), morphogenetic movements 
during development (Brouns et al., 2000; 2001), cell differentiation such as 
adipogenesis versus myogenesis (Sordella et al., 2003).
6. PDZ domains
PDZ domains are one of the most commonly found protein-protein interaction 
domains in organisms from bacteria to humans. PDZ is an acronym from the initial 
letters of the Postsynaptic density protein 95 (PSD-95), Discs large (Dig), Zonula 
occludens-1 (ZO-1) the first identified proteins containing this motif (Jelen et al.,
2003). PDZ domain proteins can be classified into three principal families according to 
their modular organisation (Fig. 1.11). The first family contains proteins consisting
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entirely of PDZ domains. The number of PDZ domains can vary from two (Na+/H+ 
exchanger regulatory factor) to more than ten in certain proteins (Nourry et al., 2003). 
The MAGUKs (membrane associated guanylate kinases, including PSD-95, Dig, and 
ZO-1), which contain PDZ domains (one or three), one SH3 domain, and a guanylate 
kinase domain (GuK) comprise a second family (Nourry et al., 2003). The third family 
encompasses proteins that contain PDZ domains as well as other protein domains, such 
as ankyrin, LIM, L27, C2, PH, WW, DEP and LRR domains (Nourry et al., 2003). All 
of these proteins act as adaptors that hold receptors and signalling molecules in large 
molecular complexes. Other PDZ proteins do not serve as functional units 
(transducisomes) but serve as enzymes and as such, can directly participate in 
signalling events. PDZ proteins are often associated with cell adhesion molecules, G 
protein-coupled receptors, and receptor tyrosine kinases (Nourry et al., 2003).
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Figure 1.11: PDZ domain proteins classified according to their modular 
organization. {Picture taken from Nourry et al., 2003)
6.1 Structure and Binding specificities of PDZ domains
PDZ domains are small peptides of 80 to 90 amino acids length. The secondary 
structure forms six p strands (pA to pF) and two a-helices, aA and aB, arranged in a 
way so that N- and C-termini are next to each other thereby resulting in a spherical
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shape (Nourry et al., 2003) (Fig.l.l2A). The X-ray crystallographic structure of the 
third PDZ domain from PSD-95 in complex with and in the absence of its peptide 
ligand has been determined, elucidating the mechanism of PDZ domain interactions 
(Doyle et al., 1996). The structure of PDZ domains allows binding to a free carboxylate 
group at the end of the peptide through a loop between the pA and pB strands that 
contains the R or KxxxGLGF signature (Fig. 1.12B). These amino acids play an 
important functional role in binding the C-terminal carboxylate group of the peptide 
and therefore the loop is referred to as the carboxylate-binding loop. The residues 
GLGF within the loop are a source of amide nitrogens that hydrogen bond with the 
terminal carboxylate group (Fig. 1.13). The glycine residues provide the structural 
flexibility necessary to form the loop. A very important aspect of peptide recognition 
by the PDZ domain is its ability to stabilise the terminal carboxylate group of the target. 
The terminal carboxylate group is stabilised by four hydrogen bonds: the two 
carboxylate oxygens participate in hydrogen bond formation with three amide nitrogens 
in the loop [(G)LGF residues] and by a water molecule coordinated with the R or K 
charged residues (Fig. 1.13).
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Figure 1.12: (A) Ribbon Diagram Showing the 
Three-Dimensional Fold of the PDZ-3 Domain 
from PSD-95 Corresponding to Residues 309-393. 
The peptide (yellow) inserts between the pB 
strand and the aB helix and forms an antiparallel 
P sheet with pB. The connecting loop between pA 
and pB is involved in binding the peptide C- 
terminus and therefore is designated the 
carboxylate-loop.
(B) Sequence alignment of Selected PDZ domains 
(Pictures and legends taken from Doyle et al., 
1996)
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The side chain of the C-terminal amino acid points into a large pocket formed by 
hydrophobic residues.
The PDZ domains have been classified into three classes according their 
specificity for C-terminal peptides. Songyang et al. (1997) using a degenerate peptide 
library determined which carboxyl-terminal residues were crucially required for protein 
interaction with the PDZ domain. They categorised PDZ domains into two classes on 
the basis of target sequence specificity. Class I domains bind to peptides with the 
consensus sequence (S/T)-X-(V/I/L) [X denoting any amino acid as it has been 
determined that this one has a limited role for the PDZ-peptide binding specificity 
(Doyle et al., 1996)]; whereas class II domains recognise the motif (F/Y)-X-(F/V/A).
o Figure 1.13: Schematic view of the
contacts identified in the crystal structure of 
the complex. Dashed lines represent 
hydrogen bonds and the two closest atom-to- 
atom distances between ValO side chain and 
all atoms in the hydrophobic pocket of the 
PDZ domain are drawn as solid black lines. 
(Figure and legend taken from Doyle et al, 
1996)
Peptide N48iminus
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Finally, there is Class III PDZ domains that prefer a DXV motif. PDZ domains 
participate in at least four different classes of interaction: recognition of carboxyl- 
terminal motifs in peptides, recognition of internal motifs in peptides, PDZ-PDZ 
dimerization, and recognition of lipids (Nourry et al., 2003) (Fig. 1.14).
Carboxyl-terminal 
motif
Internal motif
Head-to-tail
oligomenzalton
Lipids
Figure 1.14: Possible PDZ interaction modes. PDZ domains participate in at least four 
different classes of interaction: recognition of carboxyl-terminal motifs in peptides, 
recognition of internal motifs in peptides, PDZ-PDZ dimerization, and recognition of 
lipids. (Pictures taken from Nourry et al., 2003)
6.2 Functions of PDZ Proteins
PDZ domains often serve as scaffolds of protein complexes at the plasma 
membrane. They are important in transporting and targeting of different proteins to the 
sites of cellular signalling thus assuring localisation and organisation of both receptors 
and downstream effectors to proper regions of the cell. For instance, proteins that bear 
PDZ domains together with proteins having different functional activities are involved
60
Chapter 1: Introduction
in asymmetric distribution of protein complexes necessary for epithelial polarity (Bilder 
et al., 2003; Tanentzapf and Tepass 2003).
Different regions of the cytocortex have characteristics specific to that area 
because they are composed of protein complexes which differ from area to area. For 
example various protein complexes such as Crumbs-Stardust (1 PDZ domain)-Discs 
Lost (4 PDZ domains), and Cdc42-Par6 (1 PDZ domain)-Bazooka (3 PDZ domains)- 
atypical Protein Kinase C are formed in tight junctions (Doe, 2001; Ohno, 2001; 
Medina et al., 2002). Instead more basal regions of the cell membrane like septate 
junctions are composed of other protein congregates such as Discs Large (3 PDZ 
domains) -Lethal giant larvae-Scribble (4 PDZ domains) (Bilder et al., 2000).
Proteins that bear PDZ domains are localised at specific subcellular sites near 
the plasma membrane of other polarised cells as well such as neurons where they 
function as mediators of clustering of neurotransmitter receptors and ion channels 
(Sheng and Sala, 2001).
PDZ domains are very important for the assembly of protein complexes and 
therefore for building networks necessary for the cross-talk between molecules. An 
interesting feature of the PDZ domains is that they are versatile in choosing their 
partners being able to form heterodimers or to interact either with a Carboxy-terminal 
motif or with an internal one, or even with lipids. Their function is also quite 
unpredictable as they can act as localised scaffolds but also as mediators of the 
trafficking of their binding targets; however what characterises most PDZ domains is 
that most of them are localised to highly restricted regions of the cytocortex (Ponting et 
al., 1997). Despite the fact they are widespread it is still unclear how they are localised
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to microdomains of the cell membrane and how they discriminate among the many 
possible binding partners.
6.3 Diseases involving PDZ proteins
PDZ proteins have a central role during development. For instance loss of PDZ 
containing protein Shroom that binds to actin and localises in the adherens junctions, 
causes failure of the neural tube to close, leading to exencephaly, acrania, and spina 
bifida in mice (Hildebrand, and Soriano, 1999). Disruption of cask or dig, two PDZ 
proteins involved in epithelial polarity, lead to craniofacial dysmorphogenesis (Laverty, 
and Wilson, 1998; Caruana and Bernstein, 2001).
Since PDZ domains play an important role in maintaining tissue integrity it is 
implied that their disruption would cause an effect on signalling pathways or on the 
cytoskeleton leading to cancers. For example mutated function of Scribble, another 
protein for epithelial polarity, in Drosophila affects not only cell polarity but also 
causes cell proliferation and tumorigenesis in imaginal discs (Bilder et al., 2000). In 
addition Scribble mutant mice develop severe neural tube defects (Murdoch et al.,
2003). Another PDZ domain-containing protein implicated in cancer is Syntenin which 
promotes cell migration in metastatic human breast and gastric cancer lines (Koo et al., 
2002). It has been shown that expression levels of syntenin correlate with invasive and 
metastatic potential in these cell lines. Moreover, syntenin-transfected cells migrated 
more actively, showing cell surface extensions, suggestive of an effect on the actin 
cytoskeleton (Koo et al., 2002).
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To summarise, PDZ domains are involved in tumorigenesis, cell migration and 
metastasis as various PDZ containing proteins participate in cytoskeletal reorganisation 
in cancer. Therefore understanding how PDZ domains assemble and regulate protein 
networks will also help in drug design for therapeutic reasons.
6.4 Summary
Proteins that bear PDZ domains are often localised at specific subcellular sites 
near the plasma membrane of polarised cells, such as epithelial and endothelial cells 
and neurons. Among the many functions that PDZ proteins can have, very often they 
play a central role in establishing and maintaining epithelial polarity. Thus, PDZ 
proteins can serve as a hub of different protein complexes that convey signals from cell 
surface molecules to the interior, participating in signalling cascades and construction 
of the cytoarchitecture. This is a study of the function of the PDZ domain of 
DRhoGEF2 as well as an analysis of its interaction with a novel protein called DMec2.
7. MEC2
The Drosophila Mec-2 has yet to be characterised and its function remains 
unknown. It is homologous to the C. elegans Mec-2 and the human protein called 
stomatin. Stomatin was originally isolated from erythrocyte membranes and it was 
shown to form mainly dimers and a small amount of higher oligomers (Snyers et al., 
1998; Hiebl-Dirschmied et al., 1991). This protein is apparently absent from the red cell 
membrane of patients suffering from overhydrated hereditary stomatocytosis, a form of
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autosomal dominant haemolytic anemia (Stewart and Argent, 1992; Stewart et al., 
1993; Stewart, 1997). Stomatin has been associated with cell membrane microdomains, 
called lipid rafts (Mairhofer M., et al., 2002; Snyers et al., 1999). Lipid rafts are 
detergent-resistant, low density regions of the membrane that are thought to be 
important in sequestering protein complexes (Moffett, et al., 2000; Hooper, 1999). In 
addition, these microdomains are relatively rich in cholesterol, and sphingolipids. 
Stomatin is postulated to play a role similar to that of caveolin, i.e. to regulate the 
formation and maintenance of membrane domains. Stomatin and caveolin have been 
shown to share structural similarities (Hooper, 1999; Tavemarakis et al., 1999; Moffett, 
et al., 2 0 0 0 ).
There is also a C. elegans orthologue of stomatin called Mec2 involved in 
modulation of ion channels. Saturation genetic screens in C. elegans for touch- 
insensitive mutants have identified several genes needed for the function of the touch 
receptor neurons. Four genes (the stomatin-like protein MEC-2, MEC-4, MEC-10, and 
the paraoxonase-like protein MEC-6 ) encode membrane-associated proteins that 
interact with each other and form an amiloride-sensitive sodium channel complex 
(Goodman et al., 2002; Chelur et al., 2002). The central portion of the integral 
membrane protein MEC-2 contains a stomatin-like region with 64% identity to the 
human stomatin that is highly conserved from bacteria to mammals. MEC-2 interacts 
with the MEC-4 subunit of the degenerin channel (DEG/ENa+ channel) through its 
stomatin-like region, which therefore acts as a protein binding domain; this binding 
allows non-stomatin domains of MEC-2 to regulate channel activity (Zhang et al.,
2004). The sequences that lie N- and C-terminal to the stomatin-like region are unique
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to MEC-2 with the specific C-terminal domain being required for self association. Two 
other proteins needed for touch neuron function, the a-tubulin MEC-12, and the p- 
tubulin MEC-7, are needed to form touch neuron-specific 15-filament microtubules 
(Garcia-Anoveros and Corey, 1997). Additionally, MEC-5, MEC-1 and MEC-9 are 
components of the extracellular matrix (Emstrom and Chalfie, 2002).
All these components are thought to form the mechanotransduction machinery 
in C. elegans involved in the transduction of external forces to the interior of the cell. 
This working model implicates the involvement of an ion channel that opens or closes 
in response to the movement of the extracellular matrix and the microtubule network 
relative to each other. The link in C. elegans that is thought to relay the consequent 
deflection of the membrane to the microtubule network, or vice versa, is Mec-2 (Fig. 
1.15).
Figure 1.15: Schematic
representation of the
mechanotransduction 
machinery in C. elegans 
composed of ECM 
components, an ion channel, 
and the microtubule network. 
(Picture taken from Sukharey 
and Corey, 2004)
MEC-4
MEC-10 MEC-6
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Little is known about the molecular mechanism of mechanotransduction which 
is of great importance for a variety of processes in a diverse array of tissues. Apart from 
touch sensation, mechanotransduction is also involved in numerous other biological 
processes including hearing, and shear stress in vascular endothelial cells. Many 
questions arise regarding the involvement of forces at the cellular level. Can the 
mechanism that underlies the transduction of mechanical cues be similar whether these 
regard intrinsic or extrinsic forces? Can it consist of the same components? Can we 
study mechanotransduction using as a model the process of epithelial invagination? 
Finally, is it possible that DMec-2 is relaying mechanical information to modify the 
cortical actin cytoskeleton?
8. HYPOTHESIS AND AIMS OF THE THESIS
The work carried out for this thesis is based on the hypothesis that DRhoGEF2 
interacts with DMec2 during Drosophila development and this interaction affects 
DRhoGEF2 signalling and Drosophila development.
As described above DRhoGEF2 plays a critical role for the well orchestrated 
cell shape changes during Drosophila gastrulation (Barrett et al., 1997; Hacker and 
Perrimon, 1998) and there is evidence suggesting that it is used in other morphogenetic 
events during which epithelial invagination occurs (Nikolaidou and Barrett, 2004). 
During gastrulation DRhoGEF2 mutant embryos have a much stronger phenotype than 
fog  or eta embryos (Barrett et al., 1997) suggesting that there are other signals feeding 
into or out of DRhoGEF2. DRhoGEF2 has multiple domains whose function is more or
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less known or inferred from other studies. However, there are no available data 
regarding the function of its PDZ domain. Preliminary yeast two-hybrid data suggest 
that DRhoGEF2 may interact via its PDZ domain with DMec2. This interaction could 
provide the link between mechanotransduction and Rho signalling pathway. All these 
factors make the interaction between DMec2 and DRhoGEF2 a very interesting one to 
study.
In order to prove or disprove the hypothesis set above, this study looks to 
achieve two main aims. The first is to characterise the function of DMec2 in 
Drosophila development and the second is to provide a better understanding of the 
relationship between DRhoGEF2 and DMec2.
This work is divided in three areas:
1) Analysis of the role of the PDZ domain for the function of DRhoGEF2 (Chapter 3).
2) Analysis of DMec2 loss and overexpression (Chapter 4).
3) Analysis of DMec2 interaction with DRhoGEF2 (Chapter 5).
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II. MATERIALS AND METHODS
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Chapter 2:MATERIALS AND METHODS
1. BIOCHEMISTRY
1.1 Protein Expression and Purification
The wild type PDZ domain of DRhoGEF2 and a mutated form of it were 
obtained separately as recombinant proteins expressed in Escherichia coli. For the 
mutated PDZ the amino acids tyrosine and methionine in the inside of the binding 
pocket were changed for a leucine and a phenylalanine respectively by site-directed 
mutagenesis to alter the binding affinity for the substrate. Using the pET cloning 
system, a fragment encoding the above mentioned PDZ domains was digested from 
pBluescript II SK(+) (Stratagene) and subcloned into the pET28c (Novagen) between 
Smal and Notl sites for PDZ wild type and mutated form and between EcoRI and Notl 
for the Discs Large PDZ domain, to create an N-terminal fusion with a His-tag 
sequence and T7-tag sequence. The verified fusion construct was then transformed into 
BL21 (DE3) E.coli strain (Stratagene) and the bacterial cultures were in Luria-Bertani 
medium supplemented with lOOjag ml' 1 ampicillin. The cultures for the wild type PDZ 
domain and the PDZ domain of Discs Large were incubated overnight at 37°C, instead 
the culture for the mutated form of PDZ was incubated at 30°C. The following day the 
overnight cultures were diluted 1:50 and let seed for 2 hours. Protein expression was 
induced at OD6oo= 0.4-0.6 with 0.5 mM isopropylthiogalactopyranoside (IPTG) and the 
cultures were incubated for 2 hours at 37°C. Cells were harvested by centrifugation at 
lOOOOxg for lOmin and the pellet was immediately used for protein purification. The
69
Chapter 2: Materials and Methods
pellet was resuspended in BugBuster Protein Extraction Reagent (Novagen) at room 
temperature. Benzonase Nuclease was added and the cell suspension was incubated on 
a shaking platform for 20min at room temperature. The resulting cell lysate was 
centrifuged at 16000xg for 20min at 4°C to remove insoluble cell debris. The 
subsequent steps were followed for the wild type PDZ domain as well as for its mutated 
form. The supernatant containing the soluble fraction, was applied to Ni-NTA agarose 
column (Novagen) pre-equilibrated with IX Binding buffer (8 X= 4M NaCl, 160mM 
Tris-HCl, 40mM imidazole, pH 7.9). Binding of the soluble His-tag-PDZ fusion protein 
to the matrix was achieved by gently rocking the column and incubating for 5min after 
this time centrifugation followed at lOOOx g. The flowthrough fraction was collected 
and the matrix was washed extensively with IX Binding buffer and subsequently with 
IX Washing Buffer (8 X= 4M NaCl, 160mM Tris-HCl, 480mM imidazole pH 7.9). The 
His-6 -PDZ fusion was released with elution buffer (4X= 2M NaCl, 80mM Tris-HCl, 
4M imidazole pH 7.9). The purified proteins were analyzed by SDS-PAGE. Pure PDZ 
appeared on the gel as a single band corresponding to a molecular weight of 
approximately 30KDa, in agreement with the calculated value of 23KDa. The PDZ 
domain of Discs Large was found in the inclusion body fraction. The inclusion bodies 
were purified under denaturing conditions at room temperature. The inclusion body 
fraction was solubilized in IX Binding buffer including 6 M urea. The recombinant 
protein was the dialyzed against IX Dialysis Buffer (50X= 1M Tris-HCl, pH 8.5) to 
allow its refolding to occur. The purified protein was analyzed by SDS-PAGE. Pure 
Discs Large PDZ domain appeared on the gel as a single band corresponding to a
70
Chapter 2: Materials and Methods
molecular weight of approximately 30KDa, in agreement with the calculated value of 
23KDa.
1.2 Protein extraction from adult flies eyes
Thirty flies (15 males and 15 females) of each transgenic line were collected 
and put in an eppendorff tube on dry ice for 10 mins. The flies were tipped on the pad 
under the dissecting microscope and decapitated. The heads were immediately put on 
dry ice and lysed in 40jnl of modified RIPA buffer (150mM NaCl; 50mM NaF; 20mM 
HEPES, pH 8 ; 1% Triton X-100; 0.1% SDS; 0.5% sodium deoxycholate) containing a 
cocktail of protease inhibitors (Roche) in 1:1000 dilution. After lysis the eyes were left 
on ice for 10 minutes and then centrifuged at maximum speed for 5 min, at 4°C.
25 pi of the supernatant were removed into a clean eppendorff tube and to it 7pi of 5x 
sample buffer were added. The sample was boiled at 98°C for 2 min and run on the gel 
for the western blot analysis.
1.3 Bradford method
BioRad Protein Assay solution was diluted 1:5 with ddH2 0  and 1ml of that was 
added to2 pi of each sample in plastic cuvettes (10x4x45mm from Starsted). The colour 
intensity was measured using a spectrophotometer (Varian CARY 50 Bio UV-visible) 
at 580nm and the Bradford Assay Software. The program creates a linear curve from 
the standards and calculates the total protein concentration of each sample.
The results were then compared with the standard curve. The BioRad Protein Assay 
solution is a dye reagent concentrate, containing coomassie brilliant blue G-250 dye
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that changes colour on binding to the protein. The protein used as a concentration 
standard was 0.1% Bovine Serum Albumin (BSA).
1.4 Co-Immunoprecipitation Experiments
SR+ or S2 cells were washed three times with ice-cold PBS (Gibco) and were 
lysed on ice with IP buffer (NP-40 1%; Tris 25mM, pH=7.4; NaCl 150mM) containing 
a 1:1000 dilution of a cocktail of protease inhibitors (Roche). Nuclei were discarded 
after centrifugation at 10,000g for 10 min. Sepharose G-beads that have been 
previously washed three times with PBS were incubated for 1 hour at 4°C with T7- 
antibody (Novagen) and mixed with recombinant protein. Lysates were incubated for 2 
h at 4°C with the beads. Immunoprecipitates were collected and washed with the IP 
buffer containing a cocktail of protease inhibitors. Immunoprecipitated proteins were 
eluted with SDS sample buffer and were analysed by 10% SDS-PAGE.
1.5 SDS-PAGE
SDS-PAGE was performed on the immunoprecipitated proteins and cell lysates. 
For Western blotting, samples were transferred to Immobilon (Millipore) by the wet 
method. Following the transfer the membrane was blocked with 5% non-fat dry milk in 
TBS Tween buffer (lOmM TRIS, pH = 8 ; 150mM NaCl; 0.1% Tween) for 1 h at 37 °C 
and incubated with primary antibody anti-c-myc(9E10) (Santa Cruz Biotechnology, 
Inc.) at 1:1000 dilution or with anti-T7 (Novagen), at 1:5000 dilution in 5% non-fat dry 
milk in TBS Tween overnight at 4° on shaking platform. Antibody binding was 
detected using the ECL Western blot detection system (Amersham Corp.)
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2. MOLECULAR BIOLOGY
2.1 5’RACE
To obtain the 5’ end of the DMec2 cDNA 5’ RACE PCR (Smart Race, 
Clonetech) was carried out. The oligonucleotides Race out and Race in and Race_2nd 
(Table 2.1) were used in 35 rounds of PCR to amplify the gene. The RACE product 
was characterized by cloning the fragment directly into pCR-Blunt cloning vector 
(Invitrogen) and transforming into TOP 10 Cells (Invitrogen). Different independent 
clones were picked for diagnostic digest. Once the clone containing the insert was 
identified, it was sequenced. Database searches were performed using the BLAST 
network server and confirmed that we had the full-length mec-2 cDNA.
2.2 Generation of DMec2 Constructs
cDNAs encoding DMec-2myc were generated by PCR using the mec-2 cDNA 
as template. Five different constructs of mec-2 tagged with myc were constructed. In 
DMec-2myc the myc epitope (EQKLISEEDL) was inserted at the amino or carboxy- 
terminus by PCR. The forward primers N1-N4 (Table 2.1) and the reverse primer 
N_rev (Table 2.1) were designed for the generation of the amino-tagged constructs. For 
the carboxy-terminus the forward primer C for (Table 2.1) was designed while the 
reverse primer was C rev (Table 2.1). A Sal I  cloning site and a translational initiation 
sequence were introduced by the primers immediately upstream of the epitope myc tag 
sequence for the amino tagged contstructs. The resulting products for the amino- 
terminus were cloned into the Sal I and the Nde I site of a pBluescript SK I (Stratagene) 
plasmid with already cloned full length MEC-2. The carboxy-terminus product was
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cloned into a MscI and Notl sites of pBluescript SK I plasmid with already cloned full 
length MEC-2. The authenticity of all contracts was subsequently confirmed by 
sequencing. The tagged constructs were subsequently cloned between Kpnl and Notl 
sites of pcDNA3 (Invitrogen) and finally subcloned into pUAST vector between Kpnl 
and Xbal for expression in Drosophila cells using the UAS/GAL4 system.
The point mutations T348A [codon 348 mutated to GCC using primer Mutl(T- 
A) (forward primer) and Mutl/2 (reverse primer), Table 2.1) and the L350A [codon 350 
mutated to CCA using primer Mut2(L-A) (forward primer) and Mutl/2 (reverse 
primer), Table 2.1)] were introduced by PCR with Pfu polymerase (Stratagene) in order 
to generate two mutant forms of DMec2 subcloned into pUAST vector using the 
cloning strategy as described above. That the desired mutations occurred was checked 
by sequencing.
Table 2.1 Primers used for the generation of DMec2 constructs
Sequence Name
GGCGATGTGATGATGAAG Race_out
GACCCGTGACCCCAAAGCAGAA R acein
GTGACCACCCATTCCATG Race_2nd
GAGCGTCGACAAAATGGAACAAAAACTCATCTCAGAAGAGG
ATCTGGAGCCGCACCAGGATTCG
N1
GAGCGTCGACAAAATGGAACAAAAACTCATCTCAGAAGAGG
ATCTGCGCAACTCTGGGCCGGCC
N2
GAGCGTCGACAAAATGGAACAAAAACTCATCTCAGAAGAGG
ATCTGGTCAACATGGGCGCCGCC
N3
GAGCGTCGACAAAATGGAACAAAAACTCATCTCAGAAGAGG
ATCTGGGCGCCGCCGGCATGGCA
N4
GCCGGAAGATGATCGCCCGC N_rev
CCGTATTTGGCCAAATATGC C for
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GACCGGCAGCGGCCGCTCACAGATCCTCTTCTGAGATGAGTT
TTTGTTCTAGGTTGGTTTTTCGGCCA
C re v
CGCCCTAGATTCAAATCATAGGTTGGCTTTCGGCCAAGCGTC
CAGTGCG
Mutl
(T-A)
CGCCCTAGATTCAAATCATGGGTTGGTTTTCGGCCAAGCGTCC
AGTGCG
Mut2
(L-A)
GCCCATGGAGCTGCTGACTCCGTATTTGGCCAAATATG Mutl/2
2.3 Inverse PCR for Recovery of sequences flanking piggyBac elements
Fly genomic DNA was recovered from 30 flies and ground in 400 pi of Buffer 
A (lOOmM Tris-HCl, pH= 7.5; lOOmM EDTA; lOOmM NaCl; 0.5%SDS). The solution 
was incubated at 65°C for 30 min and subsequently 800pl LiCl/KAc solution (2.5v:lv) 
was added. The new solution was incubated for 15min at RT and then spun for 15 min. 
lml of supernatant was transferred into a new tube and respun for lOmin. The clean 
supernatant was transferred into a new tube and 600pi of isopropanol were added, 
mixed and the solution was spun for 15 min at maximum speed. The supernatant was 
aspirated away, pulsed, aspirated, washed with 70% ethanol and let to dry. The pellet 
was resuspended in 150pl TE and stored at -20°C.
Separate digestions with Sau3A I (Promega) and HinPl I (New England Biolabs) 
followed and the digested DNA was ligated with T4 ligase (New England Biolabs).
The ligated DNA was used for the inverse PCR.
lOpl of ligated DNA were used for the first round of PCR together with 2mM each 
dNTP, lpM  forward primer, lpM  reverse primer, lx  Taq Buffer, 2 units Taq 
polymerase (Sigma) and ddH2 0 . Run on the following PCR program:
1) 95°C for 5min
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2) 95°C for 30 sec
55°C for lmin 
72°C for 2 min
Go to 2x 34
3) 72°C for 1 Omin
The first PCR product was diluted 1:10 and the second PCR round followed using the 
same program as above with the second round primers. Purified second round PCR 
product was cloned into pGEM-T easy vector (Promega) in a 3:1 insert to vector ratio.
Table 2.2 Primers used for Inverse PCR on piggyBac DMec2 lines
Sequence Name
GACGCATGATTATCTTTTACGTGAC 5F1
TGACACTTACCGCATTGACA 5R1
GCGATGACGAGCTTGTTGGTG 5F2
TCCAAGCGGCGACTGAGATG 5R2
CAACATGACTGTTTTTAAAGTACAAA 3F1
GTGAGAAACAACTTTGGCACATATC 3R1
CCTCG AT AT AC AG ACCG AT AAAAC 3F2
TGCATTTGCCTTTCGCCTTAT 3R2
2.4 Screening by PCR EMS and X-ray treated flies
Four Ethylmethane Sulfonate (EMS) -induced mutant lines of DRhoGEF2 and 
six X-ray induced mutant lines of DRhoGEF2 were screened by PCR for mutation in 
the PDZ domain. First, the PCR conditions were set using as a template genomic DNA 
from wild type flies. For this three positive controls were used: i) genomic DNA with 
primers map6  and map 7, ii) genomic DNA with control primers, iii) plasmid DNA 
with experimental primers (EXSEQ1-5 and Newl and New2) (Table2.3). For the 
screening, DNA was extracted from stage 15-16 homozygous embryos as selected for 
the absence of GFP expression. In order to verify that no heterozygous, GFP expressing
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embryos were selected by mistake GFP primers (Table 2.3) were used as controls. The 
purified PCR product was cloned into pGEM-T easy vector (Promega) and sent for 
sequencing (MWG, Biotech).
Table 2.3 Primers used to screen EMS and X-ray treated flies
Sequence Name Exons
covered
GCTGCCAGATATCAAGATG EXSEQ1 3,4
CCAAATCTCCTCAGACCA EXSEQ2 4,5
GTAGCCTCAATCTGACTC EXSEQ3 4,5
GCTT AATG AGCCT GT GC A EXSEQ4 6,7
ATGGAGATTTCGCCTTCG EXSEQ5 6,7
GGTGTCCGCTCTGACCCATTAGTATAG Map6 9,10,11
GCGCAAGCCATACATATTCCAATGCC Map7 9.10,11
CCTCTCATAGATGATTGAGCTGGCAATCCGC Newl 3,4
ACGCCTCGAG AAACCGCT ACCT AG AAATCCCC New2 4,5
GGAGTGGTCCCAGTTCTTGTT GFP for N/A
TCTGGTAAAAGGACAGGGCCAT GFP rev N/A
3. CELL BIOLOGY
3.1 Cell transfections and Fixation
S2R+ cells were maintained in Schneider’s Drosophila medium containing 10% 
fetal calf serum (FCS), penicillin and streptomycin from Invitrogen (Carlsbad, CA). For 
transfections cells were seeded at 106 cells m l'1. Transfection reagents Fugene (Roche 
Molecular) or Cellfectin (Invitrogen) were used at a concentration of 3 pi pg'1 or 10 pi 
pg' 1 respectively of plasmid DNA (0.5pg). Transfections took place after 24 hours, and 
were maintained in the Schneider’s Drosophila Medium containing 10% fetal calf 
serum (FCS), penicillin and streptomycin for 3 days until fixation or co- 
immunoprecipitation experiments. Cellular extracts for immunoblotting were prepared
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in lysis buffer (NP-40 1%, Tris 25mM, pH=7.4, NaCl 150mM). For
immunofluorescence studies S2 cells were plated on glass bottom 35mm microwell 
slide (Nunc) coated with concanavalin A 0.5mg/ml and washed with acid. S2R+ cells 
were plated on the same slides that have been previously coated with fetal calf serum 
for 2 hours at 37 °C. The cells were then fixed with 4% paraformaldehyde (PFA). For 
immunofluorescence studies to visualise DRhoGEF2 and DRhoGEF2APDZ 
localisation S2R+/S2 cells were rinsed in HL3 buffer (70mM NaCl, 5Mm KC1, 1.5mM 
CaCh, 20mM MgCh, lOMm NaHCC>3, 5mM trehalose, 115Mm sucrose, and 5Mm 
HEPES [pH 7.2] and fixed for lOmin with 10% paraformaldehyde (Sigma) in HL3 
buffer; for experiments in which microtubules were visualized and Mec2 at microtubule 
plus ends, cells were fixed for 10 min in a prechilled mixture (to -80°) of 3.2% 
paraformaldehyde in methanol. This fixation protocol was essential to preserve 
microtubule tip association. The cells were then washed and permeabilized with 0.1 % 
Triton X-100 in PBS (PBST), blocked in 5% normal goat serum in PBST, and treated 
with primary antibodies in the same solution for 1 hr.
3.2 Immunofluorescence
To visualize F-actin, the cells were plated on serum-coated slides for 1-2 hr 
before fixation in 4% paraformaldehyde in PBS for 20 min and stained them with 
TRITC-labeled phalloidin (Sigma) (Table 2.4). To visualize DMec2myc myc antibody 
(Santa Cruz Biotechnology Inc.) was used 1:150 for immunofluorescence (Table 2.4). 
DRhoGEF2 antibody was used 1:500 (Table 2.4). Anti a-tubulin antibody was used at
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1:1000 (Table 2.4). Anti-clathrin (abeam) was used in 1:1000 dilution (Table 2.4). 
After being washed, the cells were stained with secondary antibodies (Alexa 488, Alexa 
568, Alexa 350 at a dilution 1:250). After being washed in PBST, the cells were rinsed 
in distilled water and mounted in fuorescence mounting medium (Dako Cytomation, 
Carpinteria, CA).
Table 2.4 Antibodies used for western blots and immunofluorescence
Antigen Source Obtained from Dilution
a-myc Mouse Santa Cruz 
Biotechnology
1 :150  (immunostaining) 
1 :1000  (western)
a-tubulin Rat Zymed Lab. Inc 1 :1000  (immunostaining)
a-tubulin Mouse Sigma 1 :5000  (western)
a-T7 Mouse Novagen 1:5 0 0 0  (western)
a-
RhoGEF2
Rabbit Rogers, S. 1 :100  (immunostaining)
a-clathrin Mouse Abeam Ltd. 1 :1000  (immunostaining)
Phalloidin-
TRITC
Amanita
phalloides
Sigma 1 :5 0 0 0  (immunostaining)
a-stomatin Rabbit Stewart, G.W 1:1 OOO(westem)
3.3 RNAi experiment
Briefly 2xl06 cells in lOpl serum free Schneider’s medium were added to 0.3pg 
ds RNA against DMec2 in an eppendorf tube, centrifuged at 1,200 rpm for lmin, then 
incubated at room temperature for 30 min before adding 300pl of more medium with 
serum and antibiotics. Cells were grown for 6  days at 23°C before being harvested for 
microscopic analysis or western blotting. Controls cells without being treated with ds 
RNA were grown in parallel. For the microscopic analysis cells were fixed for lOmin in 
4% paraformaldehyde in phosphate-buffered saline (PBS), washed twice in PBS with
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0.1% PBST, stained overnight at 4°C with anti-tubulin (DM1 A; Sigma) or TRITC- 
phalloidin (Sigma) in PBST with 3% bovine serum albumin, stained for 10 min in PBS 
with secondary antibody (Alexa, 568) for the anti-tubulim treated cells and washed with 
PBS.
3.4 Shear Stress Experiment
Laminar shear stress was applied to cells for various times ranging from 5 to 20 
min using parallel plate flow chambers set in series in a closed circulating system with 
0% CO2 at 37 °C. Parallel plate flow chambers were custom-made a Glaxo Wellcome, 
and circulation of the medium was produced by a peristaltic pump (Masterlex) 
calibrated to deliver a shear stress of 3 dyn/cm . The chambers were assembled as 
described previously (Houston et al., 1999). The level of shear stress chosen for the 
experiments corresponded to the physiological level of shear stress in venous vessels 
(Morawietz et al., 2000). Static controls were performed on cells not subjected to shear 
stress.
4. DEVELOPMENTAL BIOLOGY AND GENETICS
4.1 Fly husbandry
Males and females were crossed for each genetic experiment following the 
standard mating procedure (Ashbumer 1989; Greenspan 1997). The fly lines were kept 
and used under the standard methods (Asbumer 1989; Greenspan 1997). The fly food 
used was prepared by organic 210gr of molasses (Potter’s) 32gr of Agar (Sigma), 210gr 
of commeal (William Lilco and Sons), lOOgr of baker’s yeast (Westwood
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International), 90ml of Nipagin (p-hydroxybenzoic methyl acid ester from Sigma) and 
32 ml of propionic acid (Sigma), for every 3L batch of food.
4.2 Preparation of egg-laying plates
375ml of ddHiO and 11.25gr of agar (Sigma) were put into a 500ml pyrex 
beaker, and boiled in a microwave or an autoclave to dissolve the agar. In a 200ml 
conical pyrex flask 12.5gr of sucrose (Merck) and 125ml of organic apple juice (Tesco) 
were also brought to boil. Afterwards, the two solutions were mixed and microwaved 
for 5 minutes on high power. The mixture was then left to cool down to 50°C and 
poured into 60mm bacterial plates (Sarstedt). The plates were left to cool until their 
content solidified and then were put into plastic bags or wrapped in parafilm and stored 
at 4°C.
4.3 Preparation of yeast paste
Yeast paste was prepared by mixing granules of yeast (Westwood International) 
with tap water, almost in 1:1 weight to volume ratio, until the yeast granules were 
dissolved and the mixture became a paste. Yeast paste was kept at 4°C.
4.4 Collection and dechorination of embryos
Wine vinegar (Tesco) was spread by a brush on egg-laying plates and a small 
amount of yeast paste was applied to the plate. The plate was then placed on the 
opening of the cage, a 250ml aerated beaker containing flies. The flies laid their eggs
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on the plate. After the appropriate collection time, the plate was replaced with a fresh 
one.
To remove the outer chorion layer of the embryo the embryos were placed in a 
small basket with a porous bottom and the basket was placed in a 50ml beaker 
containing 20ml of 50% sodium hypochlorite (BDH), which was then incubated at 
room temperature for exactly 2 minutes. Subsequently, the embryos were washed 
thoroughly with water.
4.5 Study of embryogenesis of four DRhoGEF2 transgenic lines
125 DRhoGEF2 transgenic embryos from 4 different lines were collected and 
placed only- agar egg-laying plates. The plates with the embryos were incubated at 
25°C and scored every 24 hours for three days. The dead embryos, chorions and larvae 
that hatched from each plate were counted.
4.6 Balancers
Balancers allow maintenance of the mutation, viability of the line and provide a 
marker to identify in which of the two chromosomes of the homologous pair the 
mutation is carried (Ashbumer 1989; Greenspan 1997). Balancers are chromosomes 
that have undergone significant rearrangements caused by big inversions in most 
regions of the chromosome that prevent recombination between homologous 
chromosomes (Ashbumer 1989; Greenspan 1997). Balancer chromosomes also possess 
scorable, usually dominant, markers (Table 2.5)
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Table 2.5 Balancer lines
Names Genotype Source
FM7c y[ 1 ]arm[4]w[*]/FM7c, 
P{ry[+t7.21=ftz/lacC}YHl
Bloomington
616
FM7d P {ry[+t7.2]=ftz/lacC} YH1,
o c riip tg m /c (i)D x ,ym f n i
Bloomington
5267
FM7i P{ry[+t7.2]=ftz/lacC}YHl, 
w[+]/C(l)DX, y[l]fll]
Bloomington
5438
FM6 /CyO RpS5a[2]/FM6;noc[Sco] 1 (2)37 
Ca[4]pr[l]/CyO
Bloomington
438
FM7a/CyO FM7a, 1 (1 )TW24[ 1 ]/oc[ 1 ]ptg[3] 
1 (1 )TW[cs];CyO/1 (2)DTS91 [ 1 ]
Bloomington
4558
4.7 Ectopic gene expression
Ectopic expression of genes is achieved by the use of transgenes. This transgene 
would carry the gene of interest under a specific promoter, (Table 2.6). The transgenic 
lines used here had the gene of interest under the control of the yeast Upstream 
Activation Sequence (UAS). Introduction of only this transgene into a fly is inert, 
unless the gene that activates the promoter, the yeast gene GAL4 is introduced, which 
is usually downstream of a fly tissue specific promoter. When the fly tissue specific 
promoter is activated, it activates the expression of the GAL4. GAL4 then binds to the 
UAS sequence of the second transgene and activates the expression of the gene of 
interest in the expression domain of the promoter of the GAL4 transgene (Table 2.6) 
(Brand and Perrimon 1993; Brand et al., 1994; Phelps and Brand, 1998).
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Table 2.6 GAL4 lines
Name Genotype Comments
VP-16-V32 Mata4-Gal4
VP16V32Ap{w+}
Maternal Gal4 driver
Eyeless recessive Eye Gal 4 driver
MS 1096 X chromosome Wing Gal driver
Tubulin Tubulin-
Gal4/TM3
Ubiquitous driver
Daughterless recessive Ubiquitous driver
4.8 Drosophila lines used
Table 2.7: Wild type, mutants DMec2 and DRhoGEF2 alleles
Name Genotype Comments Source Reference
OregoR +/+ Sally Leevers Lindsley and 
Zimm,
1992)
18428 w[ 118]PBac (w+[Mc]= 
WH}Mec2[f01352]
piggyBac
insertion
Bloomington unpublished
18965 w[ 118]PBac (w+[Mc]= 
WH}Mec2[f06342]
piggyBac
insertion
Bloomington unpublished
RhoGEF24 1 RhoGEF24 VCyOftzlacZ EMS allele 
Null
Kathy Barrett Barrett et al., 
1997
RhoGEF2" RhoGEF21 '/CyOftzlacZ EMS allele 
Null
Kathy Barrett Barrett et al., 
1997
RhoGEF26 1 RhoGEF26 VCyOftzlacZ P-element
excision
Kathy Barrett Nikolaidou 
and Barrett, 
2004
4.9 Wing mounting
Adult flies were collected and placed in SH buffer (3 parts ethanol and 1 part 
glycerol). Wings were removed by holding the fly from the thorax and pulling the wing 
gently from the hinge with No5 tweezers in SH buffer. The wings were then placed in 
water and rinsed twice, then placed in ethanol. 30pl of Euparal mountant (Agar) were
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placed on a microscopic slide (BDH) for 8-12 wings. The tweezers were then placed 
underneath the wings, any drops of ethanol carried on the tweezers were removed by a 
tissue and the wings were placed in the Euparal drop on the slide. Wings that became 
folded were spread by the tweezers without damaging then and any bubbles in the 
mountant were removed. A glass coverslip (22x50mm or 18x24mm from BDH 
depending on the number of wings on the slide) was carefully placed on top of the 
wings to avoid making bubbles. The slide was then placed on a hot plate at 60°C for 24 
hours with a weight on top of the cover slip to keep the wings flat. The wings were then 
visualised and images were collected on a high resolution microscope.
4.10 Scanning Electron Microscopy (SEM) for adult eyes
• Preparation of the fly eves
Females of the appropriate genotype were transferred to vials with fresh food 
without yeast and left for 24 hrs to clear their eyes. The eyes were checked with a 
dissecting microscope and they were placed in small glass vials in 25% ethanol. The 
flies were then dehydrated for 12 hours through ethanol series each of 25%, 50%, 75%, 
100%. The wash in 100% ethanol was repeated twice. The flies can be kept in 100% 
ethanol for at least one month. The ethanol was then substituted by 100% amyl acetate 
(Sigma) and the flies were left in this solution overnight. The amyl acetate was then 
removed and replaced with fresh amyl acetate.
• Drying
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After dehydration the eyes were dessicated in the critical point dryer with the 
help of Mark Turmaine in the electron microscopy suite of the Anatomy and 
Developmental Biology Department of the University College London.
Polypropylene containers (Agar) that were thoroughly cleaned were labeled with a 
diamond knife and placed in Petri dish containing amyl acetate. The flies were 
transferred to the containers, which were wiped gently and placed in the “boat”. The 
metal grills were placed on the top of the containers in the boat and the boat placed in 
the critical point drier. Critical point drying was carried out according to the 
manufacturers’ instructions.
• Mounting
The flies were mounted with the left eye uppermost using a dissecting 
microscope, on 12mm double sided sticky carbon tabs (Agar) on 0.5” stubs (Agar). 
The eyes were arranged at the edge of the circular stub and looking upwards. Any dust 
on the eyes was carefully removed with a fine paint-brush. Mounted stubs were stored 
with silica gel in a vacuum.
• Gold coating
For SEMs the flies needed to be coated with gold. Six stubs were placed into the 
electrospray coater and manufacturer’s instructions were followed.
• Collection of data
To collect the data usually two stubs of flies, maximum of four, were placed in 
the specific plates of the scanning electron microscope and a vacuum was generated 
inside the cylinder of the microscope. The brightness and the contrast were equilibrated 
in order to avoid charging and saturation. Using the microscope knobs, the fly eye
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could be removed or placed at any angle to achieve the best field of view. All the eyes 
on the stub were observed (25-40 per genotype and photographs of the most 
representative eyes per genotype were taken.
4.11 Sectioning of adult eyes
• Fixation:
The dissected tissue was fixed into 0.5ml pre-cooled 2% glutaraldehyde in 0.1 M 
PO4 (0.2M Na2HPC>4 and 0.2M NaH2P0 4  in a 72/28 ratio respectively and then added 
the same volume of water), lml of 1% osmium was added in 0.1 M PO4. The tissue was 
incubated on ice for 30 min. The glutaraldehyde/osmium mixture was removed as much 
as necessary so that the tissue was still covered. The tissue was washed with cold PO4. 
The tube was filled with PO4. The PO4 was removed, leaving enough to keep the tissue 
covered, replaced with 0.5ml of osmium buffer and incubated for 2 hours on ice.
• Dehydration:
The tissue was rinsed with 0.1M PO4 and dehydrated by adding on ice 30% 
ethanol for 10 min (the tissue remained covered with liquid at all times). Dehydration 
by ethanol series followed as described below:
50% ethanol for lOmin 
70% ethanol for 10 min 
90% ethanol for 1 Omin 
1 0 0 % ethanol for 1 0  min twice.
The ethanol was replaced with propylene oxide for 10 min at room temperature, 
twice. An equal volume of Durcupan resin (soft resin ~100ml= Resin A: 54gr,
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Hardener B: 44.5gr, Accelerator C: 2.5gr, Plastciser D: lOgr. Mixed thoroughly for a 
long time until the colour was homogeneous and there were no fiber like structures in 
the solution) to propylene oxide was added and mixed well. Incubated overnight at 
room temperature.
• Embedding:
The resin was placed in the moulds and one specimen per mould was added. 
The tissue was oriented so that a flat surface was resting on the bottom of the mould 
very close to the edge to be cut and in the right orientation. The resin was baked at 70°C 
for exactly 36 hours.
• Sectioning:
The sectioning was performed in a microtome which was set to cut 1 micron 
sections. Sets of 10 sections were put into a separate drop of water on multispot, coated, 
microscope slides (C.A. Hendley Ltd). The water was dried from the slide on a heater 
set at >70°C. The sections were stained in toluidine blue solution (toluidine blue mixed 
dissolved with borax to 1% final concentration for each in water. Filtered before use for 
3 min. Visualised and photographed on high resolution microscope.
4.12 Genetic crosses for rescue experiment
For the rescue experiment the following crosses were set: 
w; If/CyO;MKRS/TM6 BHu x w;+; da-GAL4, w; If/+; da-GAL4/TM6BHu x w; 
CyO/+; da-GAL4/TM6BHu, w; If/CyO;da-GAL4, w;Sp/Cyoftz; Dr/TM3ftzlacZ x w; 
6.1/CyO; MKRS/TM5BHu, w;6.1/CyOftz; Dr/TM6 BHu, w; 6.1/CyOftz/Dr/TM6BHu x
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w; If/Cyoftz; da-GAL4, w; 6.1/CyOftz; da-GAL4/TM6BHu x w; 6.1/CyOftz; da- 
GAL4/TM6BHu, w;6.1/CyOftz; Dr/da-GAL4 x w; 4.1/CyO; transgenic line, 
w; 6 .1/4.1; Dr/transgenic line was compared to w; 6 .1/4.1; da-Gal4/transgenic line, 
w; 4.1/CyO; MKRS/TM6 BHu x w; CyO/Sp;transgenic line, w; 4.1/CyO; transgenic 
line/TM6 BHu (inter se), w; 4.1/CyO/transgenic line (inter se), w; Sp/CyOftz; 
Dr/TM3ftz x w; 4.1/CyO; MKRS/TM6 BHu, w; 4.1/CyOftz; Dr/TM6 BHu (inter se), w; 
4.1/CyOftz; Dr/TM6 BHu x w; CyO/Sp; transgenic line, w; 6.1/CyO; da-GAL4 x w; 
4.1/CyO; Dr/transgenic line.
w; 6 .1/4.1; Dr/da-Gal4 was compared to w; 6.1/4.1;transgenic line/da-GAL4 
w; If/CyO; MKRS/TM6 BHu x w; +; tub-GAL4/TM3 Sb, w; If/+; TM6BHu/tub-GAL4 
x w; Cyo/+; TM6BHu/tub-GAL4, w; If/CyO; tub-GAL4/TM6BHu (inter se), w; 
6.1/CyOftz; Dr/TM6 BHu x w; If/CyO; tub-GAL4/TM6BHu, w; 6.1/CyO; Dr/tub- 
GAL4 x w; 4.1/CyO;transgenic line, w; 6 .1/4.1; Dr/transgenic line was compared to w; 
6 .1/4.1; tub-GAL4/transgenic line.
w; 6.1/CyO; tub-GAL4/TM3 x w; 4.1/CyO; transgenic line/Dr 
w; 6.1/CyO; tub-GAL4/+ was compared to w; 6.1/CyO; tub-GAL4/transgenic line 
w; Sp/Cyoftz; Dr/TM3ftz x w; l.l/CyO;+, w; 1.1/CyOftz; Dr/+ x w; 1.1/CyOftz; 
TM3ftz/+, w; 1.1/CyOftz; Dr/+ x w; 1.1/CyOftz; TM3ftz/+, w; 1.1/CyOftz; Dr/TM3ftz 
(inter se), w; 1.1/CyOftz; Dr/TM3fitz x w; If/CyO; da-GAL4, w; 1.1/CyO; da-GAL4 
(inter se), w; 1.1/CyO; da-GAL4/TM3ftz x w; 1.1/CyO; da-GAL4/TM3fitz 
w; 1.1/CyO; Dr/daGAL4 x w; 4.1/CyO; transgenic line
w; 1.1/4.1; Dr/transgenic line was compared to w; 1.1/4.1; da-GAL4/transgenic line
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w; 1.1/CyO; da-GAL4 x w; 4.1/CyO; Dr/transgenic line w ;l.1/4.1; da/GAL4/transgenic 
line was compared to w; 1.1/4.1; da-GAL4/Dr
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Chapter 3: STUDY OF THE FUNCTION OF THE PDZ DOMAIN
1. INTRODUCTION
Rho guanine exchange factors (GEFs) activate GTPases by catalyzing the 
exchange of GDP by GTP (Erickson and Cerione, 2004). Because GEFs interact 
directly with their effector GTPases (Snyder et al., 2000) Rho GEF localisation can 
determine the spatial pattern of GTPase activity (Gulli and Peter, 2001). This 
localization is regulated by mechanisms that are not the same for all members of the 
Rho GEF family, however, as these possess different domains that can interact with 
various proteins and phospholipids which can determine their targeting (Rossman et al., 
2005).
For example, the Ras-specific GEF, Son-of-sevenless, appears to be regulated in 
part by recruitment to the plasma membrane via the binding of the adaptor protein, 
Grb2, to an activated receptor tyrosine kinase (Egan et al., 1993). Other GEFs utilise 
other regulatory mechanisms. Indeed, several previously described Rho GEFs can be 
activated by deletion of regions of the protein outside of the conserved Dbl domain, 
suggesting that GEF activity in these proteins is normally repressed (Whitehead et al., 
1997). Moreover, most of the Rho GEF proteins contain various additional domains that 
have been implicated in signal transduction, suggesting that they may be regulated by 
diverse inputs (Whitehead et al., 1997). For example the GEF activity of the Vav 
protein is regulated both by diacylglycerol binding (Gulbins et al., 1994) and by direct 
tyrosine phosphorylation (Crespo et al., 1997).
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There is evidence suggesting that DRhoGEF2 is used during epithelial 
invagination events such as gastrulation (Barrett, et al., 1997), salivary gland formation 
and imaginal disc folding (Nikolaidou and Barrett, 2004) and thus it is potentially 
responsible for selecting the outcome of Rho 1 activation. However, it is not known how 
DRhoGEF2 function is regulated.
DRhoGEF2 is a multidomain protein of 297 kDa belonging to the Dbl family of 
oncogenes. As all members of the family possesses a Pleckstrin homology (PH) 
domain, adjacent and C-terminal to the Dbl homology (DH) domain (Hacker and 
Perrimon, 1998). The tandem DH-PH domains represent the structural module 
responsible for catalysing the GDP-GTP exchange reaction of Rho 1 protein (Snyder et 
al., 2002). In addition, the PH domain is thought to serve as a membrane-targeting 
signal (Bottomley et al., 1998). DRhoGEF2 has also an RGS domain that, by homology 
to the mammalian and C. elegans pathway, is presumed to interact with the Ga subunit 
of a heterotrimeric G protein (Ross and Wilkie, 2000; Fukuhara et al., 2001), called 
Concertina (Cta) (Parks and Wieschaus, 1991). In its central region it contains a 
Phorbol Ester Binding (C l) domain, which is very similar to the Cl domain in Protein 
Kinase C (PKC) (Kang et al., 2006). In PKC this domain binds to phorbol ester 
Diacylglycerol (DAG) and activates the kinase (Benjamin, 2000). Similar to the PH 
domain, this motif could promote membrane association of DRhoGEF2 via lipid 
interaction and activation in response to specific signals. Lastly, at the amino-terminal, 
there is a PDZ domain whose function has not been characterized yet.
The PDZ domain is a widespread modular protein motif and has been implicated 
in the recruitment of signalling molecules to the plasma membrane by binding to the
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carboxyl terminus of transmembrane receptors (Jelen et al., 2003) or by forming 
heterodimers with other PDZ domain-containing proteins (Fan and Zhang, 2002). 
Therefore, the DRhoGEF2-PDZ domain might link the DRhoGEF2 to similar proteins 
present in invaginating tissues.
The presence of three different regulatory domains might provide a mechanism 
to activate DRhoGEF2 to different levels in response to different signals; for example, 
Cl or PH domain could be involved in keeping the cell shape throughout the epithelium 
while the PDZ domain could mediate discrete signals present locally in the invaginating 
tissues.
This chapter is an analysis of the functional role in vivo of the PDZ domain of 
DRhoGEF2. Studying the function of PDZ domain would provide a better insight into 
the Rho signalling pathway and a better understanding of the function and regulation of 
DRhoGEF2.
2. RESULTS
2.1 Looking for PDZ fly mutants
To address the function of the PDZ domain it was necessary to have mutant 
flies for this part of the protein in order to compare them with wild type flies. 
Therefore, in order to study the role of the PDZ domain for the function of DRhoGEF2, 
ten different lines of flies harboring ethyl methane sulfonate (EMS) and X-ray 
mutations (gift of H. Bellen, Baylor College of Medicine, Houston) were screened by 
PCR with the aim of finding mutations in the PDZ domain coding region. Flies that
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harboured mutations and were balanced with a modified CyO balancer chromosome 
consisting of green fluorescent protein (GFP) driven indirectly by a Kruppel (Kr) 
promoter, via the yeast GAL4-UAS regulatory system (Casso et al., 2000), were used to 
isolate homozygous DNA. GFP fluorescence could be seen in embryos as early as the 
germ band extension stage (stages 9-12); expression faded markedly during germ band 
retraction (stages 13 and 14), but increased again at the end of embryogenesis, 
culminating in strong expression in the Bolvig’s organs, and the posterior spiracles. In 
addition, GFP fluorescence was observed in macrophages which distributed in a 
punctuate pattern. Expression of GFP could also be seen in larvae, pupae, and adults. 
Homozygous potentially mutant progeny were scored using a Leica Fluorescent 
Dissecting Microscope with a long pass GFP Endow filter cube and selected by the 
absence of the marker at stage 15-16 for extraction of genomic DNA.
Firstly, PCR conditions had to be tested and optimised for every set of primers. 
The gene sequence, encoding the PDZ domain, spans from exon 3 to exon 6 (Fig.
3.1 A). Four sets of primers giving a PCR product of 300-600bp, were designed to cover 
exons and intron-exon boundaries spanning from exon 3 to exon 6 in order to cover the 
genomic fragment encoding the PDZ domain. As a control to check the absence of 
contamination with the balancer chromosome, primers specific for the GFP sequence 
were used as well with the same DNA samples. PCR products with the GFP primers 
were absent confirming the purity of the DNA preparation. The PCR products were 
purified, cloned into pGEM-T Easy vector (Invitrogen) and sequenced (MWG, using 
primers T7 and T3). Sequencing of the coding region of the Drosophila RhoGEF2-PDZ 
locus from each of the ten available lines of flies treated with ethylmethane sulfonate
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and X-ray did not show discrepancies between the generated sequence and the known 
DRhoGEF2 (accession number AF032870) (Fig.3.1A). Few point changes were 
observed in intron sequences. In conclusion, DNA sequence analysis of the EMS and 
X-ray treated flies revealed no mutation in the PDZ domain.
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Figure 3.1: A) Schematic representation of DRhoGEF2 gene: bands indicate the exons, 
the number inside the band indicates the length of the exon in base pairs, the number on 
top of the bands indicates the number of exon, and the arrows indicate the primer pairs 
used for the sequencing of PDZ locus (encoded by exons 3-6). B) Schematic 
representation of the DRhoGEF2APDZ construct.
Due to the lack of available fly mutants for the region of interest whose 
phenotypic analysis might have helped in the attribution of a functional role, a construct 
of DRhoGEF2 lacking the PDZ domain was generated (DRhoGEF2APDZ) (S. 
Rahman, unpublished) (Fig. 3.IB). The construct DRhoGEF2APDZ was generated by
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excision of the entire PDZ domain from DRhoGEF2 cDNA and then subcloned into a 
UAS vector. In order to study the role of the PDZ domain for the function of 
DRhoGEF2, this construct was used for expression under the control of the GAL4/UAS 
expression system (Brand and Perrimon, 1993) in Drosophila cell lines as well as for 
the generation of transgenic flies.
2.2 PDZ domain is not involved in the cell shape changes associated with 
overxpression of DRhoGEF2 in Drosophila S2R+ cells.
Since there were not available fly mutants, a first approach undertaken to study 
the role of the PDZ domain was the use of tissue culture Drosophila cells as a model 
system. It was hypothesized that the PDZ domain could act as a regulator of the activity 
of DRhoGEF2. Overexpression of full length wild type DRhoGEF2 leads to the 
rounding of Drosophila cells (Rogers et al., 2004). If PDZ acted as a negative regulator 
of DRhoGEF2, overexpression of the DRhoGEF2APDZ construct in S2R+ cells should 
cause enhanced cell rounding. On the contrary, if it acted as a positive regulator 
overexpression of DRhoGEF2APDZ should not cause the observed phenotype. For this 
experiment, a set of S2R+ cells was transfected with expression vector for full length 
wild type DRhoGEF2 and another set with expression vector for the DRhoGEF2APDZ 
construct, under the control of GAL4/UAS system. Cells for the two sets were plated at 
the same density (106 cells/cm2), that is confluent upon plating. The cultures were 
seeded for 2 days. The cell density should not have been modified during the course of 
the study as these cells have been observed to divide every 2 days. The transfected cells
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were identified with an antibody raised against DRhoGEF2. The actin cytoskeleton was 
visualized using TRITC-phalloidin. It was observed that wild type S2R+ cells spread 
well on the substrate and take up a flatten morphology upon plating on a plastic surface 
(Fig. 3.2A-C); in contrast cells overexpressing DRhoGEF2 were rounded (Fig. 3.2D-F). 
The same morphology was observed in cells overexpressing the DRhoGEF2APDZ 
construct (Fig.3.2G-I).
Actin DRhoGEF2 Merge
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DRhoGEF2
DRhoGEF2APDZ
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Figure 3.2: Overexpression of DRhoGEF2 and DRhoGEF2APDZ in S2R+ cells. 
Panels A, D, G show the actin cytoskeleton (red) stained with TRITC-phalloidin. 
Panels B, E, H show the transfected cells (green) as stained with an antibody against 
DRhoGEF2. Panels C, F, I are a merge of the phalloidin with a-DRhoGEF2. 
Overexpression of DRhoGEF2 and DRhoGEF2APDZ causes the cells to round up.
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Figure 3.3: Quantification of cells with round shape after overexpression with 
DRhoGEF2 or DRhoGEF2APDZ. Statistical significance was determined for the 
difference in cell diameter for cells overexpressing DRhoGEF2 or DRhoGEF2APDZ 
compared to control by Student’s t test where P < 0.005. The results show the average 
cell diameter (n=100) ± S.D. from a single representative experiment.
Measurements of the diameter of the transfected cells indicated no difference in the 
degree of rounding between the cells overexpressing DRhoGEF2 versus cells 
overexpressing DRhoGEF2APDZ. Quantification of the observed phenotype (Fig.3.3) 
showed that most of the DRhoGEF2APDZ expressing cells duplicated the morphology 
produced by DRhoGEF2 overexpression. The average cell diameter for both samples 
was approximately 14pm instead for the control cells was approximately 24pm. 
Therefore the PDZ domain does not enhance nor inhibit the unusual phenotype 
associated with DRhoGEF2 overexpression. The results show that the PDZ domain 
does not act as a regulator of the activity of DRhoGEF2 in this specific system used 
here.
It was then hypothesized that the PDZ domain is involved in the placing of 
DRhoGEF2 to the plasma membrane where it can interact with other partners to induce 
the cell shape changes. If the PDZ domain was important for the localization of the
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protein then it was expected to obtain different staining pattern for the DRhoGEF2 
when cells were overexpressing the full length protein versus the cells overexpressing 
the construct DRhoGEF2APDZ. Cells overexpressing DRhoGEF2 showed a staining 
for the protein, distributed through out the cytoplasm of the S2R+ cells (Fig. 3.2E). 
There was no difference in the staining pattern for the protein when cells were 
transfected with DRhoGEF2APDZ (Fig. 3.2H). Since overexpressed DRhoGEF2 is 
found abundantly in the cytoplasm it is not possible to assess what happened to the 
protein localization with the DRhoGEF2APDZ. With the system used here it cannot be 
concluded whether the PDZ domain is involved or not in the localization of the protein. 
The question regarding the functional role of the PDZ domain might be better 
addressed if the Rhol pathway is activated and the other interacting partners of 
DRhoGEF2 are expressed at the appropriate levels in the used system. Consequently, it 
is necessary to try various conditions in order to conclude whether the PDZ domain has 
a functional or structural role.
2.3 The role of the PDZ domain in different Drosophila tissues
To address the role of the PDZ domain as a positive or negative regulator for the 
activity of DRhoGEF2 the transgenic approach was subsequently used in order to study 
that in the fly as the tissue culture cells is a simple system and components of the Rho 
signaling pathway might be missing or not expressed at the appropriate levels. 
Transgenic flies that expressed wild type DRhoGEF2 (EMBL) and transgenic flies that 
expressed DRhoGEF2APDZ (EMBL) under the control of the GAL4-UAS expression
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system (Brand and Perrimon, 1993) were generated. The aim was to study the effects of 
the DRhoGEF2APDZ construct in the fly using different drivers and compare these 
effects with the effects of the wild type transgene.
Firstly, the effects of overexpression of three different lines of wild type 
DRhoGEF2 transgenes (denoted as RG2-la, RG2-6a, and RG2-6b) were tested using 
three different GAL4 drivers because different drivers cause different expression levels 
of the transgene. To drive expression of wild type DRhoGEF2 the eyeless-GAL4 (ey- 
GAL4) was used which targets expression to the eye. In addition, the MS1096-GAL4 
line was used which directs expression in the wing imaginal disc, and the VP16-V32- 
GAL4 which is a ubiquitously expressing driver. Crosses were carried out at 25°C and 
18°C to account for different expression levels due to temperature (Duffy, 2002). 
Overexpression of wild type DRhoGEF2 with any of the three aforementioned drivers 
caused a high lethality levels in all transgenic lines at both temperatures (Table 3.1, 3.2 
and Fig. 3.4., 3.5). These results suggested that leaky expression for eyeless and 
MS 1096 promoters in vital tissues blocked development. The high lethality levels with 
the VP16-V32 driver might be due to the fact that this driver targets expression early 
during oogenesis. The surviving adult flies overexpressing wild type DRhoGEF2 
displayed rough eyes with the eyeless driver (Fig. 3.6) and crumpled wings with the 
MS 1096 driver (Fig. 3.7). With the VP16-V32 driver there was not any visible defect of 
the surviving adult flies. It might be that the effects of the overexpression of the 
transgene by this driver are subtle or in internal organs.
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Table 3.1
Driver Transgenes Expected % 
of flies with 
appropriate 
Genotype
Observed % 
of flies with 
appropriate 
genotype
%
Lethality
%
Phenotype
Ey-GAL4 RG2-la 50 14 (81/576) 72 15 (12/81)
Ey-GAL4 RG2-6a 50 15 (60/400) 70 50 (30/60)
Ey-GAL4 RG2-6b 50 8 (43/537) 84 28 (12/43)
MS-1096 RG2-la 50 29 (80/273) 42 89 (71/80)
MS-1096 RG2-6a 50 19 (65/342) 62 40 (26/65)
MS-1096 RG2-6b 50 20 (44/219) 60 55 (24/44)
VP16-V32 RG2-la 50 10 (52/521) 80 N/D
VP16-V32 RG2-6a 50 9 (59/653) 82 N/D
VP16-V32 RG2-6b 50 15 (64/428) 70 N/D
Table 3.1: Phenotypes of wild type transgenes of RhoGEF2 expressed with three 
different drivers at 25°C. The percent of lethality and the corresponding to the driver 
phenotype for the genotype of interest are indicated in the table. In parenthesis is 
indicated the sample number. N/D: Not defined.
Table 3.2
Driver Transgenes Expected % 
of flies with 
appropriate 
Genotype
Observed % 
of flies with 
appropriate 
genotype
%
Lethality
%
Phenotype
Ey-GAL4 RG2-la 50 10 (64/638) 80 20 (13/64)
Ey-GAL4 RG2-6a 50 13 (44/336) 74 41 (18/44)
Ey-GAL4 RG2-6b 50 7 (35/535) 86 14 (5/35)
MS-1096 RG2-la 50 28 (105/376) 44 84 (88/105)
MS-1096 RG2-6a 50 22 (63/285) 56 38 (24/63)
MS-1096 RG2-6b 50 25 (69/275) 50 64 (44/69)
VP16-V32 RG2-la 50 6 (35/584) 88 N/D
VP16-V32 RG2-6a 50 10 (42/422) 80 N/D
VP16-V32 RG2-6b 50 11 (52/472) 78 N/D
Table 3.2: Phenotypes of wild type transgenes of RhoGEF2 expressed with three
different drivers at 18°C. The percent of lethality and the corresponding to the driver 
phenotype for the genotype of interest are indicated in the table. In parenthesis is 
indicated the sample number. N/D: Not defined.
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Figure 3.4: Percentages of lethality and phenotypes obtained after overexpression of 
DRhoGEF2 wild type transgenes with ey-Gal4 and MS 1096 at the two temperatures 
tested.
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Figure 3.5: Lethality percentage of DRhoGEF2 wild type transgenes expressed with 
V32-VP16 driver at the two temperatures tested.
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Figure 3.6: Overexpression of DRhoGEF2 wild type by ey-GAL4 disrupts normal eye 
development. Representative SEMs of Drosophila compound eyes. The genotypes are 
as follows: (A) OregonR (WT), (B) DRhoGEF2 transgene (line 6b used as 
representative sample), (C) DRhoGEF2APDZ transgene (line 4a used as representative 
sample). Magnifications 250x (A-C) and 500x (D-F). Red arrow shows fused 
ommatidia, green arrow shows the existence of extra bristles.
WT DRhoGEF2G2-6a DRhoGEF2APDZ2b
Figure 3.7: Overexpression of wild type RhoGEF2 and DRhoGEF2APDZ transgenes 
in the wing. Overexpression of wild type RhoGEF2 (DRhoGEF2-6a line used as a 
representative) gives a wing phenotype; for DRhoGEF2APDZ transgene
OK(DRhoGEF2APDZ used as a representative) no wing phenotype is observed.
The results are summarized in Table 3.1 and 3.2 and in Figures 3.4 and 3.5. In more 
detail, transgenic line RG2-la at 25°C showed 72% lethality and 15% (n=12) of the
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surviving progeny showed a severe eye phenotype which was manifested as fused 
ommatidia or of irregular shape, with occasionally extra bristles (Fig. 3.6B and 3.6E 
compare to 3.6A and 3.6D). When the offspring was raised at 18°C, there was 80% 
lethality and 20% (n=13) of the same eye phenotype. Driving expression of this line of 
transgene with MS 1096 driver gave a moderate percentage of lethality of 42% at 25°C, 
and 44% at 18°C; however a much higher population of the surviving progeny (89%, 
n=71 at 25°C; 84%, n= 88 at 18°C) showed a severe wing phenotype in which the wing 
was crumpled and folded (Fig. 3.7). Transgenic line RG2-la showed the highest 
lethality percentages when expressed with VP16-V32 driver (80% at 25°C versus 88% 
at 18°C). RG2-6a transgene showed 70% lethality and 10% (n=6) phenotype with the 
eyeless driver at 25°C and a similar lethality percentage for the cross at 18°C (74%), 
instead the phenotype percentage was much higher (41%, n=18). Driving expression of 
RG2-6a transgene with MS 1096 driver caused a moderate percentage of lethality as 
seen for line RG2-la (62% at 25°C; 56% at 18°C). In contrast with what observed for 
line RG2-la regarding the phenotype percentages, much less of the surviving progeny 
from line RG2-6a showed the same severe wing phenotype (40%, n=26 at 25°C; 38%, 
n= 24 at 18°C). The highest percentage of lethality was seen again when expression was 
driven by VP16-V32-GAL4 driver at both temperatures (80% at 25°C; 82% at 18°C). 
On the contrary, line RG2-6b showed the highest lethality percentage when expressed 
with the eyeless-GAL4 driver (84% at 25°C; and 86% at 18°C) but a low percentage of 
phenotype (28%, n=12 at 25°C; 14%, n= 5 at 18°C). The lethality percentage was 60% 
at 25°C and 50% at 18°C, when RG2-6b transgene was expressed with the wing driver 
MS 1096. However, a much high population of the surviving progeny showed a severe
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wing phenotype (55%, n=24 at 25°C versus 64%, n=44 at 18°C). Expression with 
VP16-V32 driver caused the death of 78% at 25°C, and 70% at 18°C of the progeny 
with the appropriate genotype.
From the results obtained here it is observed that overexpression of the 
transgenic line DRhoGEF2-6a with the ey-GAL4 causes a change in the eye at a higher 
percentage compared to the other two lines. Instead, overexpression of the transgenic 
line DRhoGEF2-la with the MS1096-GAL4 causes a change in the wing at a higher 
percentage compared to the other two lines. These results suggest that the insertion site 
of the transgene in combination with the transcriptional activator of the driver influence 
the expression levels of the transgene.
Furthermore, the above results in accordance with the results obtained from the 
tissue culture studies indicate that overexpression of DRhoGEF2 causes morphological 
changes. This suggests that a controlled expression of DRhoGEF2 is necessary for a 
normal development. High levels of DRhoGEF2 might be causing overactivation of 
Rhol which leads to these morphological aberrations.
The relevance of the PDZ domain was analyzed by overexpressing the PDZ 
mutants [i.e. overexpressing DRhoGEF2 lacking the PDZ domain, (denoted 
DRhoGEF2APDZ)] in transgenic flies using the Gal4-UAS system (Brand and 
Perrimon, 1993). To drive DRhoGEF2APDZ expression the ey-GAL4, MS1096-GAL4, 
and VP16-V32-GAL4 drivers were used. As described above it was observed that 
overexpression of wild type DRhoGEF2 transgene causes malformation of the eye and 
wing depending on the driver used. These morphological changes were used as 
parameters to assess whether the PDZ domain acted as a regulator of the activity of
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DRhoGEF2. If the PDZ domain was a positive regulator, then transgenic flies 
overexpressing DRhoGEF2APDZ should have shown less severe morphological 
changes or no changes at all. On the other hand, if it acted as a negative regulator then 
these changes should have been more severe. Therefore the same experiment described 
before for the wild type DRhoGEF2, was carried out at the same time with five 
different DRhoGEF2APDZ transgenic lines. All of the DRhoGEF2APDZ transgenic 
lines tested showed a high percentage of lethality when expressed with the ey-GAL4 
driver at 25°C. Viability did not increase when the crosses were carried out at 18°C 
except for line DRhoGEF2APDZ4a for which the lethality percentage from 50% at 25°C 
dropped to 10% at 18°C. When these lines were expressed with MS1096-GAL4 and 
VP16-V32-GAL4 moderate lethality percentages were observed and viability increased 
for all lines when the same crosses were carried out at 18°C. The results are 
summarized in Tables 3.3 and 3.4 and in Figure 3.8. DRhoGEF2APDZ2b expressed at 
25°C with ey-Gal4 showed 60% lethality; the lethality percentages dropped when the 
offspring was raised at 18°C, giving 56% lethality. Driving expression of this line of 
transgene with MS 1096 driver there was a low percentage of lethality of 12% at 25°C, 
and 6% at 18°C. RhoGEF2APDZ2b gave 16% lethality when expressed with VP16-V32 
driver at 25°C and 14% at 18°C. RhoGEF2APDZ3a transgene showed 46% of lethality 
at 25°C and 32% atl8°C with the eyeless driver. Driving expression of 
RhoGEF2APDZ3a transgene with MS 1096 driver there was a moderate percentage of 
lethality (20% at 25°C; 18% at 18°C). The viability was much higher for this line of 
transgene when expressed with VP16-V32-GAL4 driver at both temperatures (4% of 
lethality at 25°C and 18°C).
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Table 3.3
Driver Transgenes Expected % of 
flies with 
appropriate 
Genotype
Observed % of 
flies with 
appropriate 
genotype
% Lethality
Ey-GAL4 APDZ2b 50 20 (84/417) 60
Ey-GAL4 APDZ3a 50 27 (116/436) 46
Ey-GAL4 APDZ4a 50 25 (96/378) 50
Ey-GAL4 APDZ5c 50 28 (86/312) 44
Ey-GAL4 APDZ6a 50 17 (51/295) 66
MS-1096 APDZ2b 50 44 (158/364) 12
MS-1096 APDZ3a 50 40 (137/344) 20
MS-1096 APDZ4a 50 46 (121/264) 8
MS-1096 APDZSc 50 46 (158/344) 8
MS-1096 APDZ6a 50 47 (168/357) 6
VP16-V32 APDZ2b 50 42 (71/169) 16
VP16-V32 APDZ3a 50 48 (145/302) 4
VP16-V32 APDZ4a 50 47 (103/220) 6
VP16-V32 APDZ5c 50 46 (116/253) 8
VP16-V32 APDZ6a 50 40 (95/238) 20
Table 3.3: Percentages of lethality for DRhoGEF2APDZ transgenes (indicated on the 
second column of the table just as APDZ with a subscript of an arbitrary line number) 
expressed with three different drivers at 25°C. In a parenthesis is indicated the sample 
number.
RhoGEF2APDZ4a showed a high lethality percentage when expressed with the eyeless- 
GAL4 driver at 25°C but when the same cross was carried out at 18°C the lethality 
percentage dropped to 10%. Similarly to the other lines, RhoGEF2APDZ4a gave low 
percentages of lethality with MS1096-GAL4 and VP16-V32-GAL4 at both 
temperatures (8% at 25°C; 6% at 18°C with MS-1096 driver and 6% 25°C; 2% at 18°C 
with VP16-V32 driver).
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Table 3.4
Driver Transgenes Expected % of 
flies with 
appropriate 
Genotype
Observed % of 
flies with 
appropriate 
genotype
% Lethality
Ey-GAL4 APDZ2b 50 22 (62/280) 56
Ey-GAL4 APDZ3a 50 34 (90/264) 32
Ey-GAL4 APDZ4a 50 45 (156/348) 10
Ey-GAL4 APDZ5c 50 32 (113/354) 36
Ey-GAL4 APDZ6a 50 37 (100/270) 26
MS-1096 APDZ2b 50 47 (109/232) 6
MS-1096 APDZ3a 50 41 (88/215) 18
MS-1096 APDZ4a 50 47 (95/202) 6
MS-1096 APDZ5c 50 49 (103/210) 2
MS-1096 APDZ6a 50 48 (98/205) 4
VP16-V32 APDZ2b 50 43 (93/217) 14
VP16-V32 APDZ3a 50 48 (112/234) 4
VP16-V32 APDZ4a 50 49 (82/168) 2
VP16-V32 APDZ5c 50 48 (84/174) 4
VP16-V32 APDZ6a 50 43 (81/188) 14
Table 3.4: Percentages of lethality for DRhoGEF2APDZ transgenes (indicated on the 
second column of the table just as APDZ with a subscript of an arbitrary line number) 
expressed with three different drivers at 18°C. In parenthesis is indicated the sample 
number.
APDZ3a APDZ4a APDZ5c 
T ransgenic  lines
■ ey-GAL4
□  MS-1096
□  VP16-V32
APDZ2b APDZ3a APDZ4a APDZSc
Transgenic lines
Figure 3.8: Lethality percentage for five different lines of DRhoGEF2APDZ transgene 
expressed with three different drivers at 25°C and 18°C. The transgenic lines are 
indicated in the graph just with the line number.
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DRhoGEF2APDZ5c transgene showed 44% of lethality at 25°C and 36% atl8°C with 
the eyeless driver. The lethality percentage was quite low when DRhoGEF2APDZ5c 
transgene was expressed with the wing driver MS 1096, (8% at 25°C; 2% at 18°C) and 
with VP16-V32 driver (8% at 25°C, and 4% at 18°C). DRhoGEF2APDZ6a transgene 
showed the highest lethality percentage of all lines when expressed with ey-GAL4 at 
25°C (66%). However this percentage dropped to 26% when the cross was carried out 
at 18°C. High viability was observed when this transgene was expressed with MS 1096 
driver (6% at 25°C; 4% at 18°C). On the contrary there was moderate lethality when 
DRhoGEF2APDZ6a transgene was expressed with VP16-V32 driver (20% at 25°C 
compared to 14% at 18°C). To visualize any eventual defects in the eyes of 
DRhoGEF2APDZ flies in greater detail, scanning electron micrographs (SEMs) of eyes 
from wild type, DRhoGEF2 wild type transgenes and from DRhoGEF2APDZ 
transgenes were compared (Fig. 3.6). Flies overexpressing wild-type DRhoGEF2, using 
a UAS-DRhoGEF2 transgene and an eyeless-GAL4 driver had rough eyes (Fig. 3.6B 
and 3.6E). In marked contrast the UAS-DRhoGEF2APDZ transgenic flies had eyes that 
were indistinguishable in appearance from those of wild-type flies (Fig. 3.6C and 3.6F 
compared to 3.6A and 3.6D) with each ommatidium having the regular hexagonal 
shape surrounded by the right number of bristles. In a similar way, flies overexpressing 
wild-type DRhoGEF2, using a UAS-DRhoGEF2 transgene and an MS-1096-GAL4 
driver had defective wings (Fig. 3.7). On the contrary, the UAS-DRhoGEF2APDZ 
transgenic flies had wings that were indistinguishable in appearance from those of wild- 
type flies (Fig 3.7).
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The fact that lethality is observed with the tissue specific driver indicates that the driver 
is leaky. The expression levels of the transgene seem overall to be comparable between 
the lines tested (compare the different lines with the same driver). Carrying out the 
crosses at 18°C does not seem to affect significantly the expression levels compared to 
25°C.
To summarize the DRhoGEF2APDZ expressing transgenes do not show any 
morphological changes associated with the overexpression as it is observed for the wild 
type transgenes. The results of the overexpression of wild type DRhoGEF2 taken 
together with the results of the overexpression of DRhoGEF2APDZ could suggest that 
the PDZ domain acts as a positive regulator for the function of DRhoGEF2. Therefore 
when PDZ domain is absent the activity of DRhoGEF2 is moderated and kept at low 
levels.
2.4 Expression levels of DRhoGEF2 required for development
To further understand the role of the PDZ domain for the function of 
DRhoGEF2, it was aimed to use the DRhoGEF2APDZ transgenic flies in combination 
with alleles of DRhoGEF2 which cause a phenotypic change and study whether the 
DRhoGEF2APDZ construct could rescue this phenotype. As a control the flies 
expressing the wild type DRhoGEF2 transgene were tested as to whether they could 
rescue the phenotypic change caused by the DRhoGEF2 alleles.
Therefore, the wild type transgene was used with transallelic combinations of 
DRhoGEF2. The alleles used were: DRJ10GEF2 11, DRhoGEF241 and DRhoGEF26 \  
The EMS allele DRhoGEF211 has a point mutation generating a stop codon before the
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RGS domain (Fig. 3.9) and it was considered to be a null allele (Barrett et al., 1997). 
The DRhoGEF241 was also an EMS allele (Barrett et al, 1997). Since the DNA 
rearrangement in DRhoGEF24 1 occurs upstream of the RGS, Cl and PH domains (Fig. 
3.10), it is expected that this is a functionally null allele also. The allele DRhoGEF261 
had a DNA fragment derived from a P-element remaining in the intron upstream of the 
coding sequence (Fig 3.10). Therefore this is probably a hypomorphic allele giving 
reduced expression levels of the protein. Alleles DRhoGEF241 and DRhoGEF2*1 give 
identical phenotypes and are completely penetrant (Barrett et al., 1997). The 
hypomorphic allele DRhoGEF261 in combination with the null allele DRhoGEF24 1 
gives 49% viability and the surviving adult flies have crumpled wings and rough eyes. 
The null allele DRhoGEF211 in combination with the null allele RhoGEF24 1 gives 0% 
adult viability.
Thus this genetic background of null/hypomorph and null/null alleles of 
DRhoGEF2 was used as a sensitized system to assess whether wild type transgenes 
could rescue the lethality, wing and eye phenotypes. Since RhoGEF21 VRhoGEF24 1 
gives a much more severe phenotype (0% viability) in comparison to 
RhoGEF261/RhoGEF241 (49% viability) the two different allelic combinations of 
DRhoGEF2 were used for the rescue experiment in order to assess the strength of the 
DRhoGEF2 wild type transgene.
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Figure 3.9: Schematic representation of the DRhoGEF2 cDNA. The boundaries of the 
breakpoint in RhoGEF24 allele is indicated by B4.1.RhoGEF211 null allele generated 
by a stop codon is represented as a shorter RhoGEF2 containing only the PDZ domain.
P-element: 14Kb
S T O PS T A R T
Insert ~2.5 Kb
Figure 3.10: Exon-intron map of DRhoGEF2 with the insertion of P-element (grey 
boxes indicating exons). Map of the insertion and deletion of the P-element imprecise 
excision allele of DRhoGEF2, cDNA: 8435bp, genomic sequence: 17412bp.
Since DRhoGEF2 is ubiquitously expressed the drivers tubulin-Gal4 (tub-Gal4) 
and daughterless-Gal4 (da-Gal4) were chosen to drive also ubiquitously the expression 
of the wild type transgene. For the rescue experiment four lines of wild type transgenes 
(UAS-DRhoGEF2-2a denoted RG2-2a, UAS-DRhoGEF2-4a denoted RG2-4a, UAS- 
DRhoGEF2-4b denoted RG2-4b, and UAS-DRhoGEF2-5 denoted RG2-5) chosen 
randomly, were first tested whether they survive through embryogenesis so that they
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can be used in this study. Therefore, to determine whether there are embryogenesis 
problems associated with the overexpression of the transgenic lines the development of 
the flies was followed (Table 3.5 and Fig. 3.11). When transgene RG2-2a was not 
expressed 96% of the fertilized eggs made it through embryogenesis. Instead when the 
expression of this transgene was driven with either tub-Gal4 or da-Gal4, 28% and 66% 
respectively survived throughout embryogenesis. Similar results were obtained with 
transgene RG2-4a: when this transgene was not expressed 97% of the fertilized eggs 
made it through embryogenesis but when it was overexpressed with tub-Gal4 only 38% 
survived and with da-Gal4 63% did. Transgene RG2-4b gave 92% viability of the 
fertilized eggs when not expressed and when overexpressed the viability with tub-Gal4 
dropped to 36% and with da-Gal4 to 62%. Finally transgene RG2-5 when not expressed 
95% of the fertilized eggs survived embryogenesis; in contrast when overexpressed 
with tub-Gal4 of the fertilized eggs only 22% survived and when overexpressed with 
da-Gal4 75% made it through embryogenesis.
From the results above, it is concluded that the overexpression of the transgene 
had a heavy toll on the embryogenesis of the flies which was much more severe when 
any of the transgenic lines tested was expressed with tub-Gal4. Instead, overexpression 
of the transgenic lines with da-Gal4 gave moderate viability levels at early stages. 
These data indicate that tub-Gal4 drives expression of the protein at higher levels than 
da-Gal4 (Fig. 3.11).
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Table 3.5
transgene driver chorion % Dead %
RG2-2a no driver 96% 4%
RG2-2a tub 28% 72%
RG2-2a da 66% 34%
RG2-4a no driver 97% 3%
RG2-4a tub 38% 62%
RG2-4a da 63% 37%
RG2-4b no driver 92% 8.%
RG2-4b tub 36% 64%
RG2-4b da 62% 37%
RG2-5 no driver 95% 5%
RG2-5 tub 22% 78%
RG2-5 da 75% 25%
Table 3.5: Percentage of wild type transgenes expressed with tubulin-Gal4 or 
daughterless-Gal4 that make it through embryogenesis.
■ OreR
□ tub-Gal4
□ da-Gal4
Figure 3.11: Viability percentages during embryogenesis of wild type transgenic 
DRhoGEF2 flies. The graph shows the percentage of DRhoGEF2 wild type transgenes 
(denoted RG2-2a, RG2-4a, RG2-4b, RG2-5) that survive embryogenesis.
100
Transgenic lines
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It was then tested whether reducing the protein levels would allow the flies to 
survive. Reduction of the protein levels was achieved by combining DRhoGEF2 wild 
type transgene with hypomorph/null allelic combination DRhoGEF26 VDRhoGEF24
T a b le  3 .6
Genotype of interest Expected % Observed % % Lethality
RhoGEF261/RhoGEF241 25 13 (n=T00) 49
RhoGEF261 /RhoGEF24 1; 
Dr/RG2a
17 7 (n=102) 59
RhoGEF26 '/RhoGEF24 da- 
GAL4/RG23
17 0 100
RhoGEF26 l/RhoGEF24 1; 
Dr/RG4a
17 10 (n= l11) 41
RhoGEF26 '/RhoGEF24 da- 
GAL4/RG4a
17 1 94
RhoGEF26 '/RhoGEF241; 
Dr/RG4b
17 12 (n=112) 29
RhoGEF26 ‘/RhoGEF24 1; da- 
GAL4/RG4b
17 1 94
RhoGEF26 '/RhoGEF24 
Dr/RG5
17 9 (n=154) 47
RhoGEF26 l/RhoGEF24 da- 
GAL4/RG5
17 0
oo
T a b le  3 .6 : Lethality percentages from rescue experiment between hetero-allelic 
DRhoGEF2 and heterozygous wild type full length DRhoGEF2 transgenic lines driven 
with da-GAL4. The transgenes are indicated by RG with a superscript the number of 
the line. Dr stands for the eye marker drop. For the expected percentage see Materials 
and Methods for the genetic scheme.
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Table 3.7
Genotype of interest Expected % Observed % % Lethality
RhoGEF2 7RhoGEF2‘ 
Dr/RG2a
10 (n=l 18)
RhoGEF2 /RhoGEF2‘ 
Dr/RG4a
12 (n=122)
RhoGEF2 /RhoGEF2 
Dr/RG4b
10 (n=l 10)
RhoGEF2 7RhoGEF2‘ 
Dr/RG5
(n=100)
RhoGEF2 /RhoGEF2‘ 13 (n=100)
RhoGEF26 7RhoGEF241 
tub-GAL4/RG4a
100
RhoGEF2 /RhoGEF2‘ 
tub-GAL4/RG5
RhoGEF261/RhoGEF241
tub-GAL4/RG2a
RhoGEF2 /RhoGEF2‘ 
tub-GAL4/RG4b
100
Table 3.7: Lethality percentages from rescue experiment between hetero-allelic 
RhoGEF2 and heterozygous wild type lull length RhoGEF2 transgenic lines driven 
with tub-GAL4. The transgenes are indicated by RG with a superscript of the number 
of the line. Dr stands for the eye marker drop. For the expected percentage see 
Materials and Methods for the genetic scheme.
Transgenic Lines RhoGEF2 wt
| ■  Tub-GAL4 □  Da-GAL4 ■ Dr B 4 .1 /6 .T |
Figure 3.12: Rescue experiment of the DRhoGEF2 mutant phenotype by DRhoGEF2 
wild type transgenes. The graph shows the percentage of lethality for the four lines of 
wild type DRhoGEF2 overexpressed with the two drivers tub-GAL4 and da-GAL4. All 
transgenic lines were heterozygous combinations with the hetero-allelic mutants 
DRhoGEF26 VDRhoGEF24 !on the second chromosome. Dr stands for the drop marker. 
The percentage of the inert transgenes is an average of the percentages obtained in the 
two independent set of crosses.
117
Chapter 3: Function of the PDZ Domain
Flies with overexpressed DRhoGEF2 wild type driven either by tub-GAL4 or 
da- GAL4 in combination with DRhoGEF261/DRhoGEF24 1 were not recovered or 
presented very low viability percentages. There was 100% lethality for all lines except 
for RG2-4a and RG2-4b that both showed 94% lethality when expressed with da-Gal4 
driver (Fig. 3.12). Instead with tub-GAL4 there was 100% lethality except for lines 
RG2-2a that showed 88% lethality and line RG2-5 with 82% lethality (Fig. 3.12). For 
the surviving progeny, the wild type transgene was not able to rescue the phenotype 
either thus the surviving adult flies had a wing or eye phenotype. The 
DRhoGEF261/DRhoGEF24 Dr/RG2TG progeny (RG2tg indicating any transgenic 
line) showed low viability as expected from the previous results obtained for the alleles 
DRhoGEF261/DRhoGEF24 1 alone. The results are summarized in Table 3.6 and 3.7 
and Fig. 3.12.
In addition, for this rescue experiment the allelic combination null/null 
DRhoGEF211/DRhoGEF241 was used which gives 0% viability; with this combination 
the endogenous protein is probably eliminated and therefore DRhoGEF2 present in the 
flies derives from expression of the transgene. It was studied whether the UAS- 
DRhoGEF2 wild type transgene combined with these DRhoGEF2 mutants could rescue 
the observed lethality. For the rescue experiment the four different wild type transgenic 
lines described above were used and their expression was driven ubiquitously by tub- 
GAL4 and da-GAL4. DRhoGEF2" /DRhoGEF24 MKRS/RG2T0 progeny (RG2tg 
indicating any transgenic line; MKRS is a marker) was not recovered as expected in 
accordance with the previous results obtained showing that DRhoGEF211 
/DRhoGEF241 is 100% lethal.
118
Chapter 3: Function of the PDZ Domain
Two transgenic lines of DRhoGEF2 out the four tested were able to rescue to a certain 
degree the lethality observed with the heterozygous DRhoGEF21 VDRhoGEF24J. Line 
RG2-2a showed 59% lethality and line RG2-5 showed 53% lethality (Table 3.8, Fig 
3.13). On the contrary the other two lines gave 100% lethality. These results indicate 
that the insertion site of the transgene must play a role in its expression levels.
The results of the rescue experiment of the wild type transgene in combination 
with the hypomorph/null alleles and null/null alleles of DRhoGEF2 suggest that an 
appropriate amount of the protein is necessary for the normal development of the fly 
(Fig.3.14).
T a b le  3 .8
Genotype of interest Expected % Observed % % Lethality
RhoGEF2“ /RhoGEF241; 
MKRS/RG2a
17 0 100
RhoGEF21 ‘/RhoGEF24 1; 
da-GAL4/RG2a
17 7 (n=33) 59
RhoGEF2‘ '/RhoGEF24 17 0 100
MKRS/RG4a ■ ■ ■ ■
RhoGEF21 '/RhoGEF241; 
da-GAL4/RG4a
17 0 100
RhoGEF21 '/RhoGEF241; 
MKRS/RG4b
17 0 100
RhoGEF21 '/RhoGEF241; 
da-GAL4/RG4b
17 0 100
RhoGEF2' ‘/RhoGEF241; 
MKRS/RG5
17 0 100
RhoGEF2‘ '/RhoGEF241; 17 8 (n=25) 53
da-GAL4/RG5
T a b le  3 .8 : Lethality percentages from rescue experiment between hetero-allelic 
RhoGEF2 and heterozygous wild type full length RhoGEF2 transgenic lines.
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T ransgen ic  L ines
Figure 3.13: Rescue of the DRhoGEF2 mutant phenotype by DRhoGEF2 wild type 
transgenes. The graph shows the lethality percentage of the four lines of wild type 
DRhoGEF2 overexpressed with the da-GAL4. All transgenic lines were heterozygous 
combinations with the hetero-allelic mutants DRhoGEF2 VDRhoGEF24 ’on the second 
chromosome.
When the wild type transgene is combined with the null/hypomorph 
(DRhoGEF26 ’/DRhoGEF24 ’) there is an uncontrollably high expression of the protein 
that is lethal for the fly. Reducing the protein levels by combining the transgene with a 
null/null (DRhoGEF2’ ’/DRhoGEF24 ’), allows some rescuing of the lethality.
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Figure 3.14: Rescue experiment of the DRhoGEF2 mutant phenotype by DRhoGEF2 
wild type transgenes. The graph shows a comparison between the lethality percentages 
of DRhoGEF2 wild type transgene driven with da-Gal4 with combinations of 
DRhoGEF2 mutants. All transgenic lines were heterozygous combinations with the
hetero-allelic mutants DRhoGEF26 1/DRhoGEF2‘f 1 (denoted on the graph as 6.1/4.1)4.1
and DRhoGEF21 l/DRhoGEF2't 1 (denoted on the graph as 1.1/4.1) on the second 
chromosome and the four lines of wild type DRhoGEF2 (denoted on this graph by: 
RG2-2a, RG2-4a, RG2-4b, RG2-5).
>4.1
3. CONCLUSIONS
In order to understand the role of th e . PDZ domain for the function of 
DRhoGEF2 it was examined how overexpression of DRhoGEF2APDZ construct 
affected the morphology of S2R+cells. Wild type DRhoGEF2 induced cell contraction. 
The same morphology was observed when DRhoGEF2APDZ was expressed in the 
cells. Thus, under the conditions used in S2R+ cells the PDZ domain did not have an 
effect for the function of DRhoGEF2 that is it did not act as regulator for the activity of 
the protein. The localization of the protein could not be assessed as overexpression of 
the protein was found diffuse in the cytoplasm. This might be due to the fact that the
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Rhol signaling pathway has to be prior activated or that other interacting partners are 
not expressed at high enough levels.
Expression of DRhoGEF2 wild type transgene with the ey-GAL4 driver caused 
an effect on the eye. The adult eyes of the flies were rough, and under scanning electron 
microscopy were characterized by fused ommatidia and by additional bristles. The 
expression of DRhoGEF2APDZ did not give the rough eye phenotype caused by 
overexpression of DRhoGEF2 and a normal arrangement of ommatidia and bristles was 
observed instead. The eyes of DRhoGEF2APDZ flies were completely normal. In 
addition, overexpression of wild type DRhoGEF2 by MS1096-GAL4 caused a 
malformation of the wings. On the contrary, overexpression of the DRhoGEF2APDZ 
did not change the shape of the wings. These preliminary results suggest that the PDZ 
domain could act as a positive regulator for the activity of DRhoGEF2.
Finally, from the rescue experiment it is observed that appropriate expression 
levels of DRhoGEF2 are necessary for correct development. Expression of the 
transgene in combination with the trans-allelic combination of DRhoGEF2 null/null is 
able to rescue the lethality; on the contrary the expression of the transgene in 
combination with the trans-allelic combination of DRhoGEF2 hypomorph/null is not 
able to rescue the lethality. Thus moderate expression levels of DRhoGEF2 are required 
for the development of the fly. It would be interesting to study whether expression of 
the transgene DRhoGEF2APDZ is also able to rescue the lethality of null/null alleles of 
DRhoGEF2. This experiment will give a better insight into the role of the PDZ domain 
for the function of DRhoGEF2.
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Chapter 4: CHARACTERISATION OF DMEC2
1. INTRODUCTION
In order to learn more about the DRhoGEF2’s function and its positioning in 
the Rhol signaling pathway, it was sought to identify other interacting partners for this 
multidomain protein. In particular, one candidate domain that could provide the basis 
for additional communications not characterised as of yet is its PDZ domain. A yeast 
two-hybrid system was elected to screen for interacting proteins for the PDZ domain of 
DRhoGEF2 (Barrett K., unpublished data). In this screen, the PDZ encoding sequence 
was fused to Gal4 activation domain as the bait fusion; a Drosophila cDNA library was 
fused with the Gal4 DNA-binding domain. Three “PDZ-specific” proteins were 
identified over the course of a single yeast-two hybrid screen, one of which was the 
novel gene CG7635. The other two candidates were the tumor suppressor gene called 
MCC and the predicted gene CG9795. All three of these proteins have at their carboxy 
terminus the signature motif that could be a target for the PDZ domain. These three 
candidate interacting partners could be involved in an association with DRhoGEF2 at 
different times or in different tissues therefore contributing to the selection of outcome 
of Rhol activation by DRhoGEF2. In this thesis the focus was on the interaction of 
CG7635 with the PDZ domain of DRhoGEF2; analysis of the other candidate PDZ 
binding factors are described elsewhere.
In this chapter CG7635 is characterized. Subsequently it is studied whether it 
can affect the actin cytoskeleton and the microtubule network. To approach these 
questions, the functional role of CG7635 in an actin cytoskeleton context is studied in
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tissue culture cells, as well as in various fruit fly tissues. Furthermore, since its 
orthologue, the C. elegans Mec2 is involved in mechanosensation, it was aimed to study 
whether DMec2 can also be established as a molecule involved in the transduction of 
mechanical cues.
2. RESULTS
2.1 General Domain Organization and Structural Features
The predicted gene CG7635, that was named Dmec2 to follow the nomenclature 
of the C. elegans protein, is located on the X chromosome at position 18A6 of the 
cytogenetic map. The gene is predicted to be encoded by 4 exons of relatively small 
length ranging from 165 bp to 513 bp (Fig. 4.1).
751 bp 93bp 77bp
A A A
248bp 513bp 165bp 255bp
W ///s
5’RACE
Figure 4.1: Dmec2 Gene structure. The positions of the 4 Exons (yellow boxes), the 
poly(A) tail (dashed line) the gene-specific primers used for 5’RACE (red bar) and 
sequence obtained by 5’RACE (hatched box) are indicated.
In order to confirm that the available clone of DMec2, derived from a 
Drosophila cDNA library (Du, et al., 1996) used for the yeast two-hybrid assay, was
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full length, primer extension experiments were carried out to identify the 5’ end. 
Sequences obtained by 5’RACE (Smart Race, Clonetech) were verified by comparison 
to corresponding genomic DNA sequence. The sequencing of the produced DNA 
showed that the available cDNA was indeed the full length. The first ATG is found 49 
nucleotides after the beginning of the mRNA at the first exon, and in the close 
proximity there are three more start sites (45bp, 81 bp, and 90 bp apart from the first 
one). These start sites do not have around them sequences that match important 
consensus ones, with the exception of the fourth start site which has a Kozak sequence 
(CCAC upstream of the AUG) and a G at +4 ( Cavener, 1987).
The Drosophila Mec2 encodes for a 350 amino acid protein with a predicted 
molecular mass of approximately 38KDa. In order to check whether the gene is 
redundant a BLAST search of the Drosophila database (http://flvbase.bio.indiana.edu) 
with DMec2 sequence revealed that the Drosophila genome does not have a related 
gene. In addition, the BLAST searches showed that the fly Mec-2 is homologous to the 
C. elegans Mec2, and to the human protein stomatin with 63% and 61% identity and 
82% and 78% similarity, respectively (Blast , NCBI server) (Fig. 4.2). The Simple 
Modular Architecture Research Tool (SMART) (http://smart.embl.de) identified a 
region from 87-245 amino acid containing a prohibitin homology (PHB) domain found 
also in stomatin and in many other proteins associated with lipid rafts (Morrow and 
Parton et al., 2005).
It was shown by proteolytic digestion of intact human erythrocytes that stomatin 
is located solely at the cytoplasmic surface of the erythrocyte membrane and it does not 
have an extracellular portion (Hiebl-Dirschmied et al., 1991). By inference, DMec2 is
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assumed to have also a monotopic structure with both N- and C- terminal portions of 
the molecule exposed at the cytoplasmic face of the lipid bilayer (Fig. 4.3A). In 
addition, there is some evidence to support this hypothesis as the hydrophilicity plot by 
Kyte and Doolittle (Fig. 4.3B) shows a single 33-aminoacid hydrophobic (and 
presumably membrane-spanning) segment close to the N-terminus (amino-acid residues 
67-100) preceded by a hydrophilic 66-aminoacid N-terminal region and followed by the 
C-terminal part containing most of the 350aminoacids. A database search of recognized 
amino acid sequence motifs showed potential N-glycosylation sites at two positions 
(193 and 298), but because these are all in the inferred cytoplasmic region it is unlikely 
that these are so modified. The amino acid sequence has also three potential Protein 
Kinase C (PKC) phosphorylation sites (176, 184, 199) and three potential Casein K II 
(CK2) phosphorylations sites (57, 199, 211). Furthermore, it has an Alanine rich stretch 
(240-271) and five predicted threonine phosphorylated sites (56,184,199,211,311). It 
will be shown later that DMec2 interacts with the PDZ domain of DRhoGEF2. It is 
noted here that regulation of the PDZ-peptide interaction can occur by phosphorylation 
of residues near the C terminus. In fact the -2 residue (counting from the end of the 
protein and setting the last amino acid as residue 0) of the PDZ-binding C-terminal 
peptides is frequently an amino acid that can be phosphorylated such as threonine, 
serine, or tyrosine. For example, the -2 serine of inward rectifier K+ channel Kir2.3 falls 
within a consensus sequence for Protein Kinase A (PKA); phosphorylation of this site 
by PKA abolishes Kir2.3 interaction with PSD-95’s PDZ domains (Cohen et al., 1996). 
Another example is the phosphorylation of -2 serine of the p2-adrenergic receptor by 
G-protein-coupled receptor kinase GRK5 that disrupts receptor binding to the PDZ
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domain of NHERF (Cao et 1999; Hall et al., 1998). Residues that can be 
phosphorylated need not be at -2 position to affect PDZ binding. For instance -3 serine 
of the AMPA receptor subunit GluR2 C- terminus can be phosphorylated by PKC, and 
this modification prevents GluR2 binding to the PDZ domain protein GRIP (Matsuda et 
al., 1999). On the contrary, for DMec2 threonine at position 348 arguably the most 
critical residue for PDZ recognition, is not predicted to be phosphorylated and the next 
phosphorylatable residue is found quite far from the C-terminus, at position 311. In any 
event, all these sites mentioned above might represent regulatory sites; however, these 
are only speculations as there are not available data for such regulation of the 
homologous proteins. There are a number of cysteine residues at the N-terminus that 
could be palmitoylated as it has been shown to be in stomatin (Snyers et al., 1999) and 
could be contributing to the anchoring of the protein onto the inner leaflet of the plasma 
membrane. Palmitoylation confers greater membrane affinity, but can also affect a 
protein functionally or influence its interaction with other proteins and specific 
membrane domains such as lipid rafts, which are membrane microdomains associated 
with protein complexes, cholesterol, and sphingolipids.
Although the central portion of the amino acid sequences of the C. elegans 
Mec2, human stomatin and DMec2 display homology, these proteins show also 
important differences that might imply modified or different functions. The most salient 
difference between these three proteins is a signature motif at the C-terminus, 
recognizable by PDZ domain Class I, present only in DMec2 (Fig. 4.3C). This 
interaction will be discussed in Chapter 5.
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Human ---- MAEKR---------------------- HTRDSEAQR---- LP------------------- 16
C.elegans MSATMSSARNSVVSLSSNGSVKVETRLVSNERSSSIQQEGAMLPSSSSKDDDLLSTSSDE 60
Drosophila ----MEPHQDSPVYAN------------ YE DMRNS G PAS S TA-YMVNMG--------------- 32
*  :  * .  * :
Human  DSFKDSP------ SKG LGPCGWI 33
C.elegans VENMATRTLQQLEESTSIISANSDDDSVKKEKQAEKDVEKGNGKEEKANIQNEFGVCGWI 120
Drosophila ----------------------------AAGMAPEPALRVPGTTQQYRGFKTSENEPKGCMEWV 68
+  * «
Human LVAFSFLFTVITFPISIWMCIKIIKEYERAIIFRLGRILQGGAKGPGLFFILPCTDSFIK 93
C. elegans LTILSYLLIFFTLPISACMCIKWQEYERAVIFRLGRLMPGGAKGPGIFFIVPCIDTYRK 180
Drosophila VTLFSVLIFIITSPIAIFICFKWAEYERAIIFRLGRLS-GGARGPGMFFILPCIDEYRK 127
. < *.  . + + *.  . + + ****.+*★■*• + ■*. ++* . **+ . +** . **  * . *
Human VDMRTIS FDIP PQEILTKDSVTISVDGWYYRVQNAT LAVANITNADSATRLLAQTTLRN 153
C.elegans VDLRVLSFEVPPQEILSKDSVTVAVDAWYFRISNATISVTNVEDAARSTKLLAQTTLRN 240
Drosophila VDLRTVTFNVPQQEMLTKDSVTVTVDAWYYRISDPLYAVIQVEDYSMSTRLLAATTLRN 187
Human VLGTKNLSQILSDREEIAHNMQSTLDDATDAWGIKVERVEIKDVKLPVQLQRAMAAEAEA 213
C.elegans ILGTKTLAEMLSDREAISHQMQTTLDEATEPWGVKVERVEVKDVRLPVQLQRAMAAEAEA 300
Drosophila IVGTRNLSELLTERETLAHNMQATLDEATEPWGVMVERVEIKDVSLPVSMQRAMAAEAEA 247
1 1  *  *  :  .  * • • • * • ;  +  •* *  ■ ‘ ‘ ■ :  1 +  +  + +  +  + +  +  J--*
Human SREARAKVIAAEGEMNASRALKEASMVITEYPAALQLRYLQTLTTIAAEKNSTIVFPLPI 273
C.elegans AREARAKVIVAEGEQKASRALKEAAEVIAESPSALQLRYLQTLNSISAEKNSTIIFPFPI 360
Drosophila ARDARAKVIAAEGEKKSATALKEASDVISASPSALQLRYLQTLSSISAEKNSTIIFPLPM 307. + .*■*★**■* **** ... *•* + +■*. *■ * . *.***■* + + ■* * •J' . + * + +* ■* + . + + .* .
Human DML------------------------------------- QGIIGAK------ HSHLG--------288
C.elegans DLLSAFLQRTPPKVEEPPSLPKKIRSCCLYKYPDWVQGMVGSEGGGGHGHSHGGGGGGLG 420
Drosophila ELLTP----------------------------- YLAK----------------YAHLMG----- 322
. .
Human 
C.elegans 
Drosophila
SSQGAFHPSQAGSGPSTTTTSGRPLLRSMREAQFHSAAPPISAPNQSQTSVSQLDPALLI 480 
------ PPPELKQSPEKSDNIVLDALDAWPKTNL-------------------------------350
Human
C.elegans
Drosophila
R 481
Figure 4.2: Sequence alignment of DMec2, human stomatin, and C. elegans Mec2. The 
sequences were aligned using the ClustalW program, which highlights matching amino 
acids with the same colour. Under the sequences the identical amino acids are indicated 
by an asterisk, amino acids of the same nature by a double dot, instead when all three or 
two out of the three aligned amino acids are of the same nature they are indicated by a 
single dot.
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Figure 4.3: (A) Topology of the DMec2 in relation to the plasma membrane (not drawn 
to scale). (B) Hydrophilicity Plot-Kyte and Doolittle and diagrammatic representation 
of the topology of DMec2. (C) Schematic representation of DMec2 cDNA with the 
predicted domains indicated.
2.2 Generation of Constructs
In order to study the function of this novel protein in vivo, constructs encoding 
DMec-2myc were generated by PCR using the mec-2 cDNA as a template and different 
primers (Table in Materials and Methods) containing other than the myc tag, a Kozak 
sequence as well to increase the translation efficiency. Since the exact start site for 
DMec-2 protein was not known four different amino terminally tagged constructs were 
generated for the four possible start sites mentioned above (Fig. 4.4A). It was also
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unknown whether there existed a signal sequence at the amino terminus important for 
the localisation of the protein to the plasma membrane. Reckoning that a myc-tag at the 
amino terminus would risk to cover that signal sequence and thus could inhibit the 
proper localisation of the protein a carboxy terminally tagged construct was also 
generated for comparison with the amino terminally ones. (Fig.4.4A). The five 
generated constructs were then subcloned into a vector for expression in a Drosophila 
cell line using the Gal4/UAS system. After western blot analysis it was observed that 
all of the constructs were successfully expressed in S2R+ cells (Fig. 4.4B). Since there 
was no difference in the expression of the four amino terminally tagged constructs, for 
the rest of the studies the longest construct was used.
Because the Gal4/UAS system leads to a massive expression of the desired 
protein that could saturate the cell, it was aimed to find a way to moderate its levels. 
One way employed to achieve that was to carry out a time course experiment during 
which the cell lysate was harvested after one, two or three days after transfection. 
However, it was observed that expression follows a “hit and run” mode starting 3 days 
post-transfection and no expression at all happening on the first or second day.
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A
5 constructs
B
myc MEC-2
N2 WM M EC-2 N 2 N 3  N 4
N 3 myc M EC-2 + -  40KDa
a-myc
N4 Jr myC MEC-2
MEC-2 myc a-tub
Figure 4.4: A. Schematic representation of the five contructs made. B. The shorter 
constructs indicated as N2, N3, N4 are expressed in S2R+ cells as it is shown by a 
western blot analysis. The anti-tubulin blot serves as a loading control. The expression 
of N1 construct is shown later; the expression of carboxy-terminally tagged construct is 
not shown.
Therefore moderating the expression levels of the protein by harvesting the cells 
early after transfection was not possible. A second method applied to fine tune the 
expression levels of the protein was the use of a gradient of administered DNA for 
identifying the best working concentration (Fig. 4.5). The same cells were also 
transfected with UAS-GFP in order to be able to calculate the transfection efficiency. 
After ensuring by looking under the microscope for GFP expression that these sets of 
transfections had the same percentage of success, it was concluded that Gal4 and the 
UAS construct had to be 1:1 mass ratio to get protein production. Thus moderating the 
expression levels by transfecting with less DNA was not possible to achieve. Successful 
transfections depended also on the transfection agent and the amount used. Once these
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conditions were established further modifications of the transfection protocol were 
avoided.
DMec2myc (0.2-0.5 Act-Gal4 (0.2-0.5pg)
Act-Gal4 (0.5pg) DMec2myc (0.5jLtg)
+ -  40kDa
IB:a-myc
Figure 4.5: Expression levels of UAS-DMec2myc using a gradient of transfected DNA. 
S2R+ cells were transfected with increasing amounts of UAS-DMec2myc (0.2-0.5pg) 
and a constant amount of Actin5c-Gal4 (0.5pg) or increasing amounts of Actin5c-Gal4 
(0.2-0.5pg) and a constant amount of UAS-DMec2myc (0.5pg). Three days post­
transfection the cells were harvested, subjected to SDS-PAGE (10%) and analysed by 
western blot using an anti-myc antibody.
2.3 DMec2 does not alter the morphology of Drosophila cells
Subsequently, it was studied whether DMec2 could cause cell shape changes. 
Whether DMec2 could affect the actin cytoskeleton was studied by overexpressing it in 
Drosophila tissue culture cells. For that reason, S2R+ cells were transfected with the 
longest amino-terminally tagged DMec-2myc. Three days post-transfection the cells 
were fixed and double stained with anti-myc and the actin binding compound 
phalloidin labeled with TRITC. S2R+ wild type cells upon plating spread well on the 
surface and are flat. Quantification using Image J and measuring the spreading by
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taking as a parameter the diameter of the cells showed that the cells did not change size 
compared to the wild type (Fig. 4.6). The average cell diameter of the cells where
20 n
Diameter (pm) 15 j
10 J 
5  1
0  J- - - - -
■ Control 
□ DMec2
Figure 4.6: Quantification of cell spreading after overexpression of DMec2myc 
construct. Statistical significance was determined for the difference in cell diameter for 
cells overexpressing DMec2 compared to control by Student’s t test where P < 0.005. 
The results show the average cell diameter (n=150) ± S.D. from a single representative 
experiment.
WT m yc- DMec2
Figure 4.7: DMec2 expression in S2R+ cells. S2R+ cells were transfected with 
Actin5c-GAL4 and expression vector for the amino terminally tagged UAS-DMec2myc. 
Three days after transfection the cells were fixed and stained with an antibody to myc 
to show localization of expressed protein. The experiment was analysed by confocal 
microscopy. This is a representative figure where the expressed protein is seen as green 
dots. DAPI staining shows the nucleus and TRITC-phalloidin stains the actin 
cytoskeleton. DMec2 is found in the cytoplasm in a punctate form.
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DMec2 was overxpressed was 18pm compared to that of the wild type cells that was 
17 pm. From the same experiment it was also observed that overexpression of amino 
terminally-tagged DMec2myc did not have an effect on the actin cytoskeleton, the cells 
did not change shape and in general their morphology was unaltered compared to the 
wild type (Fig. 4.7). Amino-terminally myc-tagged UAS-DMec2 construct was seen as 
an abundant population of puncta throughout the cytoplasm. These results could 
indicate that the protein is not localised to the plasma membrane as initially thought or 
that normally is found in the cytoplasm and it needs a signal in order to be transported 
to the plasma membrane. Therefore, the possibility that DMec2 could indeed have an 
effect on the actin cytoskeleton cannot be excluded. The lack of morphological 
differences, after overexpression of DMec2, contrary to what was expected, might be 
explained by the fact that the protein is not found in the right conditions to have an 
effect on the cytoskeleton. Rhol signalling pathway might have to be activated or 
DMec2 itself has to be somehow activated in order to induce changes in the 
morphology of the cell. Another reason for failing to see an effect might be due to the 
fact that other interacting partners are absent or in very low expression levels in the 
cells used.
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2.4 DMec2 and vesicle localisation
The punctate staining of DMec2 obtained from the immunofluorescence studies 
is reminiscent of an inclusion of the protein in vesicles. That suggestion prompted the 
study o f vesicular localisation for DMec2myc. In order to test the possibility that DMec2 
is localised in vesicles, S2R+ cells were transfected with Actin5c-GAL4 and expression 
vector UAS-DMec2myc. Three days after transfection the cells were fixed and double 
stained with an antibody to myc to show localisation of expressed protein and with an 
antibody to clathrin as a vesicle marker. Clathrin was used because it mediates transfer 
of vesicles that bud from the trans-Golgi (Molecular Cell Biology, 4th edition). Using 
that marker could indicate whether DMec2 might be following the Golgi pathway for 
attachment to the plasma membrane. As it is suggested by figure 4.8, there is 
colocalisation between DMec2 and vesicles in the region around the nucleus. However, 
it cannot be concluded that DMec2 is included in the vesicles; it might be just in the 
same area with the vesicles. Moreover, it is observed in figure 4.8 that there is also a 
massive population of DMec2 further away from the nucleus not colocalising with the 
vesicles marked by the anti-clathrin antibody. This could indicate that the protein is not 
included in the vesicles or that it is included in another kind of vesicular structures that 
could have been visualised using another marker.
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Figure 4.8: DMec2myc expression in S2R+cells and vesicles localisation. The expression 
of the protein is massive with a substantial population of DMec2myc found in vesicles 
around the nucleus and a conspicuous amount scattered in the cytoplasm or other type of 
vesicles.
Vesicles that bud from the trans-Golgi network then can fuse with late endosomes; 
subsequently vesicles which bud from the late endosomes can be sorted to lysosomes. 
Therefore, the population of DMec2 further away from the vesicles coated with clathrin 
might represent inclusion of the protein in lysosomes on its way to be degraded.
2.5 Loss of DMec2 does not affect the actin cytoskeleton nor the microtubule 
network of Drosophila cells
In previous section was shown that overexpression of amino terminally-tagged 
DMec2myc does not have an effect on the morphology of Drosophila cells in tissue 
culture conditions. In addition, it was studied whether loss of DMec2 has any effect on 
the cell shape of S2R+ cells.
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Figure 4.9: Western Blot analysis for RNAi experiment, using an antibody to DMec2 
orthologue, stomatin. For the western blot analysis cell lysate was used from non 
transfected S2R+ cells, S2R+ cells expressing UAS-DMec2, and cells treated with 
dsRNA to DMec2 for six days. As a control for the anti-stomatin antibody cell lysate 
was used from HUVECS expressing stomatin. Control for loading is shown as an 
immunoblot with anti-alpha-tubulin antibody. RNAi has eliminated most of the 
endogenous DMec2 present in S2R+ cells.
RNA interference (RNAi) is a hitherto well established method to do functional 
analysis of genes. RNAi in Drosophila cells is.efficient, reducing or eliminating target- 
gene expression to elicit partial to complete loss-of-function phenotypes upon the 
simple addition of double stranded RNA (ds RNA) to the culture medium (Clemens et 
al., 2000). In order to test in detail the effects of DMec2 on the cell morphology, S2R+ 
cells were treated with dsRNA against DMec2 for six days. Subsequently they were 
fixed and stained for immunofluorescence studies. Some of the treated cells were 
harvested and the cell lysate was analysed by western blotting using an antibody against 
stomatin, in order to confirm that the protein was eliminated by the introduction of
WB: a-stomatin
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gene-specific dsRNA (Fig. 4.9). The western blot (Fig. 4.9) showed that the antibody 
recognises the endogenous protein giving as expected a fainter band compared to the 
band obtained from lysate of cells transfected with UAS-DMec2myc. RNAi eliminates 
most of the protein as it is observed by the absence of a band on the western blot. As a 
control for the stomatin antibody lysate from HUVECS (Human umbilical vein 
endothelial cells) was used and as expected a band appears on the western blot 
recognizing the stomatin protein. These results show that the RNAi treatment was very 
efficient.
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Figure 4.10: Quantification of cell spreading of control cells and cells treated with 
double stranded RNA against DMec2 for six days. Statistical significance was 
determined for the difference in cell diameter for cells where DMec2 has been 
eliminated compared to control by Student’s t test where P < 0.005. The results show 
the average cell diameter (n=120) ± S.D. from a single representative experiment.
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Control S2R+ cells spread well and are flat when they are plated on plastic surface, as 
previously described. The same spreading and flattening upon plating was observed 
with the cells treated with DMec2 double stranded RNA. Quantification of the 
spreading of the cells by taking as a parameter the diameter of the cells (Fig. 4.10) 
showed that there was no significant difference between the untreated and the treated 
with RNAi cells and the cell size for both cell categories was approximately 20pm.
In order to see the effects of DMec2 elimination on the actin cytoskeleton, the 
cells were stained with phalloidin labelled with TRITC. As seen in Figure 4.11, no 
change in form was observed after treatment of cells with RNAi targeting DMec2; the 
treated cells were undistinguishable from the wild type cells.
WT DMec2 dsRNA
actin 
tubulin
Figure 4.11: RNAi experiment. F-actin was visualized with TRITC-labeled phalloidin 
6 days after the addition of DMec2 specific dsRNA. Tubulin was visualized with anti­
alpha tubulin antibody 6 days after the addition of DMec2 specific dsRNA. Elimination 
of DMec2 does not have an effect on the actin nor microtubule network.
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Furthermore, the cells were stained with anti-a tubulin to visualise the 
microtubule network. In the wild type cells a radial microtubule array was observed. 
Treatment of cells with RNAi did not perturb the microtubule network. The 
microtubules were still seen as a meshwork of long struts diverging from the centre of 
the cell.
In conclusion, depletion by RNAi of DMec2 has no effect on the actin or 
microtubule network. Taken together the results from the overexpression and loss of 
DMec2 experiments, it is shown that with the assays used the protein under study does 
not have an effect on the actin filaments or microtubule network in Drosophila cells 
and general cell shape of the S2R+ cells.
2.6 DMec2 and Microtubule Network
It is known that microtubules play a major role in defining cell shape through 
the specific interaction of their plus ends with proteins at the cell cortex. In addition, it 
has been shown that DRhoGEF2 colocalises with EBl-a microtubule associated 
protein- at the tips of microtubules (Rogers, et al., 2004). Therefore, it was aimed to 
check whether DMec2 could be found associated at the tips of microtubules. To this 
end, S2R+ cells were transfected with DMec2myc and its localisation was visualised 
after stabilisation of the mictotubule network. Microtubules were visualised with anti P- 
tubulin, and exhibited the usual radial array. As it is seen in figure 4.12 DMec2 is not 
associated with the tips of the microtubules under the conditions tested; instead the 
protein is found in the perinuclear area.
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Figure 4.12: DMec2 and tips of Microtubules. S2R+ cells were transfected with 
Actin5c-GAL4 and expression vector UAS-DMec2myc. Three days after transfection the 
cells were fixed with a special protocol to preserve the microtubule network and stained 
with an antibody to myc to show localization of expressed protein and with an antibody 
to P-tubulin to visualise the microtubule network. This is a representative figure where 
the expressed protein is seen as green dots and the microtubule network is seen in red.
WT a-tubulin
a-tubulinmycMec2
Figure 4.13: DMec2 and microtubule network. S2R+ cells were transfected with 
Actin5c-GAL4 and expression vector UAS-DMec2myc. Three days after transfection the 
cells were fixed and stained with an antibody to myc to show localization of expressed 
protein and with an antibody to p-tubulin to visualize the microtubule network. The 
experiment was analysed by confocal microscopy. This is a representative figure where 
the expressed protein is seen as green dots and the microtubule network is seen in red. 
Overexpression of DMec2 does not affect the microtubule network.
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To further study the relationship of DMec2 with the microtubule network it was 
analysed whether DMec2 could have an effect by overexpressing it. For that reason, 
S2R+ cells were transfected with the expression vector UAS-DMec2myc. Three days 
post-transfection the cells were fixed and stained. Microtubules were visualised with 
anti P-tubulin; a dense, radial microtubule array was observed in both wild-type cells 
and UAS-DMec2myC expressing cells (Fig. 4.13). Thus overexpression of DMec2 did 
not seem to perturb the microtubule network under the conditions tested. In the 
previous section was shown that loss of DMec2 did not have an effect on the 
microtubule cytoskeleton. Taken together these results suggest that DMec2 does not 
alter the microtubule system and it is not associated with the tips of it at the cell cortex. 
It is possible that the cells are not found in the right environment so that DMec2 can 
interact with the microtubules.
2.7 Characterisation of S2R+ cell line for shear stress experiments
It is known that Rho is important for sensing mechanical stress (Geiger and 
Bershadsky, 2001). Indeed, Rho GTPases have been implicated in endothelial 
responses to shear stress (Li et al., 1999; Tzima et al., 2001), a frictional force exerted 
by laminar flow. It was recently shown that Rhol is activated during the early stages of 
endothelial actin cytoskeletal remodelling induced by shear stress and that it is required 
for initial cell contraction and depolarisation (Wojciak- Stothard and Ridley, 2003). 
This suggests that Rho is mediating cytoskeletal changes in response to a form of 
physical force such as shear stress. In addition, one of the effectors of Rho is the 
mechano-enzyme, Myosin II. From this evidence it was reasoned that components
143
Chapter 4: Characterisation of DMec2
upstream of Rhol might also be responding to mechanical cues other than chemical 
ones. To explore a possible involvement of DRhoGEF2 and DMec2 in this process it 
was aimed to establish DMec2 as a relay molecule acting between two mechanosensors 
and demonstrating that it plays a key role in actin remodelling and reinforcement in 
response to mechanical forces. To this end, it was first tested whether the Drosophila 
cell line S2R+ (embryonic epithelial derivative) is amenable to such experiments, due 
to the lack of Drosophila endothelial cell line. A time course experiment was initially 
carried out during which S2R+ cells were subjected to shear stress caused by fluid 
running on top of them at 3dyn/cm (Wojciak-Stothard and Ridley, 2003). Human 
umbilical vein endothelial cells (HUVECs) within 5 min of stimulation with shear 
stress show a rapid increase in the number of actin stress fibers (Wojciak-Stothard and 
Ridley, 2003). This was taken as the hallmark event of the manifestation of a 
cytoskeletal response to shear stress. Therefore the cells were fixed after 5, 10, 15, 20 
minutes of fluid force application and stained with phalloidin labelled with TRITC to 
visualise F-actin. The shear stress applied seems not to cause the formation of stress 
fibers during the time intervals and the magnitude of force used (Fig. 4.14).
Nevertheless, it has to be pointed out that there are other kinds of forces that a 
cell can respond to other than shear stress. Different types of cells are best suited to 
respond to different types of stimuli.
In order to study the involvement of DMec2 and DRhoGEF2 in a cytoskeletal 
remodelling due to shear stress another cell line is necessary to be used as a model 
system.
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Figure 4.14: Shear stress experiment. Both pictures show F-actin staining in S2R+ 
cells. The direction of flow is indicated by an arrow. A shows a cell in control (static) 
conditions, whereas B shows cells stimulated with shear stress 3 dyn/cm2 for 5 min.
2.8 Function of DMec2 in vivo
To characterise the role of DMec2 during the development of Drosophila, it was 
sought to find mutants for this gene. Two piggyBac transposon insertions in the DMec2 
locus have been generated by Exelixis and have been defined molecularly by recovery 
of flanking genomic sequences. The transposon called piggyBac is structurally related 
to Class II inverted repeat elements, it is 2.5 kb long, possesses 13-bp inverted terminal 
repeats and a 2.1-kb ORF, and demonstrates specificity for the tetranucleotide target 
sequence TTAA, which it duplicates upon insertion and precisely regenerates upon 
excision ( Lobo et al., 1999). piggyBac excisions from the germ line are nearly always 
precise, it does not share chromosomal hotspots associated with P element and is more 
effective at gene disruption because it lacks the P element bias for insertion in 5’
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regulatory sequences (Thibault et al, 2004). The limits of the piggyBac insertions for 
both DMec2 lines, #18428, and #18965 were confirmed by Inverse PCR.
Genomic DNA was harvested from flies with the transposon inserted into the 
CG7635 gene and digested by Hin PI I or Sau3AI for the recovery of the 3’ and 5’ end 
respectively of the piggyBac sequence. After digestion, the fragments were ligated. The 
ligated genomic DNA was used for two rounds of inverse PCR using two sets of 
primers (Table in Materials and Methods) for each end of the piggyBac sequence. The 
PCR products were cloned into pGEM-T easy vector (Promega) and sequenced (MWG 
Biotech). The flanking genomic sequences recovered coincided with those obtained by 
Exelixis. Line # 18428, has the transposon inserted in the first exon (position 132918bp 
of the genomic sequence, accession number AE003511) and for line # 18965 the 
transposon is found in the fourth exon (position 134584bp of the genomic sequence, 
accession number AE003511), (Fig. 4.15).
248bp 513bp 165bp
751bp 93bp 77bp
127bp 12lbp
Insertion 
Line# 18428
4 1 Insertion 
—J Line# 18965
Figure 4.15: Schematic representation of piggyBac insertion into Dmec2
The flies with the piggyBac insertion were homozygous viable with no visible 
phenotype. A complementation test using two different deficiencies, Df(l)JA27 and
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Df(l)ED7441 ranging [18A5-18D] and [18A3-18C2] respectively (both deleting 
approximately 40 predicted genes) (Fig. 4.16) were crossed with each piggyBac line. 
The results of these crosses are summarised in the table below (Table 4.1). Given the 
Mendelian expectation of 34% for the viable genotypes (hemizygous deficiency on Y 
chromosome is lethal), offspring from these crosses showed no reduced viability. In 
addition, there was no a visible phenotype.
DMec
18 A3 18A4 18B1 18C 18D
Df(l)JA27/FM7
Df(l)ED7441/FM7
Figure 4.16: A schematic drawing of the chromosome arm and deficiencies around 
DMec2 locus. Regions deleted in the deficiencies are marked with dashed line.
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Table 4.1.
Genotype Expected % of 
flies with 
appropriate 
genotype
Observed % of 
flies with 
appropriate 
genotype
% Lethality
Df(l)JA27/18428 34 39 (n=168) 0
Df( 1 )ED7441/18428 34 43 (n = l12) 0
Df(l)JA27/18965 34 39 (n=194) 0
Df( 1 )ED7441 /18965 34 33 (n=138) 0
Table 4.1: Results from the crosses of the Deficiencies with the piggyBac lines. In 
parenthesis is indicated the sample number.
2.8.1 Overexpression of DMec2 does not alter the morphology of different tissues
Not having any lethal alleles of DMec2 that might have allowed to assess the 
function of the gene in vivo the transgenic approach was undertaken. Thus, in order to 
study whether DMec2 could affect the actin cytoskeleton and induce morphological 
changes, transgenic UAS-DMec2myc flies were generated (EMBL) for overexpression 
of the gene in different tissues. Five transgenic lines were chosen at random and tested 
for the effects of overexpression using three different drivers at 18°C and 25°C as the 
temperature dependence of GAL4 activity in Drosophila is well established (Duffy, 
2002). The GAL4-driven DMec2myc protein was analysed by Western blot to ensure 
that the DMec2myc fusion protein was being produced in the transgenic flies (Fig. 4.17).
The three different drivers used were: i) the eyeless-Gal4 driver which allows 
gene expression to be specifically targeted to the eye, ii) the MS1096-Gal4 which 
drives expression in the wing and iii) VP16-V32-GAL4 which drives expression 
ubiquitously. Overexpression of DMec2 with VP16-V32-GAL4 did not cause high 
lethality (Table 4.2) and no observable effect. Overexpression of the gene using the ey- 
GAL4 and MS1096-GAL4 drivers did not cause any defects of the tissues under study;
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in other words there were no flies recovered which had an
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Figure 4.17: Western Blot analysis of protein extracts from adult fly eyes to check for 
expression of the DMec2 protein in the transgenic flies. The proteins were separated by 
SDS-PAGE (12%) and transferred to nitrocellulose. DMec2 was identified with anti- 
myc antibody.
effect in the shape of the eye, or an effect on the shape, hairs, vein network or 
campaniform sensilla sensory organs of the wing or any other effect. The eyes from 
adult flies carrying one copy of DMec2 transgene were study in more detail for subtle 
defects using scanning electron microscopy (SEM) and sectioning of the eye tissue. 
Scanning electron micrographs of the adult eyes revealed normal hexagonal shape 
ommatidia and normal number of bristles (Fig. 4.18). The sectioning of the adult eyes 
of the flies revealed no subtle defects of the different UAS-DMec2 lines. The 
photoreceptors were characterized by normal shape (Fig.4.19). To sum it up, the eye of 
the transgenic flies were indistinguishable from those of the wild type. There was no 
difference in the results between the two temperatures used to carry out the crosses.
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Table 4.2:
Driver Transgenes Expected % 
of flies with 
appropriate 
Genotype
Observed % 
of flies with 
appropriate 
genotype
% Lethality
Ey-GAL4 Mec2la 50 49 (n=192) 2
Ey-GAL4 Mec2lb 50 45 (n=120) 9
Ey-GAL4 Mec25 50 57 (n=146) 0
Ey-GAL4 Mec2'“ 50 49 (n=158) 2
Ey-GAL4 Mec2" 50 50 (n= l15) 0
MS-1096 Mec2,a 50 55 (n=220) 0
MS-1096 Mec2lb 50 49 (n=180) 2
MS-1096 Mec25 50 56 (n=239) 0
MS-1096 Mec210 50 48 (n=239) 4
MS-1096 Mec2n 50 54 (n=271) 0
VP16-V32 Mec21a 50 50 (n=344) 0
VP16-V32 Mec2lb 50 52 (n=338) 0
VP16-V32 Mec25 50 50 (n=128) 0
VP16-V32 Mec210 50 51 (n=367) 0
VP16-V32 Mec2" 50 52 (n=246) 0
Table 4.2: UAS-DMec2 expression in different tissues. Crosses were carried out at 25° 
C. In parenthesis is indicated the sample number.
Figure 4.18: Characterisation of the DMec2 eye effect (A-C).Scanning electron 
micrographs of adult eyes of (A) OreR (wild type, +), and (B-C) two of the transgenic 
lines of UAS-DMec2 (UAS-DMec2/ey-Gal4). Overexpression of DMec2 does not have 
an effect on overall eye size, ommatidial shape or bristle number.
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Figure 4.19: (A-C) Toluidine blue-stained transverse 
retinal section of eyes of wild type (A) and two different 
DMec2 transgenic lines (B-C) showing normal eye 
development. Eye section stained with toluidine blue to 
to visualize the shape of the ommatidia.
The absence of defects observed after overexpression of DMec2 might be due to 
the fact that still the protein is not expressed at high enough levels. Therefore it was 
tested whether higher expression would have an effect. The expression levels of DMec2 
were increased by generating flies having three copies of DMec2 and expression was 
driven in the eye. This did not yield any observable effects in the eye nor reduced 
viability with VP16-V32-GAL4.
The results show no effect of the overexpression of DMec2 in the studied 
tissues. This could mean several things: 1) DMec2 is not essential for embryogenesis, 
or eye or wing formation or 2) there might be a compensation for its overexpression, or 
3) DMec2 has a completely different function that could not be assessed with the 
methods used here. For instance it can be a behavioural gene.
w t
B UAS-DMec1a
C UAS-DM0C211
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2.9 Behavioural test for touch insensitivity
Since there were no observable effects after overexpression of DMec2 in cells 
and transgenic flies, it was then tested whether this is a behavioural gene. The C. 
elegans mec-2 mutants are touch insensitive. Assuming that the piggyBac lines have a 
disrupted gene affecting its normal function, larvae from piggyback Dmec2 
homozygous females and hemizygous males were studied for touch insensitivity. As a 
paradigm for the behavioural test the assay described by Keman et.al., (Neuron 
12., 1994) was used. Every larval segment has various external and internal 
mechanosensory organs, including sensory hairs, campaniform sensilla, chordotonal 
organs and multidendritic neurons, which could be involved in both sensing the 
stimulus and eliciting the response. A larvae shows a stereotypical response after being 
stroked by a mechanical stimulus which is a series of multiple waves of the thoracic 
segments and retreat away from the stimulus. In the screen, larvae moving forward 
were stroked with the tip of an eyelash across one side of the thoracic segments and the 
response of the larvae was observed. To quantify the responsiveness of a larva, scores 
of 0-4 were assigned to the following behaviours: no response (0), hesitation (1), 
anterior withdrawal/turn (2), single reverse contractile wave (3), multiple waves/retreat 
(4). One hundred and fifty first instar larvae were tested for touch sensation and all of 
them fell in the fourth category which is the wild type one; that is after the stimulus the 
larvae showed multiple waves of the thoracic segments and retreated. These results 
might suggest that the gene is not disrupted by the piggyBac insertion or that the gene 
is not involved in mechanotransduction of external stimuli in Drosophila. UAS-RNAi
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DMec2 flies (Joshua Ainsley, personal communication) also did not show any defects 
in sensing mechanical cues or defects in locomotion.
3. CONCLUSIONS AND DISCUSSION
In this chapter it was tested whether DMec2 can induce cell shape changes. 
From the results herewith presented, the functional role of DMec2 per se is not 
understood. Overexpression of DMec2 does not seem to affect the cell morphology of 
quiescent Drosophila S2R+ cells. It is noted here the evidence that exists about the 
DMec2 orthologue, the human stomatin, expressed in mammalian cells and its effect on 
the actin cytoskeleton. Treatment of UAC (Human amniotic) cells with IL-6 and 
dexamethasone upregulated stomatin five to six-fold and this treatment was 
accompanied by a slight morphological change (the cells became bigger and 
intracellular contacts were more visible) suggesting some modification of the 
cytoskeleton and/or the plasma membrane. The same treatment had no effect on HeLa 
(cervix carcinoma) and HMEC (endothelial) cells or any other cell line investigated 
(Snyers et al., 1997). In the same study it was also shown that stomatin colocalized with 
actin to some extent in induced UAC cells and that there was a specific association of 
stomatin with cortical actin microfilament system. The presence of high order 
oligomers of stomatin on the cytoplasmic side of plasma membrane, its partial 
association with the cytoskeleton as well as its co-localization with cortical filaments 
suggest a structural role and indicate that stomatin can play a role in the cortical 
morphogenesis in UAC cells and perhaps other cells (Snyers et al., 1997). However, it
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cannot be excluded that DMec2 may actually have an effect on the actin cytoskeleton 
as from experiments designed to assess the subcellular distribution of DMec2 in 
Drosophila cells there is some indication that the protein may be retained in vesicles 
and for that reason might not be reaching the right place for it to act. It cannot be ruled 
out that the punctate staining corresponds to other organelles, e.g lysosomes, or that the 
protein aggregates in the cytoplasm because of a certain instability. Using another cell 
line or another expression vector might have been able to shed more light into the role 
of DMec2. Endogenous stomatin in UAC cells after upregulation with interleukin-6 and 
dexamethasone appears divided into two separate pools: one in the plasma membrane 
and one perinuclear (Snyers et al., 1997). Interestingly, stomatin fused to the myc- 
epitope at the N-terminus does not reach the plasma membrane but is blocked in the 
Golgi apparatus and/or the endoplasmic reticulum which might represent polypeptides 
en route to the plasma membrane (Snyers et al., 1998). On the contrary, C-terminal 
tagged stomatin displays a fluorescence concentrated in fine plasma membrane folds 
and extensions and also in the intra-cytoplasmic pool within the Golgi region, staining 
pattern identical to endogenous stomatin in UAC cells (Snyers et al., 1998). The 
problem of the intracellular retention of the protein in perinuclear aggregates might 
have been solved by introducing an internal tag proximal to the C terminus. For 
example it has been reported that small tags at the N or C terminus of flotillin caused a 
perturbation of the protein trafficking and resulted in its retention in perinuclear 
aggresomes. Instead when the tag was introduced internally close to the C terminus 
flotillin was efficiently transported to the membrane as the wild type protein (Morrow 
et al., 2002). Alternatively, this perinuclear pattern might be a fixation artifact and
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having used another permeabilisation agent a different staining pattern might have been 
obtained. For example experiments in MDCK cells showed that endogenous RhoB was 
found in cytoplasmic vesicles when the cells were permeabilised with Triton X-100; 
instead when they were permeabilised with saponin the protein was found in a 
juxtanuclear structure (Michaelson et al., 2001).
In another set of experiments it was examined whether small interfering RNA 
(siRNA) against DMec2 affected cell shape. Depletion of DMec2 protein seems also 
not to alter the cell shape of the cells examined. In conclusion, with the assays used, 
DMec2 had no visible effect on S2R+ cells’ actin organization, microtubule network, or 
morphology in general. These results might be due to the fact that the protein is not 
found in the right conditions in order to act. One possibility could be that DMec2 is part 
of a complex of proteins one or several of which interact with the cytoskeleton and 
which interacting partners are missing from the used system. Another possibility is that 
oligomerisation with itself is prevented, or that the right stimulation was not put 
forward in order to have an effect on the cell shape in response to the overexpression or 
elimination of the protein. Alternatively, an association with the actin cytoskeleton 
could have been better checked with sedimentation experiments and a gel overlay 
assay.
Since the cell culture studies did not give much insight, the transgenic approach 
was then undertaken to elucidate the role of DMec2. However, even overexpression of 
DMec2 in a couple of different tissues on the whole fly did not seem to have an effect. 
Programmed overexpression of DMec2 by the eye-specific driver eyeless did not give a 
distinct eye phenotype. The eyes of DMec2/ey-GAL4 flies had normal size, with bristle
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number and hexagonal shaped ommatidia as the wild type OreR flies. To pinpoint the 
function of DMec2, the effects of increasing the DMec2 activity by generating flies 
having three copies of DMec2 was examined but again overexpression of DMec2 did 
not have an effect on the overall eye size. These data suggest that DMec2 
overexpression in the fly eye does not disrupt the ordered structure observed in the 
wild-type eye, both externally and internally. Overexpression of DMec2 was driven 
also in the wing and in the whole fly; however, no effect was observed in either case.
Two lines of flies with the transposon piggyBac inserted in the DMec2 gene 
were also tested. These lines were crossed with deficiency lines that eliminate Dmec2 
gene together with other genes however these yielded viable flies with no phenotype. 
With the aim of generating a stronger allele, it was taken advantage of the fact that the 
piggyBac is inserted with an FLP site in the same orientation for two lines. In that case 
the two piggyBac lines were combined to excise the gene between the FLP sites. A 
heat-shock flipase was used in order to excise the gene. Subsequently the excision of 
the gene would have been confirmed with PCR. UAS-RNAi flies for DMec2 gene were 
also viable (Joshua Ainsley, personal communication) with no phenotype and no touch 
insensitivity. Therefore the excision of the gene was aborted.
It is not known what is the significance of similarity of DMec2 to only the 
central part of stomatin and Mec2. All three of these proteins contain a central domain, 
called the prohibitin like domain (PHB). This domain is present in a number of proteins 
that are associated with lipid rafts which are microdomains in the plasma membrane 
involved in the clustering of signalling molecules. The PHB domain is evolutionarily 
conserved and is found in eukaryotic and prokaryotic membrane proteins. Except for
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the prokaryotic proteins carrying the PHB domain some eukaryotic ones seem to have 
similar functions but others do not, therefore it is not clear whether this domain renders 
these proteins structurally or functionally related. The human stomatin modulates the 
gating of ion channels but how this is done is not well understood (Price et al., 2004). 
In addition, there are other mammalian proteins such as flotillins implicated in various 
cellular processes that possess the conserved central region common to the 
aforementioned proteins (Liu et al., 2005). The genome of C. elegans encodes nine 
stomatin-related genes, three of which have been studied genetically and are involved 
in mechanotransduction (MEC-2) (Huang et al., 1995; Tavemarakis and Driscoll.,
1997), locomotion (UNC-24) (Barnes et al., 1996) and responsiveness to volatile 
anaesthetics (UNC-1) (Rajaram et al., 1998). In C. elegans Mec2 has been shown also 
to interact with ion channel subunits and potentiate the current when expressed in 
Xenopus oocytes (Goodman et al., 2002). It has actually been shown that MEC-2 
interacts with the MEC-4 degenerin ion channel subunit via its stomatin-like region, 
which therefore in this case acts as protein binding domain, while its nonstomatin 
domains regulate channel activity (Zhang et al., 2004). Finally, the E. coli plasma- 
membrane proteins HflK and HflC (high frequency of lysogenisation) have the region 
of similarity found in the stomatin family and have a role in the switching from 
lysogenic to lytic cycle during X-phage infection (Tavemarakis et al., 1999). All these 
proteins have different functions in the organisms they are part of therefore it is 
suggested that this central region forms a distinct domain; it is thought that the 
specificity for the function of these proteins is conferred by their amino and carboxy 
termini which are not conserved amongst them. On the other hand the conserved
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domain may serve a structural role. For example in C. elegans and mammalian stomatin 
part of this region seems to be important for homo-oligomerisation (Snyers et al.,
1998). Perhaps the general role of this domain might be in lipid raft association as it is 
usually observed that the apparently unrelated PHB-containing proteins are associated 
with these microdomains.
In conclusion, the role of DMec2 remains an enigma. It might be that DMec2 is not 
an essential gene or that its function is completely different from what it has been tested 
for here. For example it may be a behavioural gene involved in sensing anaesthetics or 
pain as some other members of the stomatin family are. Since it is not known where 
and when it is expressed it is difficult to speculate on its function. More experiments 
are definitely needed to establish the physiological function of this gene.
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Chapter 5: ANALYSIS OF THE PHYSICAL AND FUNCTIONAL 
INTERACTION BETWEEN DRhoGEF2 AND DMec2
1. INTRODUCTION
DRhoGEF2 is thought to receive a signal from Fog through Cta, but it has a 
more severe phenotype in gastrulation than cta and fog  (Barrett et al., 1997). For this 
reason, it is possible that DRhoGEF2 may be activated in a Fog/Cta-independent 
pathway. In fact, because fog  and cta have a non-essential function in the mesoderm, it 
is thought that there is a second pathway commanding cells to undergo shape changes 
(Costa et al., 1994). One potential interaction with other components of other signaling 
pathways could occur through the PDZ domain of DRhoGEF2.
Interestingly the typical GLGF motif that is thought to comprise the ligand 
binding pocket of PDZ domains (Doyle et al., 1996) is changed to GYGM in 
DRhoGEF2. The GLGF binding loop has been shown specifically to interact with a 
(S/T)-X-(V/I/L) (X denoting any amino acid) motif found at the carboxyl terminus of 
various proteins (Songyang et al., 1997). Consequently, the DRhoGEF2-PDZ domain 
having a slightly different binding motif might have a different binding specificity.
The novel protein DMec2 was initially identified by a yeast two-hybrid screen 
(K. Barrett, unpublished data) as a candidate interacting partner of the PDZ domain of 
DRhoGEF2. DMec2 has a cytoplasmic region with type I C-terminus PDZ-binding 
motif (T-N-L) conforming to the consensus sequence (S/T)-X-(V/I/L) (Songyang et al., 
1997). Therefore, the yeast-two-hybrid assay indicates that DMec2 might actually be a
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target for the binding loop of DRhoGEF2-PDZ domain despite the fact that the latter is 
different from the archetypal PDZ domain. Because DMec2 was initially detected as 
the prey of PDZ in a yeast-two-hybrid assay, it was sought to confirm the interaction by 
co-immunoprecipitation. Therefore, the physical interaction between these two proteins 
is described and further characterized. In addition, two separate approaches were taken 
to elucidate the functional relevance of this interaction: first the interaction was tested 
using Drosophila cells as a model system to study possible effects on the actin 
cytoskeleton. In the second approach, the interaction was tested genetically using 
transgenic flies and alleles of the two genes.
2. RESULTS
2.1 Physical Interaction between the PDZ domain of DRhoGEF2 and DMec2
2.1.1 The Carboxy terminus of DMec2 interacts with the PDZ domain of 
DRhoGEF2
In order to test whether the PDZ domain interacts with the carboxy terminus of 
DMec2 co-immunoprecipitation experiments were carried out. S2R+ cells were 
transfected with an expression vector for the N-terminal myc-epitope-tagged DMec2 
(described in Chapter 4). The PDZ domain of DRhoGEF2 was digested from the full 
length cDNA and subcloned in frame with the T7 tag present in a vector (pETc, 
Novagen) for expression in E.coli cells (BL.21, Invitrogen) after IPTG induction. The 
cell lysate containing DMec2 was mixed with the purified recombinant T7-PDZ and
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immunoprecipitated with an anti-T7 antibody on protein G-Sepharose beads and 
analyzed by Western Blot with anti-myc. As shown in figure 5.1, the PDZ domain 
precipitates the myc-tagged DMec2 from transfected cells as seen by a band at 40kDa 
mark.
-rPDZ +rPDZ
DMec2
Consensus
DMec2T348A
DMec2L350A
IP a-T7 
IB: a-myc
IB a-T7
P K T N  L
s / t  X ITLTV 
P K A N  L
P K T N A
IgG 
40 kC>a
•— 23 kDa
Tot cell lysate 
O-myc
a-tub
Figure 5.1: Interaction between DMec2 and the PDZ domain of DRhoGEF2. Cells 
were transfected with amino terminally myc-tagged DMec2 constructs: wild type 
(DMec2wt), mutated DMec2 where Threonine 348 was changed to Alanine (T348A), 
and mutated DMec2 where Leucine 350 was changed to an Alanine (L350A). The 
whole cell lysate was mixed with recombinant amino terminally T7 tagged PDZ 
domain. The T7-PDZ was immunoprecipitated with the anti-T7 antibody coupled to G- 
Sepharose coated beads. Shown is the western blot of immunoprecipitated DMec2 
probed with anti-myc. The expression of the DMec2 protein was determined by 
Western blot analysis of the whole cell lysate with the anti-myc antibody. The presence 
of the recombinant PDZ domain was analysed with the anti-T7 antibody by reprobing 
the co-immnoprecipitation blot. The anti-tubulin blot serves as a loading control.
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Confirmation of the presence and absence of the recombinant protein is shown by the 
same blot below, after stripping and reprobing it for a-T7, revealing the T7-tagged 
recombinant PDZ migrating at ~ 23 kDa. Control for loading is shown as an 
immunoblot with anti a-tubulin.
To check whether this interaction is critically dependent on the integrity of the 
C-terminal PDZ domain binding motif, the ability of mutants of the putative target 
sequence of DMec2 to interact with the PDZ domain was tested. Since residues 0 and - 
2 of the ligand are particularly important determinants for the PDZ domain binding and 
form the basis for classification of PDZ domain specificity (Songyang et al., 1997) the 
amino acids threonine (-2 residue) and leucine (0 residue) at the carboxy-terminus were 
mutated separately to an alanine by PCR using as a template the wild-type N-terminal 
myc-epitope-tagged DMec2. Expression vector for myc-epitope-tagged 
DMec2(T348A) and expression vector for myc-epitope-tagged DMec2(L350A) were 
transfected into S2R+ cells. For the following co-immunoprecipitation experiments the 
same T7-epitope-tagged recombinant PDZ domain of DRhoGEF2 was used as before. 
As expected, these mutants failed to immunoprecipitate with the PDZ domain (Fig. 
5.1). These results indicate that the interaction occurs through the consensus sequence 
motif at the carboxy-terminus of DMec2. In addition, they indicate that the amino-acids 
at position 0 and -2 are necessary for the interaction to take place since mutation of 
these putative amino-acids is able abolish the binding of the target to the PDZ domain.
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2.1.2 Specificity of the Interaction between PDZ domain and DMec2
To test whether the interaction between DMec2 and the PDZ domain of 
DRhoGEF2 is specific, a mutated form of the PDZ domain was generated by site 
directed mutagenesis (K. Barrett, unpublished). To generate this mutated form the 
corresponding residues on the PDZ domain of DRhoGEF2 involved in the binding were 
deduced by alignment of the primary sequences with the third PDZ domain of PSD-95 
(PSD-95-3) and labeled according to their positions in the crystal structures of PSD-95-
3. Consequently, in the PDZ mutant two amino acids in the carboxylate-binding groove 
were mutated. More precisely, tyrosine a hydrophobic amino-acid with a bulky 
aromatic side chain was substituted with a leucine that is also a non-polar, hydrophobic 
amino-acid. For the same mutant a methionine, a non-polar and hydrophobic amino- 
acid was substituted with phenylalanine also a hydrophobic amino-acid but with much 
bulkier side chain, an aromatic group -the construct presented here was called 
PDZ(YLMF). In other words the GYGM motif was changed to GLGF. Therefore with 
these two mutations the carboxylate-binding loop of the PDZ domain of DRhoGEF2 
ends up being identical to the binding loop of the third PDZ domain of PSD-95. The 
aim of these substitutions was to modify the interaction and not to abolish it. It is 
reported that variations in the size and geometry of the hydrophobic pocket presumably 
account for the differential preference of various PDZ domains for valine, leucine, 
isoleucine, phenylalanine, or alanine at the very end of peptide ligands (Songyang et al., 
1997).
164
Chapter 5: Interaction between DRhoGEF2 and DMec2
igG
40 kDa
a-tubulin
Figure 5.2: Specificity of the Interaction between C-terminal of DMec2 and the PDZ 
domain of DRhoGEF2. Cells were transfected with amino-terminally myc-tagged 
DMec2 construct and mixed with recombinant amino-terminally T7 tagged PDZ 
domain of DRhoGEF2 wild type (PDZwt) or a mutated form of it [PDZ(YLMF)]. The 
T7-PDZ domains were immunoprecipitated with the anti-T7 antibody coupled to G- 
Sepharose coated beads. Shown is the western blot of immunoprecipitated DMec2 
protein probed for anti-myc antibody. The anti-tubulin blot serves as a loading control.
The mutated form of the PDZ domain of DRhoGEF2 [designated hereafter 
PDZ(YLMF)] was digested from the full length cDNA and subcloned in frame with the 
T7 tag present in the vector (pETc, Novagen) for expression in E.coli cells (BL.21, 
Invitrogen) after IPTG induction. N-terminal myc-epitope-tagged DMec2 was obtained 
after transfection of S2R+cells. The cell lysate containing DMec2 was mixed with the 
purified recombinant T7-PDZ(YLMF) and immunoprecipitated with an anti-T7
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antibody on protein G-Sepharose beads and analyzed by Western Blot with anti-myc. 
Co-immunoprecipitation of the wild type PDZ domain was carried out in parallel with 
the co-immunoprecipitation experiment of the mutated PDZ domain. The Western blot 
analysis (Fig. 5.2) showed a weak association between the DMec2 and the mutated 
form of PDZ domain as is seen from a fainter band compared to the band obtained from 
the co-immunoprecipitation with the wild type PDZ domain. Quantification of the band 
from the co-immunoprecipitation with PDZ(YLMF) gives a 35% decrease in the signal 
relative to the signal obtained from the PDZ wild type band. This result could suggest 
that the mutated form of the PDZ domain forms a pocket with a modified size and 
shape that causes a less efficient interaction with the Carboxy-terminus of DMec2. The 
experiment described here indicates that the interaction of DMec2 with the mutated 
form of PDZ domain was less strong therefore it indicates a specific interaction 
between DMec2 and the PDZ domain of DRhoGEF2.
2.2 Functional Role of the Interaction of DMec2 with PDZ domain
2.2.1 Interaction between DRhoGEF2 and DMec2 in Drosophila tissue culture 
cells
After having shown in vitro that DRhoGEF2 interacts with the carboxy- 
terminus of DMec2 via its PDZ domain, the physiological relevance of this interaction 
was studied. In order to study the functional significance of this interaction that is 
whether the two proteins can induce cell shape changes, Drosophila S2 cells were used 
as a model system. A set of S2 cells was co-transfected with an expression vector for
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N-terminal myc-epitope-tagged DMec2 and full length DRhoGEF2. As controls were 
used a set of S2 cells transfected with the expression vector for N-terminal myc- 
epitope-tagged DMec2 alone and another set with expression vector for 
DRhoGEF2 alone. Expression of the proteins was under the control of the (Actin-5c 
driver)Gal4/UAS system as was previously described. For all experiments cells were 
plated at the same density 106 cells/cm2 that is confluent upon plating. The S2 cells 
upon plating attach well and spread on a plastic substrate (Fig. 5.3).
a-DRhoGEF2 a-myc Merge
Wild type
UAS-DRhoGEF2 Q
UAS-DMec2
UAS-DRhoGEF2 
+ UAS-DMec2 D
Figure 5.3: Overexpression of DMec2 together with DRhoGEF2 does not enhance nor 
inhibits the cell rounding that it is observed after overexpression of DRhoGEF2 alone. 
S2 cells were transfected with (Act5c-Gal4) UAS-DRhoGEF2 and UAS-DMec2myc. 
DRhoGEF2 is visualised in green with an antibody against DRhoGEF2. DMec2 is 
visualised in red with an antibody against the myc tag. Scale bar 1 Opm.
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When transfected with DRhoGEF2 the cells rounded up as was described in Chapter 3. 
Instead transfection of S2 cells with DMec2 alone does not seem to cause a change in 
cell shape. It was aimed to study whether DMec2 could make the cell shape change 
obtained after overexpression of DRhoGEF2, more or less severe. Co-expression of 
DRhoGEF2 with DMec2 did not modify the observed phenotype; the cells still rounded 
to the same degree (Fig. 5.3) giving a size within the range observed when the cells 
were transfected with DRhoGEF2 alone. The degree of cell rounding was quantified by 
taking as a parameter the diameter of the cells (Fig. 5.4). The results obtained here 
show that DMec2 does not inhibit nor enhances the phenotypic changes observed after 
overexpression of DRhoGEF2.
25 1 
20 -
Diameter 15 .
(nm)
10 -  
5 - 
0 -
Figure 5.4: Quantification of cell rounding by taking as a parameter the diameter of the 
cells after transfection of S2 cells with DRhoGEF2 and DMec2. Statistical significance 
was determined for the difference in cell diameter for cells overexpressing DRhoGEF2, 
DMec2 or both compared to control by Student’s t test where P < 0.005. The results 
show the average cell diameter (n=100) ± S.D. from a single representative experiment.
■  Control
□  RhoGEF2
□  DMec
■  RhoGEF2+DMec2
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2.2.2 Interaction between DRhoGEF2 and DMec2 in flies
Since the tissue culture studies were not very informative regarding the 
functional significance of the interaction between DMec2 and DRhoGEF2, it was tested 
whether the two interacted genetically. Two approaches were used to study the genetic 
interaction between DMec2 and DRhoGEF2. In the first approach, the interaction 
between the two genes was studied using a hetero-allelic combination for DRhoGEF2 
that causes an easily scored phenotypic change and a mutant copy of DMec2. More 
precisely, the genetic background of DRhoGEF2 null/hypomorph has an adult wing 
phenotype that was used as a sensitised system to assess the genetic interaction of 
DRhoGEF2 with DMec2. The addition of a heterozygous mutation of another molecule 
presumably participating in the same signaling pathway was expected to cause a more 
severe phenotype. Since there is still some signal through DRhoGEF2, a reduced signal 
from another component would decrease the signal further and enhance the phenotype. 
The enhancement would suggest that the two components either interact with each 
other or they synergise in the developmental process. More specifically, for this 
experiment the DMec2 mutants having a piggyBac insertion into the gene were 
combined with transallelic combination of a null DRhoGEF24 1 (Barrett, et al., 1997) 
(described in Chapter 3) over a hypomorphic DRhoGEF261 (Barrett et al., 1997) allele 
(described in Chapter 3), and their phenotypes and viability percentages were 
compared. Both piggyBac lines have 100% viability. Hetero-allelic combinations of 
DRhoGEF24 VDRhoGEF261 (DRhoGEF241/6*) were approximately 60% viable (Table
5.1 and Fig.5.5). Of the surviving adults, approximately 55% had crumpled wings 
(Fig.5.6). When the heteroallelic combination of DRhoGEF2 null/hypomorph was
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Table 5.1
RhoGEF241/61 18428/+;RhoGEF241/61 18965/+;RhoGEF24 V61
Viability 60% 63% 57%
Wing
phenotype
55% 54% 52%
Table 5.1: Genetic interactions between hetero-allelic DRhoGEF2
(DRhoGEF24 VDRhoGEF26 ') and heterozygous piggyBac lines (18428 and 18965) of 
DMec2. In the table the wing phenotype and viability percentages are reported. The 
piggyBac lines are 100% viable.
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Figure 5.5: Viability and wing phenotype percentages for heteroallelic combination of 
DRhoGEF24 VDRhoGEF261 (4.1/6.1) with heterozygous piggyBac linesl8428, and 
18965.
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present in a trans-heterozygous combination with the piggyBac alleles 18428 and 
18965 of DMec2 there was no change in the viability or wing phenotype percentages. 
DRhoGEF241/DRhoGEF261 with heterozygous DMec2 allele 18428 showed 63% 
viability. Of the surviving adults 54% had the crumpled wings. Approximately the 
same percentages were observed when DRhoGEF24 VDRhoGEF261 was combined 
with a heterozygous DMec2 allele 18965. Flies with this genotype were 57% viable and 
of the surviving flies 52% of them had the wing phenotype. From these results is seen 
that the DMec2 mutants do not have a synergistic effect on the heterozygous 
combination of DRhoGEF2 alleles (Table 5.1 and Fig.5.5).
Figure 5.6: Genetic Interaction between DRhoGEF2 and DMec2. (A) Wild type wing, 
(B) 18428/+; DRhoGEF24 '/DRhoGEF261 wing.
DMec2 is not redundant therefore there should not be another gene in the fly 
genome that could compensate for it. It is difficult to assess whether there is a genetic 
interaction between DMec2 and DRhoGEF2 using the piggyBac mutants of DMec2 as 
their nature was not known. It might be that the piggyBac insertion does not disrupt the 
gene and therefore these are still functional alleles of DMec2.
A B
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Therefore in order to test whether DRhoGEF2 and DMec2 interact genetically a 
second approach was undertaken by using transgenic flies for both genes. 
Overexpression of Rhol in the developing fly eye using the synthetic promoter called 
GMR causes a rough eye phenotype (Hariharan et al., 1997). Thus the Drosophila eye 
was used as a system to study the effects of overexpression of DMec2. Overexpression 
of DMec2 using the ey-Gal4 did not seem to have an effect on eye development. In 
contrast, it was shown that excessive activity of DRhoGEF2 perturbed the normal 
development of the eye. When overexpressed in transgenic lines, wild type forms of 
DRhoGEF2 disrupted the normal ommatidial structure of the eye and resulted in an 
externally “rough” effect (Fig. 5.7 and 5.8 and Table 5.2). Overexpression of wild type 
DRhoGEF2 together with overexpression of DMec2 did not seem to relieve nor make 
more severe the eye effect (Fig.5.7, 5.8 and Table 5.2) observed when DRhoGEF2 
transgene was expressed on its own. The eyes of transgenic flies for both DMec2 and 
DRhoGEF2 exhibited the same rough eye effect (Fig.5.8) at the same percentages (Fig. 
5.7, and Table 5.2) as that of the transgenic flies for DRhoGEF2 alone. These results 
suggest that DMec2 does not interact genetically with DRhoGEF2. It is noted that the 
eyeless-GAL4 driver is leaky that is why a high lethality percentage is observed.
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Table 5.2
Ey-Gal4/RG2-6b;Mec29/+ Ey-Gal4/RG2-6b ;+
Viability 14% 12%
Eye effect 18% 10%
Table 5.2: Percentages of viability and eye phenotype obtained from overexpressed 
wild type DRhoGEF2 transgene and wild type DRhoGEF2 transgene in combination 
with DMec2 transgene.
■ Viaibility □ Eye phenotype
Figure 5.7: Viability and eye effect percentages for heterozygous combination of 
DRhoGEF2 wild type transgene (line 6b) with DMec2 wild type transgene (line 9) 
driven by ey-Gal4 (Ey).
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Figure 5.8: Study of a genetic interaction between DRhoGEF2 and DMec2. Scanning 
electron microscopy images of Drosophila eyes from (A) Wild type eye, (B) UAS- 
RhoGEF26b/ey-GAL4, (C) UAS-Mec29 /ey-Gal4, (D) RhoGEF26b/ey-GAL;UAS- 
Mec29 /+ transgenic flies, showing the “rough-eye” phenotypes in transgenic flies that 
overexpress DRhoGEF2 and DMec2 in Drosophila eyes as UAS-RhoGEF26b/ey-GAL4 
do.
3. CONCLUSIONS AND DISCUSSION
PDZ-containing proteins are often engaged in the formation of supramolecular 
complexes that carry out localized signaling functions at particular subcellular locations 
(Harris and Lim, 2001) allowing an efficient signal transduction (Harris and Lim, 
2001).
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The role of the PDZ domain of DRhoGEF2 in forming a protein-protein 
complex was addressed. Thus the physical interaction between the PDZ containing 
nucleotide exchange factor DRhoGEF2 and the novel protein DMec2 was examined. 
First, it was shown by a co-immunoprecipitation experiment that the interaction occurs 
through the carboxy terminus of DMec2. Recombinant PDZ domain was able to 
immunoprecipitate the wild type DMec2. However when the last amino acid of DMec2 
leucine was mutated to alanine and similarly when threonine two amino acids before 
the carboxy end of the protein was mutated to alanine then the PDZ was not able to 
interact with the constructs and pull them down. These results show that the binding 
occurs through the C-terminus of DMec2. The lack of interaction between the mutants 
of DMec2 and the PDZ domain might be due to the fact that the smaller side-chain of 
alanine could be creating an energetically costly unfilled hole within the hydrophobic 
cavity rendering the interaction unfavorable. Since the interaction is abolished even 
when one of the two putative amino acids are mutated it seems that both of them are 
likely to be necessary for the interaction to occur. This is consistent with the fact that 
these two amino acids at the C-terminal PDZ domain binding motif are centrally 
involved in the interaction with PDZ domains. Indeed, PDZ domains bind to short 
sequences of five to seven residues in their target proteins (Doyle et al., 1996; 
Songyang et al., 1997). The specificity of these recognition motifs that per se are of 
little importance is typically improved by the requirement that they occur at the C- 
terminus. The requirement for a C- terminus motif results from a steric rather than an 
electrostatic mechanism: the peptide-binding pocket is constructed in a way that 
residues beyond the C-terminus are incompatible with it (Doyle et al., 1996; Harris and
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Lim, 2001). In addition, experiments on the effects of salt on the binding reaction 
suggest that electrostatic contributions are of little consequence (Harris et al., 2003), 
despite the fact that C-terminal ligands have a negatively charged carboxylate.
The human Na+/H+ Exchanger Regulatory Factor (NHERF/EBP50) has a PDZ 
domain which is similar to the PDZ domain of DRhoGEF2 having a GYGF binding 
loop. By alignment of the primary sequences of these two PDZ domains, it is seen that 
they also have a similar amino acid sequence outside the loop. In addition, the target of 
NHERF/EBP50 has a carboxyl-terminal Leucine. Therefore, the crystal structure of the 
PDZ1 domain of NHERF/EBP50 could provide insights into the structural basis for 
carboxyl-terminal Leucine recognition by class I PDZ domains (Karthikeyan et al., 
2001). Taking that binding as a paradigm, it could be inferred that the side chain and 
carboxylate group of DMec2’s Leucine could enter into a deep cavity formed by 
Tyrosine, Glycine, Methionine (of the GYGM loop), Valine (two amino acids outside 
the loop), and Valine, Isoleucine (in the aB helix). The carboxyl-terminal oxygen atom 
of Leucine could bind hydrogen directly with the amide nitrogen atoms of Tyrosine and 
Glycine, and indirectly with the carbonyl oxygen atom of Methionine through a water 
molecule and through two water molecules with Lysine (Fig. 5.9.). The hydroxyl 
oxygen of DMec-2’s Threonine two amino acids away from the last Leucine residue 
(Thr-2) could hydrogen bind with the amide nitrogen of Histidine in the aB helix. In 
addition, there could be hydrogen bonds between the carbonyl oxygen of Thr-2 and the 
amide nitrogen of Valine as well as between the amide nitrogen of Thr-2 and the
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Figure 5.9: Schematic representation of a speculative binding model between the PDZ 
domain of DRhoGEF2 with its target, the carboxyl terminus of DMec2 (in the 
shadowed side of the drawing).
carbonyl oxygen of Valine (Val present two amino acids after the binding loop, 
between pA and PB), (Fig.5.9).
Subsequently, it was studied whether the interaction between DMec2 and the 
PDZ domain of DRhoGEF2 was specific because that would give an indication of a 
possible functional relevance of this binding. For this experiment a mutated form of the 
binding pocket of DRhoGEF2-PDZ domain was used to immunoprecipitate DMec2. 
The immunoprecipitation of DMec2 by this mutated PDZ domain was less efficient 
than the one by the wild type PDZ domain. To create the PDZ binding groove mutant
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the Tyrosine, an amino acid with a bulky aromatic side group, was substituted with a 
Leucine whose side chain consists entirely of hydrocarbons and vice versa the 
Phenylalanine, an amino acid with a bulky aromatic group was substituted with 
Methionine, an amino acid with a side group composed of a hydrocarbon chain (except 
for a sulfur atom); it is conceivable therefore that there is some change in the geometry 
and size of the binding groove that could have an effect on the interaction with the 
stereochemical complementarity of the peptidic carboxyl-terminal residue and the 
volume/shape of the cavity. This result indicates that the interaction between DMec2 
and the PDZ domain of DRhoGEF2 is specific.
It was then studied whether DMec2 and DRhoGEF2 interaction has a functional 
relevance. In the first approach using Drosophila cell lines as a model, co-transfection 
of S2 cells with DRhoGEF2 and DMec2 did not have an additional effect to the 
abnormal phenotype of rounding up due to overexpression of DRhoGEF2 alone. The 
fact that we do not see any further or less rounding of the cells when DRhoGEF2 is co­
expressed with DMec2 compared to what is happening when DRhoGEF2 is 
overexpressed alone although these two proteins physically interact, might be because 
this interaction does not have a physiological relevance and actually it does not occur in 
this cell system or that the conditions of the system are not the right ones to observe a 
change in the organization and distribution of the actin cytoskeleton. Maybe the two 
proteins are not in the right stoichiometric proportions, or other interacting partners are 
absent from the system used or that DMec2 has to be activated. Alternatively, it might 
be due to the fact that the result of this interaction is uncoupled from effects on the 
cytoskeleton or that it affects other aspects other than cell rounding. Another
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possibility might be that DRhoGEF2 overexpression causes such a severe phenotype 
that nothing can affect it more. Since DRhoGEF2 is hypothesized to act in a restricted 
area somehow it has to reach that area or if it is always present to a specific place then 
somehow it has to be activated locally. It is not clear whether DMec2 physically binds 
and brings DRhoGEF2 to the place of action or it acts by creating the right architectural 
milieu for DRhoGEF2 recognition and subsequent activation.
The Drosophila wing was previously shown to be a good model system to study 
the interaction of DRhoGEF2 with other signaling components as these interactions 
cause phenotypic changes in the wing (K. Nikolaidou unpublished data). Therefore, to 
test whether there is a physiological relevance of the interaction between DMec2 and 
DRhoGEF2, DMec2 mutants were put together with a heteroallelic combination of 
DRhoGEF2 null/hypomorph that causes the wings to become malformed. This study 
showed that the two genes do not interact. An explanation for not observing a genetic 
interaction between DMec2 and DRhoGEF2 is the possibility that this not the right 
system to be looking at. It is possible that the DRhoGEF2 phenotypic change of the 
wings is not specific to the pathway that DMec2 participates. Since DRhoGEF2 has a 
lot of phenotypes, maybe DMec2 is in a different pathway. It is also possible that 
DMec2 acts downstream of DRhoGEF2. For example DMec2 is not used to activate 
DRhoGEF2 but to become activated by it. Therefore, since DRhoGEF2 in this hetero­
allelic combination of null/hypomorph is almost absent DMec2 cannot be activated and 
so even if it is removed no phenotypic change can be observed.
Studies using transgenic flies for both genes did not reveal a genetic interaction 
between DMec2 and DRhoGEF2. It is possible that DMec2 is not expressed in high
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enough levels therefore increasing its copy number might give an effect. Because 
DRhoGEF2 overexpression in the eye causes a severe effect it is possible that the 
effects of overexpressed DMec2 cannot be observed. Therefore future work to test 
whether these genes interact will have to include a sensitized system without bringing it 
to its limit, such as the null/hypomorph alleles of DRhoGEF2. Using this genetic 
background then overexpressed DMec2 can be introduced to study whether there is 
enhancement or suppression of the null/hypomorph phenotype. More experiments are 
needed in order to conclude whether DMec2 interacts genetically with DRhoGEF2.
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VI. DISCUSSION
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Chapter 6 : DISCUSSION
1. Summary
This study showed that DRhoGEF2 causes a rough eye and a crumpled wing 
effect when overexpressed in the respective tissues. In contrast, overexpression of 
DRhoGEF2 lacking the PDZ domain did not cause these effects. These preliminary 
results could suggest that the PDZ domain is acting as a positive regulator for the 
function of DRhoGEF2. In addition it showed that overexpression or loss of DMec2 
does not induce cell shape changes in Drosophila tissue culture cells. Furthermore, 
overexpression of DMec2 in the Drosophila eye and wing does not have an effect. 
DMec2 binds to the PDZ domain of DRhoGEF2. However, overexpression of DMec2 
with DRhoGEF2 in cells and in flies does not change the effects caused by 
overexpression of DRhoGEF2 alone.
2. The function of DMec2
As outlined in the Introduction cell shape changes in morphogenesis are 
controlled by a sub-family of the Ras family of small GTPases called Rho. The activity 
of Rho, is controlled by RhoGEFs. The proper function of the Rho pathway requires 
that the activated Rho is specifically located at the plasma membrane. The mechanism 
by which Rho is thus located is not yet fully understood. One possibility is that on 
receipt of a stimulating signal RhoGEF becomes attached to the membrane. Rho then 
associates with membrane-bound RhoGEF. These stimulating signals can be an
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extracellular biochemical one or in particular cases can arise from a mechanical stress 
coming from outside the cell. Thus for these cases, one could envisage that a protein in 
the cell membrane has two functions: one to anchor RhoGEF; the other to transduce the 
mechanical stimuli that control the activity of Rho.
The work in this thesis arose from an observation using the yeast two-hybrid 
assay that DRhoGEF2 interacted with DMec2. DMec2 belongs to the stomatin family. 
Stomatin-like proteins are integral membrane proteins with an affinity for lipid raft 
microdomains (Morrow and Parton, 2005). The central part of these proteins, called the 
PHB domain, may be the recognition motif for the partitioning of the proteins into lipid 
rafts. The fact that DMec2 carries this domain, rendered it a very attractive candidate as 
a binding partner for the PDZ domain of DRhoGEF2 which is thought to act in specific 
parts of the plasma membrane. It was envisioned that DMec2 could be acting as a 
chaperone for DRhoGEF2, with the PHB domain detecting the membrane 
microdomains and then PDZ domain of DRhoGEF2 being responsible for the 
attachment onto the membrane. Another reason DMec2 was a very appealing candidate 
was the possibility that DMec2 could be involved in the transduction of mechanical 
cues. Consequently, DRhoGEF2 could have also been involved in the modification of 
the actin cytoskeleton due to physical forces. Thus, DMec2 was thought to have a dual 
role: to help in the localization of DRhoGEF2 as well as to relay information about the 
physical microenvironment contributing in the spatially restricted activity of 
DRhoGEF2.
Experiments carried out here to elucidate the function of DMec2 indicate that 
this protein does not seem to have an effect on the actin or microtubule cytoskeleton.
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Based on the tissue culture studies and the experiments using transgenic flies, it seems 
unlikely that DMec2 participates in the signaling pathway involving DRhoGEF2 
leading to cell shape changes. DRhoGEF2 may have other functions for which DMec2 
is required. Alternatively, DRhoGEF2 may be influencing any function DMec2 may 
have. As described above, the interaction between DMec2 and the PDZ domain of 
DRhoGEF2 might not occur in vivo. However, from the co-immunoprecipitation 
experiments it cannot be excluded that DMec2 could be interacting with another PDZ 
containing protein.
The mammalian orthologue of DMec2, stomatin, and the C.elegans Mec2 do 
not have a PDZ interaction motif but associate with ion channels via their PHB region. 
It is therefore possible that DMec2 is interacting via its PHB domain with an ion 
channel leaving its C-terminus free for interaction with other proteins hence 
participating in a signaling pathway that has still to be identified.
3. Various domains are involved in the localization of RhoGEFs
Specific subcellular locations are used as hubs of signal transduction pathways. 
As the starting point o f signaling pathways are in defined regions of the plasma 
membrane, the active proteins initiating them are spatially restricted to a region. Thus, 
there is a relationship between localization and function of the proteins. The precise 
subcellular localisation of proteins can depend on certain protein domains and, in some 
cases, more than one domain is required for proper localisation.
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RhoGEFs are one example showing that localisation of the protein is important 
for activating a signaling pathway. It is thought that the RhoGEFs reside in the 
cytoplasm and a cue recruits them to the plasma membrane where they can activate 
Rho. If RhoGEFs reside in the cytoplasm how are they recruited to the plasma 
membrane? Are they anchored to some cellular structure until a signal comes along to 
allow their move to the plasma membrane or do they float in the cytoplasm inactive due 
to a conformational (auto)inhibition?
Here it was hypothesized that the PDZ domain of DRhoGEF2 was important for 
the targeting of the protein to the membrane. To address this question a 
DRhoGEF2APDZ construct was used in Drosophila cells and its staining pattern was 
compared with that of the wild type protein. In the absence of activation of the 
pathway, overexpressed DRhoGEF2 appeared to be distributed throughout the 
cytoplasm. The same staining was observed for the protein lacking the PDZ domain. 
Since the wild type protein in quiescent cells was found in the cytoplasm it was 
impossible to observe a variation in the localisation with the DRhoGEF2APDZ 
construct. Therefore, it might be that the signaling pathway has to be activated in order 
to observe the translocation of the protein. Recently this activation has been achieved 
by transfection with concertina (Rogers et al., 2004).
With a substantial cytosolic pool, DRhoGEF2 may be recruited to specific sites 
by interaction with different proteins. Recruitment of DRhoGEF2 to particular sites 
may result in the formation of signaling microdomains, where, depending upon the 
state of activation of its DH/PH domain, DRhoGEF2 could activate Rhol and hence 
control local actin filament rearrangements. Rogers et al., (2004) have reported that
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DRhoGEF2 associates with the growing ends of microtubules but upon activation it is 
released from the microtubules and it associates with the plasma membrane.
Is the PDZ domain of DRhoGEF2 the only possible mechanism via which 
DRhoGEF2 could associate with the plasma membrane? In fact, RhoGEFs can be 
recruited to the plasma membrane via several different domains; even if they contain a 
PDZ domain, that is not necessarily used for the shuttling of the protein to the 
appropriate site of action. For example, Tiaml is localized to the plasma membrane by 
virtue of an amino-terminally located PH domain (Michiels et al., 1997). For PDZ- 
RhoGEF the proline-rich motif next to the DH/PH domain is essential for plasma 
localization (Togashi et al., 2000). One example that the PDZ domain is used as a 
means of translocation is the mammalian PDZ containing protein called LARG. LARG 
is recruited from the cytoplasm to the plasma membrane by plexin-Bl via its PDZ 
domain (Hirotani et al., 2002; Swiercz et al., 2002).
Other RhoGEFs have PDZ recognition motifs and so are recruited to a 
subcellular localization by a PDZ containing protein as in the case of ySPIX that is 
recruited to the dendritic spines by the adaptor protein called Shank (Park et al., 2003). 
Kalirin-7 also requires its PDZ motif for positioning in dendritic spines and mutant 
Kalirin-7 lacking this motif is diffusely distributed in the cytoplasm (Penzes et al., 
2001). There is also the case of RhoGEFs that do not have a PDZ domain or a PDZ 
binding motif. These RhoGEFs are localized via adaptor proteins as for instance p i90 
RhoGEF that is probably recruited to subcellular complexes by the adaptor protein JIP- 
1 (JNK interacting protein-1) (Meyer et al., 1999). One of the homologues of 
DRhoGEF2, the mammalian pll5RhoGEF that does not bear a PDZ domain, is
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recruited to the plasma membrane by its RGS and PH domain upon stimulation of the 
receptor (Bhattacharyya and Wedegaertner, 2003).
Similarly, DRhoGEF2 could be recruited to the plasma membrane via another 
domain. In fact it has other than the PDZ domain two more domains the PH, and the Cl 
domain which could be involved in the localization or attachment of proteins to the 
plasma membrane. The PH domain binds to phosphatidylinositol (Lemmon et al., 1996) 
and the Cl domain binds to membrane lipids also such as phosphatidylinositol 3- 
phosphate (Haijes et al., 2006). Thus these domains by binding to lipid molecules could 
contribute to the membrane association of DRhoGEF2. Some RhoGEFs bind to 
phospholipids via the PH domain with low affinity and little specificity, which implies 
that these interactions are insufficient for membrane localization (Snyder, et al., 2001). 
Therefore it is possible that these domains synergize for the correct positioning of the 
protein as on their own are not able to provide a strong link to the plasma membrane. 
One domain might be necessary for the targeting to the plasma membrane and another 
domain might be necessary for the fine localization and retention to a precise 
membrane site.
Future work would have to include analysis of a series of epitope-tagged 
DRhoGEF2 derivatives deleted for the specific domains. This has to be tested in cells 
transfected with concertina as it has been shown that concertina causes the release of 
DRhoGEF2 from the microtubule tips allowing its association with the plasma 
membrane (Rogers et al., 2004). Because the protein might be localized in plasma 
membrane microdomains an immunogold electron microscopy analysis is necessary for 
more accurate results.
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Moreover, PDZ containing proteins are crucial in the generation of signaling 
complexes at cellular membranes (Fanning and Anderson, 1999). DRhoGEF2, through 
an interaction with other proteins could recruit additional proteins to these complexes. 
It is possible therefore that the PDZ domain is not involved in the subcellular 
localization of DRhoGEF2. Instead it could be important for the localization of an 
upstream component as for example the receptor. Another possibility is that the PDZ 
domain could play a role in transporting the target of DRhoGEF2. Activation of certain 
G protein coupled receptors causes translocation of Rhol from the cytoplasm to the 
membrane (Fleming et al., 1996; Kranenburg et al., 2001). Therefore, one critical step 
in the activation of Rhol signaling pathway is probably to bring the RhoGEF in close 
proximity to Rhol at specific sites of the plasma membrane. It has been recently shown 
that DRhoGEF2 recruits Rhol to the cellularization front (Barmchi et al., 2005). It 
would be very interesting to use DRhoGEF2 mutants for the PDZ domain to test 
whether DRhoGEF2 is still able to localize Rhol.
4. Role of the PDZ domain for the function of DRhoGEF2
The PDZ domain-mediated interaction between RhoGEF and another molecule 
may play an important role in the regulation of the GEF activity. For instance the PDZ 
domains of the mammalian PDZ-RhoGEF and LARG interact with the C-terminus of 
Plexin-Bl and the insulin-like growth factor (IGF-1) receptor (Taya et al., 2001; 
Hirotani et al., 2002; Swiercz et al., 2002; Perrot, et al., 2002; Aurandt et al., 2002; 
Driessens et al., 2002). This interaction is necessary for the activation of Rhol upon
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stimulation of the receptor with the ligand suggesting a role for this PDZ-mediated 
interaction in the regulation of the GEF activity.
This study also examined whether the PDZ domain acts as a positive or negative 
regulator for the function of DRhoGEF2. Overexpression of DRhoGEF2 in S2R+ cells 
caused their rounding. PDZ-RhoGEF when overexpressed in Swiss3T3 and MDCKII 
cells causes the cell rounding as well (Togashi et al., 2000). Similarly overexpression of 
p i90 RhoGEF (specific activator for Rhol) in N1E-115 cells results in neurite 
retraction and cell rounding (Gebbink et al., 1997). DRhoGEF2APDZ overexpression 
did not inhibit nor enhanced the cell rounding observed after overexpression of the wild 
type construct. This could indicate that the PDZ domain is not involved in the effects of 
DRhoGEF2 on the actin cytoskeleton. Deletion of the PDZ domain of PDZ-RhoGEF 
also did not show any demonstrable effects on the ability of PDZ-RhoGEF to induce 
Rho-dependent pathways (Fukuhara et al., 1999). Similarly, deletion of the PDZ was 
shown not to affect the biological activities of the Racl exchange factor Tiaml 
(Michiels et al., 1997).
The role of the PDZ domain for the function of DRhoGEF2 was also studied 
using transgenic flies. In contrast to the results obtained from the tissue culture studies, 
experiments using transgenic flies showed that the PDZ domain does have a significant 
role. Overexpression of DRhoGEF2 in the eye and wings caused a rough eye effect and 
a malformation of the wings, when its expression was programmed to these specific 
tissues. These effects might be due to the fact that an increase in cellular concentration 
of DRhoGEF2 when overexpressed causes an increased activation of Rhol. On the 
other hand overexpression of the protein lacking the PDZ domain did not have these
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effects. These results indicate that the PDZ domain could act as a positive regulator for 
the function of DRhoGEF2. Since the PDZ domain is essential for the overexpression 
effects this suggests the PDZ domain is required for Rhol activation. If that is the case 
there are two possibilities how that might occur: 1) DRhoGEF2 might be an 
intermediate between Fog receptor and Rhol activation, or 2) DRhoGEF2 might be an 
intermediate between another molecule (from another signaling pathway) and Rhol 
activation.
For instance DRhoGEF2 could be interacting with the fog receptor (Fig. 6.1). 
When DRhoGEF2 is overexpressed more protein can interact with the receptor; 
therefore the signal is amplified which leads to a Rhol overactivation. On the other 
hand if DRhoGEF2 cannot bind to the receptor because it lacks the PDZ domain then 
the upstream signal cannot be amplified. Furthermore, let’s set two assumptions:
a) Concertina antagonizes DRhoGEF2- that is DRhoGEF2 could act as a GAP for 
Concertina (a G ai2 homolog). This could happen because DRhoGEF2 bears an 
RGS like domain and RGS domains have been shown to stimulate GTP hydrolysis 
of Ga subunits (Berman et al., 1996; Popov et al., 1997). In addition, there is 
evidence that the mammalian p i 15RhoGEF acts as a GAP for G an  (Kozasa et al., 
1998).
b) DRhoGEF2 interacts with the Fog receptor via the PDZ domain and this interaction 
is necessary for the Fog-induced Rhol activation.
Overexpressing only the PDZ domain would turn on the signaling pathway, thus Fog 
could overactivate Concertina. DRhoGEF2 not being overexpressed could not 
compensate for the Concertina overactivation because it would not be in sufficient
190
Chapter 6: Discussion
levels to turn off Concertina in a feedback loop. If no Rhol activation is occurring that 
would indicate that DRhoGEF2 is an intermediate between Fog and Rhol activation.
Alternatively overexpression of DRhoGEF2 entails by itself an amplified signal. 
When PDZ domain is missing the binding partner cannot transduce the amplified signal 
downstream in order to influence the activation or the effects of Rhol. Therefore the 
signal passing through the PDZ domain is necessary for the function of DRhoGEF2.
The activity of DRhoGEF2 has to be tightly regulated in order to achieve the 
right activation levels for Rhol. The multidomain nature of DRhoGEF2 provides 
elements for its strict regulation. Each structural element may be assigned with a 
positive or negative role for the fine tuning of the RhoGEF activation at each stage of 
the pathway it participates. The closely related to the Drosophila DRhoGEF2, PDZ- 
RhoGEF was shown to interact with the G otland G an  subunits and that this 
interaction was mediated by the RGS domain of PDZ-RhoGEF that acts as a negative 
regulator limiting the extent of activation by the Ga subunit (Fukuhara et al., 1999). It is 
possible that the RGS domain of DRhoGEF2 has the same function when it interacts 
with Concertina. It is tempting to speculate that the PDZ domain of DRhoGEF2 acts as 
a positive regulator for the transduction of the signal at the beginning of the pathway 
instead RGS is needed to damp the intensity of the signal in a subsequent stage (Fig. 
6 .1).
Future work to explore the biochemical specificity of DRhoGEF2 and the 
relative contribution of each structural domain needs to include expression plasmids for 
epitope-tagged forms of wild type and truncated DRhoGEF2 mutants.
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Figure 6.1: Model of the regulation of the Rhol signaling pathway by DRhoGEF2.
In a first step PDZ domain of DRhoGEF2 acts as a positive regulator for the function of 
DRhoGEF2 possibly by an interaction with the receptor Fog and in a second step the 
RGS domain through a possible interaction with Concertina acts as a negative one to 
attenuate the intensity of the signal.
5. PDZ domain of DRhoGEF2: One Versus Multiple targets
Rho GTPases mediate the transduction of extracellular signals that lead to actin 
rearrangements. However, the mechanism by which they cause cytoskeletal 
modifications is not completely understood. Regulated reorganization of the actin 
cytoskeleton is required for precise cell shape changes that occur during morphogenesis 
(Sullivan and Therkauf, 1995).
DRhoGEF2 functions as a Rhol specific activator and is an important mediator 
of the cell shape changes observed during embryogenesis. In addition, there is some 
evidence suggesting that DRhoGEF2 may regulate specific aspects of Rhol function 
(Nikolaidou and Barrett, 2004). However it is not known how the GEF activity of 
DRhoGEF2 is controlled. DRhoGEF2 has various domains therefore potentially can be
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regulated by multiple upstream signals. Evidence supporting control through multiple 
signaling pathways comes from experiments on Drosophila embryogenesis. It has been 
shown that DRhoGEF2 is required for the well orchestrated cell shape changes during 
gastrulation (Barrett, 1997; Hacker and Perrimon, 1998). The fact that the phenotypic 
changes offog  or eta embryos are not as severe as that of DRhoGEF2 embryos (Barrett 
et al., 1997) indicates the requirement for additional signals that work together with 
DRhoGEF2. One possibility for how these signals are coming into and out of 
DRhoGEF2 is via its PDZ domain.
The aim of this project was to explore the association of DRhoGEF2 with 
DMec2 via the PDZ domain and test whether DMec2 could be the transducer of one of 
these missing signals. As a first approach, it was tested if DMec2 expressed in 
Drosophila cells could associate with the PDZ domain of DRhoGEF2 obtained as a 
recombinant protein from bacteria. As determined by co-immunoprecipitation the two 
associated through the carboxy terminal of DMec2. The PDZ domain of DRhoGEF2 is 
classified as class I, selecting peptides with a hydroxyl amino acid at position -2
(Songyang et al., 1997). The class I PDZ domains interacts preferentially with the C-
/
terminal amino acid sequence (S/T)X(V/I/L) (X representing any amino acid), and bind 
to the peptides that terminate in a hydrophobic amino acid such as Val, lie, or Leu. 
Because the three amino acids of the C terminus of DMec2 are TNL, the finding here is 
consistent with this prediction. Co-immunoprecipitation experiments using a two amino 
acid mutated form of the PDZ domain binding loop showed a less efficient association 
with the DMec2 than with the wild type sequence, indicating a specific interaction 
between DMec2 and the PDZ domain of DRhoGEF2. Future work to explore better the
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binding of DMec2 with the PDZ domain of DRhoGEF2 will have to include full length 
DRhoGEF2 and the DRhoGEF2APDZ obtained from cell lysates after co-transfection 
with DMec2. Furthermore, in order to test in greater detail the specificity of the 
interaction several similar PDZ-containing proteins will have to be included. In 
addition, to test better the affinity of the interaction, future studies will have to include 
experiments of isothermal titration calorimetry which is a method used to quantify the 
binding affinity between two proteins if there is a change in enthalpy upon binding of 
the two partners. This experiment is carried out by a stepwise injection of one protein in 
solution into a cell containing the solution of the binding partner. When the two 
proteins interact heat is released or absorbed in direct proportion of the proteins’ molar 
ratio.
To test whether this binding had a functional consequence, the effect of an 
interaction between DMec2 and DRhoGEF2 on the actin cytoskeleton of Drosophila 
cells was examined. Overexpression of DRhoGEF2 in S2 cells caused the cells to 
round. When DRhoGEF2 was co-expressed with DMec2 the phenotype was not 
enhanced nor inhibited. This might be interpreted as showing that DRhoGEF2-DMec2 
interaction is unimportant however much more needs to be known before that 
conclusion can be accepted. It might be that other factors are needed for the two 
proteins to cause an effect. The nature of these factors needs further investigation. For 
instance, it might be that DMec2 has to be activated before the two proteins can come 
together in the cell. It might be that after the interaction occurs there are other 
downstream targets in addition that cause an effect on the actin cytoskeleton. Another 
possibility is that the interaction between DMec2 and DRhoGEF2 does not have an
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effect on the actin cytoskeleton. DMec2 might just be creating the right structural 
environment for the attachment o f DRhoGEF2 to the plasma membrane. Another 
explanation might be that overexpression of DRhoGEF2 causes such a dramatic change 
in the cell shape that the effects of another protein cannot be observed.
An additional approach was undertaken in order to test if the two genes interact. 
Transgenic flies overexpressing in the eye or wing wild type DRhoGEF2 showed 
phenotypic changes in those organs and high lethality levels. Overexpression of DMec2 
alone did not seem to have an effect in the eye, wing or lethality levels. If DMec2 had a 
synergistic or inhibitory effect to the function of DRhoGEF2 then when put together 
with DRhoGEF2 it should enhance or suppress the phenotype. However, in this study 
overexpression of DMec2 did not seem to influence the effects of DRhoGEF2 
overexpression. This could mean that the two genes do not interact.
The yeast-two-hybrid assay used to find interacting partners for the PDZ 
domain of DRhoGEF2 revealed two more potential candidates which have not been 
either confirmed or excluded yet. In addition, there is another possible interaction 
between the PDZ domain and a protein called T48 whose function is as yet unknown 
(Maria Leptin, unpublished data). And there could also be the possibility that none of 
these interactions is really happening in vivo and there could be other candidates that 
are missed out. For instance the PDZ domain could interact directly with the receptor 
fog.
One question that arises from the indication that there are several potential 
binding partners is whether it is possible that all of these candidates are actually 
interacting with the PDZ domain of DRhoGEF2. One possibility is that they could be
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interacting at different times and/or tissues or different subcellular locations. An 
example where PDZ-containing protein binds to several partners is the mammalian 
RhoGEF called LARG. LARG binds to the carboxy terminus of plexin-Bl receptor 
(Hirotani et al., 2002), LPA receptor (Yamada et al., 2005), and IGF-1 receptor (Taya 
et al., 2001). However such alternative binding seems less likely for DRhoGEF2.
DRhoGEF2 is ubiquitously expressed but it seems to have a specialized 
function. If DRhoGEF2 has such a specialized function it is quite unlikely to have 
several binding partners for its PDZ domain. One argument in support of this is the 
conservation of this signaling pathway in processes with similar outcomes even if they 
happen in different tissues. For example, DRhoGEF2 is involved in processes that 
require the contraction of actomyosin rings such as epithelial folding occurring in 
gastrulation (Barrett et al., 1997), and also in imaginal disc development and in salivary 
gland formation (Nikolaidou and Barrett, 2004). In all these processes Fog and 
Concertina are used as upstream components of a pathway leading to DRhoGEF2 and 
Rhol (Nikolaidou and Barrett, 2004). Since DRhoGEF2 has to control the activation of 
Rhol for this purpose alone DRhoGEF2 itself has to be tightly regulated and 
promiscuous interactions for its PDZ domain could not be afforded. Thus, two of these 
possible interacting partners have to be eliminated and just one has to be the bona fide  
partner in this particular pathway that leads to the aforementioned changes of the actin 
organisation. This is not to say that there cannot exist another partner for DRhoGEF2 
that might be involved in the activation of Rhol for other purposes such as regulation 
of the cytoskeleton during another process (i.e. mitosis).
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6. Studying Biomechanics in vivo
In the beginning of this study it was hypothesized that a link between 
mechanotransduction and the DRhoGEF2 signalling pathway could be established (See 
Introduction). This was based solely on the fact that DRhoGEF2 physically interacted 
with DMec2, a protein whose homologue in C. elegans is known to be involved in the 
transduction of mechanical signals caused by an external force. Therefore, it was hoped 
to study the influence of forces on the function of DRhoGEF2 during gastrulation. This 
hypothesis prompted the study of how to approach this objective. Here, I describe one 
developmental process-dorsal closure- on which the role of forces has been studied, in 
order to set the problem, and explain the variables that can be studied. I then draw 
parallels with gastrulation to explain whether this study is feasible or not.
Several questions arise regarding the study of biomechanics. Is it possible that a 
developing tissue has mechanical properties and is it possible that such properties might 
contribute to forces for morphogenesis? In other words, during developmental 
processes is there a change in the equilibrium of forces that hypothetically define the 
cell architecture or tissue integrity that can generate a resultant force of enough 
magnitude that can be harnessed by the cytoskeleton?
One example suggesting that such a possibility could occur in nature comes 
from studies during dorsal closure in Drosophila (Kiehart et al., 2000; Hutson, et al., 
2003). During this process the surface of the embryo is under intrinsic tension and 
multiple forces are contributing to its completion (Kiehart et al., 2000). These forces 
are generated by a wave of constrictions at the leading edge of the lateral epidermis and 
by a tension in the amnioserosa (the membrane that covers the hole) (Kiehart et al.,
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2000). These forces can contribute to the movement of the leading edge of the lateral 
epidermis toward the dorsal midline to close the hole. However what is required for the 
completion of the process (zippering stage) is the opposing force generated by an 
anisotropic (discontinuous/not uniform within the tissue) tension in the lateral 
epidermis (Kiehart et al., 2000). Overall, dorsal closure is characterised by a set of 
cellular processes that generate forces with a contribution to the event.
Is this the only developmental event during which forces have such an explicit 
role? Is it plausible that Drosophila gastrulation could be seen as a biomechanical 
process? If yes, would that imply that the individual proteins required to carry out this 
process could be influenced by forces?
Comparably to the dorsal closure, the main event in gastrulation is movement. 
There are four central movements that make the cell rearrangements during 
gastrulation: 1) epithelial bending, 2) rearrangements of cells within the plane of 
epithelia 3) delamination of single cells as well as of whole epithelia for epithelial- 
mesenchymal transitions, and 4) cell migration of single or group of cells.
During epithelial bending the invaginating cells constrict their apical 
circumference induced by actomyosin networks (Dawes-Hoang et al., 2005), causing 
the cells to become wedge-shaped. This cell shape change draws the sheet of cells 
inward at that point as long as the cells are attached to each other. In theory, this stage 
could be thought of as driven mainly by contraction forces. In a mechanical model for 
the morphogenetic folding of embryonic epithelia based on hypothesised mechanical 
properties of the cellular cytoskeleton, a wave of constrictions is triggered by a single 
cell at the centre of the future furrow, making the initial constriction (Odell et al.,
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1981). Since the cells are thought to be joined to each other the initial constriction 
causes a propagating contraction which is sufficient to cause invagination of the 
embryonic epithelia. However, this does not seem to happen in nature. Instead it 
appears that cells constrict autonomously under the genetic control of fate-determining 
transcription factors. More precisely, the cell shape changes associated with ventral 
furrow formation by a small number of constricting cells depend on the transcription 
factors Snail and Twist, and single wild type cells in a snail twist mutant mesoderm are 
able to undertake the typical shape rearrangements independently of the neighbouring 
mutant cells that remain unchanged (Leptin and Roth, 1994). Thus during apical 
constriction there is the generation of intrinsic forces rather than extrinsic ones. In 
addition DRhoGEF2 function may not be essential for the generation of contractile 
force, but rather for regulating the temporal and spatial coordination of actomyosin 
contractility (Barmchi et al., 2005). Therefore it is rather difficult to make a link 
between DRhoGEF2 and physical forces.
During the subsequent movements such as cell intercalation, epithelial to 
mesenchymal transition as well as cell migration DRhoGEF2 has not been shown to 
play a role.
In order to study the contribution of forces during morphogenesis there has to be 
a tensional force generated in the actin cytoskeleton which is opposed by another tissue 
or by the extracellular matrix in order to feedback to alter the cell form. The 
hypothetical mechanotransduction machinery is thought to be composed of two anchors 
(See Introduction): the extracellular matrix/integrins and the microtubule/actin 
cytoskeleton. Are these components put in place in the gastrulating Drosophila
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embryo? The extracellular matrix and its receptors, have been found to play no role in 
gastrulation movement, as they are expressed only after gastrulation (Leptin, 2005). Ion 
channels are also components of another model of mechanotranduction machinery. In 
C. elegans Mec2 interacts with members of the DEG/ENaC channels involved in 
mechanosensation (Goodman et al., 2002). In Drosophila one member of this family 
called ripped pocket (RPK) is expressed in early stage (0-3 h) embryos-much before 
gastrulation- but it is not present in later stages of embryogenesis and it has not been 
implicated in mechanosensation (Adams et al., 1998). Other members called pickpocket 
(PPK) are expressed much later in development in the sensory dendrites of a subset of 
peripheral neurons of late stage embryos and early larvae (Adams et al., 1998).
In conclusion, the system to be used in order to study how tension that arises 
within a tissue, generates a force which is transduced across and harnessed by the 
cytoskeleton during a morphogenetic event has to be carefully chosen. For example the 
sea urchin embryo is an appropriate model to study the mechanics of epithelial 
invagination because mechanical properties can be attributed to its filamentous 
cytoskeleton, the cell-cell junctional complexes and adhesion sites between cells and 
the extracellular matrix with traceable roles in morphogenesis (Davidson et al., 1999).
In order to study forces during a morphogenetic event first it has to be 
established that there is a relative tension/stiffness between at least two contiguous 
tissues. Secondly, the cellular structures responsible for this tension can be identified by 
disrupting their assembly for instance by using cytochalasin D to disrupt the actin, 
nocodazole to disrupt the microtubule network and glycine extraction to disrupt the
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extracellular matrix. Subsequently, the tension can be released for example by 
photoablation in order to identify from where the endogenous forces emanate.
7. Conclusion
The appropriate response to an extracellular stimulus is dependent on the 
intensity and duration of the signal. Regulation of the Rhol signalling occurs at 
multiple levels, including the receptor, the G protein, the GEF and the effector. In 
addition the specificity of the signal might be due to the restricted expression of a 
ligand that initiates the response.
The observations made in this study suggest that the PDZ domain may mediate 
an interaction between DRhoGEF2 and its partner to play an important role in the 
regulation of the GEF activity. The mechanism by which this domain regulates the 
function of the protein is not clear. DRhoGEF2 might be at the crossroad of various 
pathways integrating different signals or it might be acting in a feedback loop. It still 
remains an open question an important aspect of the DRhoGEF2 regulation: if and how 
it is localised to the plasma membrane. Further studies will follow to identify the 
missing players from the Rhol signalling pathway.
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